{
  "54347-0": {
    "loincCode": "54347-0",
    "context": "mically created name that is unique for each LOINC term. When specific LOINCs are referenced, they are presented as the LOINC number and FSN followed by the LCN. For example: 54347-0 Albumin:SCnc:Pt:Ser/Plas:Qn: LCN: Albumin [Moles/Vol] in Serum 1.3.3 Tall Man Casing LOINC Components are not case-sensitive. However, some LOINCs, typically those containing",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "43863-0": {
    "loincCode": "43863-0",
    "property": "desired. As another example",
    "context": "shorter list of candidate terms. Which LOINC term is most appropriate? Notice that your test name specifies 24H timing. With this information, you can feel confident that 43863-0 Benzthiazide [Presence] or 3401-7 Benzthiazide [Mass/time] is the best LOINC for your test, depending on the test property desired. As another example, if you are mapping a t",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "3401-7": {
    "loincCode": "3401-7",
    "property": "desired. As another example",
    "system": "of",
    "context": "Which LOINC term is most appropriate? Notice that your test name specifies 24H timing. With this information, you can feel confident that 43863-0 Benzthiazide [Presence] or 3401-7 Benzthiazide [Mass/time] is the best LOINC for your test, depending on the test property desired. As another example, if you are mapping a test named “Benzthiazide” system of",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "54353-8": {
    "loincCode": "54353-8",
    "property": "as well as Electrophoresis as the Method. With those two pieces of information",
    "context": "use the timing was not requested in the search. We are now left with two tests. 77342-4 is not the right one because duration is unspecified. The right choice will be mapping to 54353-8 Beta 1 globulin [Mass/volume] in Urine by Electrophoresis. 2.2 Minimum Test Information Necessary to Map Care must be taken to understand the contexts, details, specimen inform",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "77342-4": {
    "loincCode": "77342-4",
    "component": "specified as 24H because the timing was not requested in the search. We are now left with two tests. 77342-4 is not the right one because duration is unspecified. The right choice will be mapping to 54353-8 Beta 1 globulin [Mass/volume] in Urine by Electrophoresis. 2.2 Minimum Test",
    "context": "obulin urine electrophoresis, we can eliminate those with a timing component specified as 24H because the timing was not requested in the search. We are now left with two tests. 77342-4 is not the right one because duration is unspecified. The right choice will be mapping to 54353-8 Beta 1 globulin [Mass/volume] in Urine by Electrophoresis. 2.2 Minimum Test In",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "8030-9": {
    "loincCode": "8030-9",
    "property": "LOINC Scale LOINC term examples Presence/absence",
    "context": ". LOINC Mapping Guide Hematology and Serology Page 20 Type of result value LOINC Property LOINC Scale LOINC term examples Presence/absence, OR graded results PrThr Ord 8030-9 Streptococcus pneumoniae Ab: PrThr:Pt:Ser:Ord Example: Present, Absent Absence or, if present, the specific type or identity of what is present Prid Nom 34601-5 Drugs identi",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "34601-5": {
    "loincCode": "34601-5",
    "context": "ts PrThr Ord 8030-9 Streptococcus pneumoniae Ab: PrThr:Pt:Ser:Ord Example: Present, Absent Absence or, if present, the specific type or identity of what is present Prid Nom 34601-5 Drugs identified:Prid:Pt:Body fld:Nom Example: None, Amphetamine, Barbiturate, Oxycodone Identification of the type of analyte that is already known to be present Type N",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "882-1": {
    "loincCode": "882-1",
    "component": "is present in this patient 882-1 ABO and Rh group [Type] in Blood Nom Imp An overall interpretation of two or more results",
    "context": "pic observation [Identifier] in Urine by Cyto stain Nom Type The analyte is known to be present and this code answers which “type” of the component is present in this patient 882-1 ABO and Rh group [Type] in Blood Nom Imp An overall interpretation of two or more results, where the interpretation text is typically drawn from a predefined list 49316-3 Hem",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "80221-5": {
    "loincCode": "80221-5",
    "context": "f the type of analyte that is already known to be present Type Nom 882-1 ABO & Rh group:Type:Pt:Bld:Nom Example results: O pos, O neg, A pos, A neg Quantitative ACnc Qn 80221-5 N-methyl-D-aspartate receptor Ab.IgG: Titr:Pt:Ser:Qn:IF Example: 1:4 Impression/ Interpretation Imp Nom 88700-0 Babesia microti Ab.IgG & IgM:Imp:Pt:Ser:Nom: Example: Ab not",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "88700-0": {
    "loincCode": "88700-0",
    "context": "esults: O pos, O neg, A pos, A neg Quantitative ACnc Qn 80221-5 N-methyl-D-aspartate receptor Ab.IgG: Titr:Pt:Ser:Qn:IF Example: 1:4 Impression/ Interpretation Imp Nom 88700-0 Babesia microti Ab.IgG & IgM:Imp:Pt:Ser:Nom: Example: Ab not detected, Recent infection, Past infection 2.4.3.1 Quantitative Properties Quantitative Properties describe measura",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "14158-0": {
    "loincCode": "14158-0",
    "units": "were instead reported as m",
    "context": "or just MRat to the search will parry down the list significantly. Now the correct code can be identified since only one test remains that looks at “Cortisol,” that being 14158-0. You may also gain reassurance since the code has a decent rank (#7558) among the top 20,000 LOINCs used by other labs. Now let’s say that the units were instead reported as m",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "44310-1": {
    "loincCode": "44310-1",
    "property": "of ratio in mass-based units. By including “mass” and “ratio”",
    "units": "of Measure The LOINC Property can often b",
    "context": "atinine. From this, you know that this has a Property of ratio in mass-based units. By including “mass” and “ratio”, or “MRto”, into the search, the list comes down to one item: 44310-1 Cortisol/Creatinine [Mass Ratio] in 24-hour Urine which would be the correct LOINC term for the test. 2.4.3.1.3 Property and Units of Measure The LOINC Property can often b",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "21055-9": {
    "loincCode": "21055-9",
    "context": "ported as a qualitative ordinal result, quantitative viral load in copies/volume or log copies/volume, or both an ordinal result and if positive, a quantitative viral load 21055-9​ Adenovirus DNA: PrThr: Pt: Ser/​Plas: Ord: Probe.amp.tar 38375-2​ Adenovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.am",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "38375-2": {
    "loincCode": "38375-2",
    "context": "ng initial results as ordinal, followed by viral load in log copies/mL if the ordinal result is “Detected” 21055-9​ Adenovirus DNA: PrThr: Pt: Ser/​Plas: Ord: Probe.amp.tar 38375-2​ Adenovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 66723-8​ Adenovirus DNA: LnCnc: Pt: Ser/Plas: Qn: Probe.amp",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "86512-1": {
    "loincCode": "86512-1",
    "context": "g copies/mL if the ordinal result is “Detected” 21055-9​ Adenovirus DNA: PrThr: Pt: Ser/​Plas: Ord: Probe.amp.tar 38375-2​ Adenovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 66723-8​ Adenovirus DNA: LnCnc: Pt: Ser/Plas: Qn: Probe.amp.tar 66730-3​ Adenovirus DNA: LnCnc: Pt: CSF: Qn: Probe.amp",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "39528-5": {
    "loincCode": "39528-5",
    "context": "d as it results in a loss of information, and the list of codes provided by the vendor should not include the generic LOINC code when more specific ones are available (note that 39528-5 is not listed in the second column). LOINC Mapping Guide Drug and Toxicology Page 34 Adenovirus DNA PCR • Approved for serum, CSF, and urine • May be reported as a qualit",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "49338-7": {
    "loincCode": "49338-7",
    "context": "May be reported as a qualitative ordinal result or a quantitative viral load as copies/volume or log copies/volume 38375-2 Adenovirus DNA: PrThr: Pt:CSF:Ord:Probe.amp.tar 49338-7 Adenovirus DNA: NCnc: Pt:CSF:Qn:Probe.amp.tar 66730-3 Adenovirus DNA: LnCnc: Pt:CSF:Qn:Probe.amp.tar Laboratory D: result built in the LIS as an ordinal text string 38375-2 A",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "66730-3": {
    "loincCode": "66730-3",
    "context": "ovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 66723-8​ Adenovirus DNA: LnCnc: Pt: Ser/Plas: Qn: Probe.amp.tar 66730-3​ Adenovirus DNA: LnCnc: Pt: CSF: Qn: Probe.amp.tar 66719-6​ Adenovirus DNA: LnCnc: Pt: Urine: Qn: Probe.amp.tar Guide for Using LOINC Microbiology Terms ​• 90 11 Putting",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "49334-6": {
    "loincCode": "49334-6",
    "context": "rus DNA: PrThr: Pt: Ser/​Plas: Ord: Probe.amp.tar 38375-2​ Adenovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 49334-6​ Adenovirus DNA: NCnc: Pt: Ser/Plas: Qn: Probe.amp.tar 49338-7​ Adenovirus DNA: NCnc: Pt: CSF: Qn: Probe.amp.tar 48609-2​ Adenovirus DNA: NCnc: Pt: Urine: Qn: Probe.amp.t",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "48609-2": {
    "loincCode": "48609-2",
    "context": "Thr: Pt: CSF: Ord: Probe.amp.tar Laboratory H​: testing CSF and urine specimens, reporting results as copies/mL 49338-7​ Adenovirus DNA: NCnc: Pt: CSF: Qn: Probe.amp.tar 48609-2​ Adenovirus DNA: NCnc: Pt: Urine: Qn: Probe.amp.tar Laboratory I​: testing all three specimens specimens, reporting initial results as ordinal, followed by viral load in",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "66723-8": {
    "loincCode": "66723-8",
    "context": "virus DNA: PrThr: Pt: Ser/​Plas: Ord: Probe.amp.tar 38375-2​ Adenovirus DNA: PrThr: Pt: CSF: Ord: Probe.amp.tar 86512-1​ Adenovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 66723-8​ Adenovirus DNA: LnCnc: Pt: Ser/Plas: Qn: Probe.amp.tar 66730-3​ Adenovirus DNA: LnCnc: Pt: CSF: Qn: Probe.amp.tar 66719-6​ Adenovirus DNA: LnCnc: Pt: Urine: Qn: Probe.amp",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "66719-6": {
    "loincCode": "66719-6",
    "context": "ovirus DNA: PrThr: Pt: Urine: Ord: Probe.amp.tar 66723-8​ Adenovirus DNA: LnCnc: Pt: Ser/Plas: Qn: Probe.amp.tar 66730-3​ Adenovirus DNA: LnCnc: Pt: CSF: Qn: Probe.amp.tar 66719-6​ Adenovirus DNA: LnCnc: Pt: Urine: Qn: Probe.amp.tar Guide for Using LOINC Microbiology Terms ​• 90 11 Putting it all together The previous chapters provided detailed info",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6932-8": {
    "loincCode": "6932-8",
    "context": "are shown below for comparison. ​For more details, see the “OBX segments” section in Chapter 2 and/or the “Phenotypic susceptibility testing” section in Chapter 5. OBX|1|NM|​6932-8​^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN||0.05|ug/mL||S|||F|... OBX|1|CE|​6932-8​^Penicillin [Susceptibility] by Minimum inhibitory concentrat",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "81118-2": {
    "loincCode": "81118-2",
    "context": "Not detected), and laboratories using Assay B would use LA9633-4 (Present), LA11885-3 (Equivocal), and LA9634-2 (Absent). Both laboratories would map to the same LOINC term: 81118-2​ Legionella sp Ab.IgM:PrThr:Pt:Ser:Ord LCN: ​Legionella sp IgM Ab [Presence] in Serum The above LOINC term happens to be associated with ​Example​ LOINC Answer List ​LL744-4​",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "58779-0": {
    "loincCode": "58779-0",
    "component": "Long common name of Component 58779-0 Arachis hypogaea recombinant (rAra h) 1 Ab.IgE Peanut recombinant (rAra h) 1 IgE Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 6",
    "method": "by adding the word",
    "context": "ng this all together, the formal and common names of the Components for the allergen examples above become: LOINC code Formal name of Component Long common name of Component 58779-0 Arachis hypogaea recombinant (rAra h) 1 Ab.IgE Peanut recombinant (rAra h) 1 IgE Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 6",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "58777-4": {
    "loincCode": "58777-4",
    "component": "Long common name of Component 58779-0 Arachis hypogaea recombinant (rAra h) 1 Ab.IgE Peanut recombinant (rAra h) 1 IgE Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 65769-2 Arachis hypogaea native (nAra h) 1 Ab.IgE Peanut native (nAra h) 1 IgE Ab 65771-8 Ara",
    "context": "s above become: LOINC code Formal name of Component Long common name of Component 58779-0 Arachis hypogaea recombinant (rAra h) 1 Ab.IgE Peanut recombinant (rAra h) 1 IgE Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 65769-2 Arachis hypogaea native (nAra h) 1 Ab.IgE Peanut native (nAra h) 1 IgE Ab 65771-8 Ara",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "65769-2": {
    "loincCode": "65769-2",
    "context": "0 Arachis hypogaea recombinant (rAra h) 1 Ab.IgE Peanut recombinant (rAra h) 1 IgE Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 65769-2 Arachis hypogaea native (nAra h) 1 Ab.IgE Peanut native (nAra h) 1 IgE Ab 65771-8 Arachis hypogaea native (nAra h) 3 Ab.IgE Peanut native (nAra h) 3 IgE Ab Keep in mind that r",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "65771-8": {
    "loincCode": "65771-8",
    "context": "Ab 58777-4 Arachis hypogaea recombinant (rAra h) 3 Ab.IgE Peanut recombinant (rAra h) 3 IgE Ab 65769-2 Arachis hypogaea native (nAra h) 1 Ab.IgE Peanut native (nAra h) 1 IgE Ab 65771-8 Arachis hypogaea native (nAra h) 3 Ab.IgE Peanut native (nAra h) 3 IgE Ab Keep in mind that related names are exactly as described; they are related to the part to which they",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "15583-8": {
    "loincCode": "15583-8",
    "property": "PrThr indicates whether an analyte is present",
    "context": "being the only Scale associated with them. The Property PrThr indicates whether an analyte is present, or the graded amount of analyte present, as seen with RAST class terms. 15583-8 Vaccinium myrtillus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord: LCN: Blueberry IgE Ab RAST class [Presence] in Serum Example answer list: 0, 1, 2, 3, 4, 5, 6 51546-0 Chicken feather",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "51546-0": {
    "loincCode": "51546-0",
    "system": "The LOINC System represents the specimen",
    "context": "class terms. 15583-8 Vaccinium myrtillus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord: LCN: Blueberry IgE Ab RAST class [Presence] in Serum Example answer list: 0, 1, 2, 3, 4, 5, 6 51546-0 Chicken feather Ab.IgG:PrThr:Pt:Ser:Ord: Chicken feather IgG Ab [Presence] in Serum Example answer list: Positive, Negative 4 System The LOINC System represents the specimen",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "94593-1": {
    "loincCode": "94593-1",
    "context": "tion of multiple allergies in a single assay and can be tailored to a set of allergens appropriate for an individual patient. At present, LOINC provides a single multiplex term, 94593-1 Multiplex allergen panel - Serum or Plasma, to use as the order for a multiplex test. This is a “naked panel,” which means it does not contain any child LOINC terms and can be u",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "447-51": {
    "loincCode": "447-51",
    "context": "ncy 4 Lin MC, Vreeman DJ, McDonald CJ, Huff SM. Correctness of Voluntary LOINC Mapping for Laboratory Tests in Three Large Institutions. AMIA Annu Symp Proc. 2010 Nov 13;2010:447-51. [PMID: 21347018] LOINC Mapping Guide Hematology and Serology Page 51 checking represents an exceptional value, even for expert mappers. (Regenstrief has yet to see a mappin",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "31073-0": {
    "loincCode": "31073-0",
    "component": "Property:Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser",
    "property": "Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser",
    "system": "Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser",
    "context": "st? (Answer options follow this model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "51786-2": {
    "loincCode": "51786-2",
    "component": "Property:Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:S",
    "property": "Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:S",
    "system": "Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:S",
    "context": "Component:Property:Timing:System:Scale:Method) Local test: HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:S",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "33807-9": {
    "loincCode": "33807-9",
    "context": ": HIV-2 Antibody - Serum - Rapid Immunoassay - Present/Absent ❏ 31073-0: HIV 2 Ab band pattern:Imp:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ✓ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:Ser/Plas:Ord:IA 81641-3 is the only term listed that matche",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "81641-3": {
    "loincCode": "81641-3",
    "component": "(HIV 2 Ab)",
    "property": "(P",
    "context": "Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ✓ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:Ser/Plas:Ord:IA 81641-3 is the only term listed that matches the Component (HIV 2 Ab), the Property (PrThr, indicating Presence or Threshold), and I (IA. rapid for Rapid Immunoassay) See Section 2 C",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "5224-1": {
    "loincCode": "5224-1",
    "component": "(HIV 2 Ab)",
    "property": "(PrThr",
    "context": "p:Pt:Ser:Nom:IB ❏ 51786-2: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA ❏ 33807-9: HIV 2 Ab.IgG:PrThr:Pt:Ser:Ord: ✓ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:Ser/Plas:Ord:IA 81641-3 is the only term listed that matches the Component (HIV 2 Ab), the Property (PrThr, indicating Presence or Threshold), and I (IA. rap",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "2839-9": {
    "loincCode": "2839-9",
    "system": "mismatch ❏ Timing diff",
    "context": "rd: ❏ 81641-3: HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid ❏ 5224-1: HIV 2 Ab:ACnc:Pt:Ser/Plas:Ord:IA 3. Why is the LOINC below a poor choice for the local test? LOINC: 2839-9: Progesterone:MCnc:Pt:Ser/Plas:Qn: Local test: Progesterone Concentration - Urine (24H) ❏ Analytes are different ❏ Properties do not align ❏ System mismatch ❏ Timing diff",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "17016-7": {
    "loincCode": "17016-7",
    "component": "Property:Timing:System:Scale:Method) Local test: Influenza Virus B Ab",
    "property": "Timing:System:Scale:Method) Local test: Influenza Virus B Ab",
    "system": "Scale:Method) Local test: Influenza Virus B Ab",
    "context": "wer options follow this model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: Influenza Virus B Ab, IgM concentration - Serum - Immunofluorescence  17016-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:  86570-9: Influenza virus B Ab.IgM:PrThr:Pt:Ser:Ord:IA  57328-7: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA  47315-7:",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "86570-9": {
    "loincCode": "86570-9",
    "component": "Property:Timing:System:Scale:Method) Local test: Influenza Virus B Ab",
    "property": "Timing:System:Scale:Method) Local test: Influenza Virus B Ab",
    "system": "Scale:Method) Local test: Influenza Virus B Ab",
    "context": "Property:Timing:System:Scale:Method) Local test: Influenza Virus B Ab, IgM concentration - Serum - Immunofluorescence  17016-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:  86570-9: Influenza virus B Ab.IgM:PrThr:Pt:Ser:Ord:IA  57328-7: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA  47315-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA  49078-9",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "57328-7": {
    "loincCode": "57328-7",
    "context": "cal test: Influenza Virus B Ab.IgM concentration - Serum - ELISA ❏ 17016-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn: ❏ 86570-9: Influenza virus B Ab.IgM:PrThr:Pt:Ser:Ord:IA ❏ 57328-7: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA ✓ 47315-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA ❏ 49078-9: Influenza virus B Ab.IgM:MCnc:Pt:CSF:Qn:IA 47315-7 i",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "47315-7": {
    "loincCode": "47315-7",
    "component": "(Influenza virus",
    "property": "(ACnc)",
    "context": "❏ 57328-7: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA ✓ 47315-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA ❏ 49078-9: Influenza virus B Ab.IgM:MCnc:Pt:CSF:Qn:IA 47315-7 is the only LOINC listed that matches the Component (Influenza virus B Ab.IgM), matches the Serum specimen, has a “concentration” Property (ACnc), and specifies an Immunoassay M",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "49078-9": {
    "loincCode": "49078-9",
    "component": "(Influenza virus B Ab.IgM)",
    "property": "(ACnc)",
    "context": "86570-9: Influenza virus B Ab.IgM:PrThr:Pt:Ser:Ord:IA ❏ 57328-7: Influenza virus B Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA ✓ 47315-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA ❏ 49078-9: Influenza virus B Ab.IgM:MCnc:Pt:CSF:Qn:IA 47315-7 is the only LOINC listed that matches the Component (Influenza virus B Ab.IgM), matches the Serum specimen, has a “concentr",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "82062-1": {
    "loincCode": "82062-1",
    "property": "(ACnc)",
    "context": "315-7: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA ❏ 49078-9: Influenza virus B Ab.IgM:MCnc:Pt:CSF:Qn:IA 6. Why is the LOINC below a poor choice for the local test? LOINC: 82062-1 - Beef+Chicken meat+Pork+Turkey meat Ab.IgE RAST class:PrThr:Pt:Ser: Local test: Beef+Poultry+Pork Allergy in Serum (Presence) ❏ Analytes are different ❏ Properties do not",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "78752-3": {
    "loincCode": "78752-3",
    "component": "Property:Timing:System:Scale:Method) Local test: Qualitative screen 11-Hydroxy delta-9 tetrahydrocannabinol in Serum or Urine  78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen  80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm  70178-9: 11-Hydroxy delta-9 tet",
    "property": "Timing:System:Scale:Method) Local test: Qualitative screen 11-Hydroxy delta-9 tetrahydrocannabinol in Serum or Urine  78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen  80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm  70178-9: 11-Hydroxy delta-9 tet",
    "system": "Scale:Method) Local test: Qualitative screen 11-Hydroxy delta-9 tetrahydrocannabinol in Serum or Urine  78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen  80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm  70178-9: 11-Hydroxy delta-9 tet",
    "context": "d either build a single test result for the specific specimen tested or a single test result to accommodate values from either specimen if testing may be performed on both. ❏ 78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen ❏ 80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm ❏ 70178-9: 11-Hydroxy delta-9 tet",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "80111-8": {
    "loincCode": "80111-8",
    "context": "test result to accommodate values from either specimen if testing may be performed on both. ❏ 78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen ❏ 80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm ❏ 70178-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Bld:Ord: ❏ 40864-1: 11-Hydroxy delta-9 tetrahydrocann",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "70178-9": {
    "loincCode": "70178-9",
    "context": "performed on both. ❏ 78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Body fld:Ord:Screen ❏ 80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm ❏ 70178-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Bld:Ord: ❏ 40864-1: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Ser/Plas:Qn: ❏ 80112-6: 11-Hydroxy delta-9 tetrahydrocannab",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "40864-1": {
    "loincCode": "40864-1",
    "context": "ol:PrThr:Pt:Body fld:Ord:Screen  80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Bld:Qn:Confirm  70178-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Bld:Ord:  40864-1: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Ser/Plas:Qn:  80112-6: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Body fld:Qn:Confirm  78753-1: 11-Hydroxy delta-9 tetrahydr",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "80112-6": {
    "loincCode": "80112-6",
    "context": "cannabinol:MCnc:Pt:Bld:Qn:Confirm ❏ 70178-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Bld:Ord: ❏ 40864-1: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Ser/Plas:Qn: ❏ 80112-6: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Body fld:Qn:Confirm ✓ 78753-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Ser/Plas:Ord:Screen ❏ 48934-4: 11-Hydroxy delta-9",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "78753-1": {
    "loincCode": "78753-1",
    "method": "(screen) and Systems (Serum or Urine) of the two ways the IVD assay may be LOINC Mapping Guide Allergy Page 60",
    "context": "nnabinol:PrThr:Pt:Bld:Ord: ❏ 40864-1: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:Ser/Plas:Qn: ❏ 80112-6: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Body fld:Qn:Confirm ❏ 78753-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Ser/Plas:Ord:Screen ❏ 48934-4: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:XXX:Qn: ❏ 78754-9: 11-Hydroxy delta-9 tetrahydr",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "48934-4": {
    "loincCode": "48934-4",
    "context": "c:Pt:Ser/Plas:Qn: ❏ 80112-6: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Body fld:Qn:Confirm ❏ 78753-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Ser/Plas:Ord:Screen ❏ 48934-4: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:XXX:Qn: ❏ 78754-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Urine:Ord:Screen ❏ 48935-1: 11-Hydroxy delta-9 tetrahydrocan",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "78754-9": {
    "loincCode": "78754-9",
    "method": "(screen) and Systems (Serum or Urine) of the two ways the IVD assay may be LOINC Mapping Guide Allergy Page 60 resulted",
    "context": "l:MCnc:Body fld:Qn:Confirm ❏ 78753-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Ser/Plas:Ord:Screen ❏ 48934-4: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:XXX:Qn: ❏ 78754-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Urine:Ord:Screen ❏ 48935-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:XXX:Ord: ❏ 78751-5: 11-Hydroxy delta-9 tetrahydroc",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "48935-1": {
    "loincCode": "48935-1",
    "property": "to the unit Property",
    "units": "Property",
    "context": "e reported in the same manner for both (i.e. there is no capability to set up the assay differently on the instrument for the different specimen types), there may be cases where 48935-1: 11- Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:XXX:Ord: also needs to be provided by the IVD vendor. The LIS build may have a single result for Qualitative screen 11- Hydroxy",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "78751-5": {
    "loincCode": "78751-5",
    "property": "to the unit Property Answer Unit A MCnc Example: A-3 1 log copies/mL B NFr 2 mg/d C SCn",
    "method": "(screen) and Systems (Serum or Urine) of the",
    "units": "Property Answer Unit A MCnc Example: A-3 1 log copies/mL B NFr 2 mg/d C SCn",
    "context": "ocannabinol:MCnc:Pt:XXX:Qn: ✓ 78754-9: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:Urine:Ord:Screen ❏ 48935-1: 11-Hydroxy delta-9 tetrahydrocannabinol:PrThr:Pt:XXX:Ord: ❏ 78751-5: 11-Hydroxy delta-9 tetrahydrocannabinol:MCnt:Pt:Hair:Qn: 78753-1 and 78754-9 are the only two terms listed that match the Method (screen) and Systems (Serum or Urine) of the",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "642-650": {
    "loincCode": "642-650",
    "context": "ng are popular citations. ● Abhyankar S, Demner-Fushman D, McDonald CJ. Standardizing clinical laboratory data for secondary use. Journal of biomedical informatics. 2012;45(4):642-650. doi:10.1016/j.jbi.2012.04.012. [PMID: 22561944] ● Vreeman DJ, Hook J, Dixon BE. Learning from the crowd while mapping to LOINC. J Am Med Inform Assoc. 2015;22(6):1205-11. doi:",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "1205-11": {
    "loincCode": "1205-11",
    "context": "45(4):642-650. doi:10.1016/j.jbi.2012.04.012. [PMID: 22561944] ● Vreeman DJ, Hook J, Dixon BE. Learning from the crowd while mapping to LOINC. J Am Med Inform Assoc. 2015;22(6):1205-11. doi: 10.1093/jamia/ocv098. [PMID: 26224334] ● Kim H, El-Kareh R, Goel A, Vineet F, Chapman WW. An Approach to Improve LOINC Mapping through Augmentation of Local Test Names. Jo",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "651-657": {
    "loincCode": "651-657",
    "system": "intended to include all units of measu",
    "units": "of Measure (UCUM) is a code system intended to include all units of measu",
    "context": "● Kim H, El-Kareh R, Goel A, Vineet F, Chapman WW. An Approach to Improve LOINC Mapping through Augmentation of Local Test Names. Journal of biomedical informatics. 2012;45(4):651-657. doi:10.1016/j.jbi.2011.12.004. [PMID: 22210167] 3.3 Mapping RELMA is the Regenstrief LOINC Mapping Assistant, a Windows application to assist with the association of your loca",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6841-1": {
    "loincCode": "6841-1",
    "component": "Number Compone nt Mnemonic Component Name Pre LOINC Mapping Post LOINC Mapping Example Allergen",
    "context": "st Name Component Number Compone nt Mnemonic Component Name Pre LOINC Mapping Post LOINC Mapping Example Allergen, Food, Grape 55015 Grape Allergen, Food, Grape IgE 6841-1 Grape IgE Ab [Units/volume] in Serum 6841-1G rape IgE Ab [Units/volume] in Serum 0055381 Allergen, Food, Egg Whole 55381 Egg Whole Allergen, Food, Egg Whole IgE 7291-8D",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "7291-8": {
    "loincCode": "7291-8",
    "context": "lume] in Serum LOINC Mapping Guide Allergy Page 68 Answers to examples Test Number ARUP Current State Reason for mismatch Answers/Comments Example 0055381 7291-8 Allergen codes are included as related names linked to the appropriate LOINC Components. 55151 6034-3 To reduce ambiguity, LOINC uses the Latin name of the species of th",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6034-3": {
    "loincCode": "6034-3",
    "component": "part of the fully specified name. The common",
    "context": "t State Reason for mismatch Answers/Comments Example 0055381 7291-8 Allergen codes are included as related names linked to the appropriate LOINC Components. 55151 6034-3 To reduce ambiguity, LOINC uses the Latin name of the species of the biological substance that causes the allergy in the Component part of the fully specified name. The common",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "37989-1": {
    "loincCode": "37989-1",
    "component": "with the allergens separated by a ‘+’. 98641 7248-8 Some",
    "context": "OINC Long Common Name, Display Name, and other term names. In addition, most LOINC Parts have associated synonyms that are assembled into a list called “Related Names”. 55368 37989-1 To clearly represent combinations, the set of allergens tested are enclosed in parenthesis in the LOINC Component with the allergens separated by a ‘+’. 98641 7248-8 Some",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "7248-8": {
    "loincCode": "7248-8",
    "component": "with the allergens separated by a ‘+’. 98641 7248-8 Some plants have more than one type of allergen",
    "context": "55368 37989-1 To clearly represent combinations, the set of allergens tested are enclosed in parenthesis in the LOINC Component with the allergens separated by a ‘+’. 98641 7248-8 Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 55078 6087-1 Some plants have",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6087-1": {
    "loincCode": "6087-1",
    "context": "by a ‘+’. 98641 7248-8 Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 55078 6087-1 Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 97658 35534-7 Not in the guide",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "35534-7": {
    "loincCode": "35534-7",
    "component": "To clearly represent combinations",
    "context": "same tree. 55078 6087-1 Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 97658 35534-7 Not in the guide - IgE vs IgG 55037 31161-3 incorrect component To clearly represent combinations, the set of allergens tested are enclosed in parenthesis in the LOINC Compo",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "31161-3": {
    "loincCode": "31161-3",
    "component": "To clearly represent combinations",
    "context": "e than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 97658 35534-7 Not in the guide - IgE vs IgG 55037 31161-3 incorrect component To clearly represent combinations, the set of allergens tested are enclosed in parenthesis in the LOINC Component with the allergens separated by a ‘+’. 5",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "25801-2": {
    "loincCode": "25801-2",
    "component": "To clearly represent combinations",
    "context": "rrect component To clearly represent combinations, the set of allergens tested are enclosed in parenthesis in the LOINC Component with the allergens separated by a ‘+’. 50147 25801-2 Not in the guide - specificity of choosing the correct variant of an organism 98617 6136-6 Some plants have more than one type of allergen, for example, IgE antibodies can",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6136-6": {
    "loincCode": "6136-6",
    "component": "with the allergens separated by a ‘+’. 50147 25801-2 Not in the guide - specificity of choosing the correct variant of an organism 98617 6136-6 Some plants have more than one type of allergen",
    "context": "n organism 98617 6136-6 Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 93506 6136-6 incorrect component Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 2007211 6206-7",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "6206-7": {
    "loincCode": "6206-7",
    "component": "Some plants have more than one type of allergen",
    "context": "6136-6 incorrect component Some plants have more than one type of allergen, for example, IgE antibodies can develop towards tree pollen and the fruit of the same tree. 2007211 6206-7 The Long Common Name will use the common name of that entity, e.g., Peanut, if one exists. In the case of very well specified allergens, the Component will also indicate whe",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "58778-2": {
    "loincCode": "58778-2",
    "method": "by adding the word",
    "context": "nt will also indicate whether the allergen has a natural source or has been generated via recombinant method by adding the word, native or recombinant, respectively. 2007211 58778-2 We insert standard acronym names used by most allergen manufacturers as synonyms.These begin with lower case \"n\" or \"r\" to distinguish native from recombinant allergens follow",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "64965-7": {
    "loincCode": "64965-7",
    "context": "\"r\" to distinguish native from recombinant allergens followed by the first 3 letters of the genus (in Latin), a space and the first letter of the species (in Latin). 2007211 64965-7 We insert standard acronym names used by most allergen manufacturers as synonyms.These begin with lower case \"n\" or \"r\" to distinguish native from recombinant allergens follow",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "63477-4": {
    "loincCode": "63477-4",
    "context": "\"r\" to distinguish native from recombinant allergens followed by the first 3 letters of the genus (in Latin), a space and the first letter of the species (in Latin). 2007211 63477-4 We insert standard acronym names used by most allergen manufacturers as synonyms. These begin with lower case \"n\" or \"r\" to distinguish native from recombinant allergens follo",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "90880-6": {
    "loincCode": "90880-6",
    "context": "\"r\" to distinguish native from recombinant allergens followed by the first 3 letters of the genus (in Latin), a space and the first letter of the species (in Latin). 2007211 90880-6 We insert standard acronym names used by most allergen manufacturers as synonyms. These begin with lower case \"n\" or \"r\" to distinguish native from recombinant allergens follo",
    "sourceFile": "LOINC-Mapping-Guide-Allergy-Version-1.0.pdf"
  },
  "80699-2": {
    "loincCode": "80699-2",
    "context": "he following term is used to report the percent of cells that do not express CD4 or CD8 out of a population of cells that express CD3 and T-cell receptor (TCR) alpha and beta: 80699-2 CD4-CD8-/100 CD3+TCR alpha beta+ cells in Blood However, in some cases the parent population may vary depending on the clinical context and/or the laboratory, so we also have",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "32760-1": {
    "loincCode": "32760-1",
    "context": "d/or the laboratory, so we also have newer terms that have 100 cells as the Divisor. For these, we recommend reporting the parent cell population using a separate LOINC term: 32760-1 Cell type in Unspecified specimen 2.5 Cytoplasmic Markers Most available markers are surface markers. Because they are the most prominent, they are not labeled as such. Cytopla",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "8112-5": {
    "loincCode": "8112-5",
    "component": "Property:Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-C",
    "property": "Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-C",
    "system": "Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-C",
    "context": "test? (Answer options follow this model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-C",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "32509-2": {
    "loincCode": "32509-2",
    "component": "Property:Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD1",
    "property": "Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD1",
    "system": "Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD1",
    "context": "Component:Property:Timing:System:Scale:Method) Local test: CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ❏ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD1",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "56775-0": {
    "loincCode": "56775-0",
    "context": ": CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood ✓ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD16+CD56+:NCnc:Pt:Bld:Qn: The two main differences between",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "32536-5": {
    "loincCode": "32536-5",
    "property": "and System. The eas",
    "context": "in Blood ✓ 8112-5: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD16+CD56+:NCnc:Pt:Bld:Qn: The two main differences between the choices are the Property and System. The eas",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "42188-3": {
    "loincCode": "42188-3",
    "property": "and System. The easiest way is to eliminate everything not Bld for the sys",
    "context": "r:Pt:Bld:Qn ❏ 32509-2: Cells.CD3-CD16+CD56+/100 cells:NFr:Pt:Tiss:Qn: ❏ 56775-0: Cells.CD3-CD16+CD56+:NCnc:Pt:Tiss:Qn: ❏ 32536-5: Cells.CD3-CD16+CD56+:NCnc:Pt:Bone mar:Qn: ❏ 42188-3: Cells.CD3+CD16+CD56+:NCnc:Pt:Bld:Qn: The two main differences between the choices are the Property and System. The easiest way is to eliminate everything not Bld for the sys",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "8125-7": {
    "loincCode": "8125-7",
    "system": "mismatch ❏ Scale dif",
    "context": "58 Local test: CD34 blasts [Units/volume] in Blood, Bone Marrow, or Blood Product ❏ 33023-3: Cells.CD34/100 cells:NFr:Pt:Bld^BPU:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 8125-7: Cells.CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "61123-6": {
    "loincCode": "61123-6",
    "component": "Property:Timing:System:Scale:Method) Local test: Percentage of lymphocytes in the bone marrow that are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manu",
    "property": "Timing:System:Scale:Method) Local test: Percentage of lymphocytes in the bone marrow that are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manu",
    "system": "Scale:Method) Local test: Percentage of lymphocytes in the bone marrow that are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manu",
    "context": "model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: Percentage of lymphocytes in the bone marrow that are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manu",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "46238-2": {
    "loincCode": "46238-2",
    "context": "Local test: Percentage of lymphocytes in the bone marrow that are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count ✓ 46237-4: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Bone m",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "11108-8": {
    "loincCode": "11108-8",
    "context": "are positive for kappa by flow cytometry ❏ 61123-6: Lymphocytes/100 leukocytes:NFr:Pt:XXX:Qn:Flow cytometry ❏ 46238-2: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count ✓ 46237-4: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Bone mar:Qn: ❏ 21375-1: Lymphocytes.kappa/Lymphocytes.lambda:NRto:Pt:B",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "46237-4": {
    "loincCode": "46237-4",
    "component": "(Lymphocytes.kappa) and has a “number fraction” Property (NFr). In this case",
    "property": "(NFr). In this case",
    "method": "a",
    "context": "tes/100 cells:NFr:Pt:Bone mar:Qn:Manual count ✓ 46237-4: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Bone mar:Qn: ❏ 21375-1: Lymphocytes.kappa/Lymphocytes.lambda:NRto:Pt:Bld:Qn: 46237-4 is the only LOINC listed that matches the Component (Lymphocytes.kappa) and has a “number fraction” Property (NFr). In this case, there isn’t a similar LOINC that has a Method a",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "21375-1": {
    "loincCode": "21375-1",
    "component": "(Lymphocytes.kappa) and has a “number fraction” Property (NFr",
    "property": "(NFr",
    "context": "tes.kappa/100 lymphocytes:NFr:Pt:Body fld:Qn ❏ 11108-8: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count ✓ 46237-4: Lymphocytes.kappa/100 lymphocytes:NFr:Pt:Bone mar:Qn: ❏ 21375-1: Lymphocytes.kappa/Lymphocytes.lambda:NRto:Pt:Bld:Qn: 46237-4 is the only LOINC listed that matches the Component (Lymphocytes.kappa) and has a “number fraction” Property (NFr",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "57439-2": {
    "loincCode": "57439-2",
    "method": "available",
    "context": "pa/100 lymphocytes:NFr:Pt:Bone mar:Qn: ❏ 21375-1: Lymphocytes.kappa/Lymphocytes.lambda:NRto:Pt:Bld:Qn: 6. Why is the LOINC below a poor choice for the local test? LOINC: 57439-2 - Cells.terminal deoxyribonucleotidyl transferase:PrThr:Pt:Body fld:Ord: Local test: Terminal deoxyribonucleotidyl transferase cells/100 cells in Body fluid by Flow cytometry",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "33023-3": {
    "loincCode": "33023-3",
    "component": "Property:Timing:System:Scale:Method) LOINC Mapping Guide Cell Markers Page 58 Local test: CD34 blasts [Units/volume] in Blood",
    "property": "Timing:System:Scale:Method) LOINC Mapping Guide Cell Markers Page 58 Local test: CD34 blasts [Units/volume] in Blood",
    "system": "Scale:Method) LOINC Mapping Guide Cell Markers Page 58 Local test: CD34 blasts [Units/volume] in Blood",
    "context": "Component:Property:Timing:System:Scale:Method) LOINC Mapping Guide Cell Markers Page 58 Local test: CD34 blasts [Units/volume] in Blood, Bone Marrow, or Blood Product ❏ 33023-3: Cells.CD34/100 cells:NFr:Pt:Bld^BPU:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 8125-7: Cells.CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Q",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "14136-6": {
    "loincCode": "14136-6",
    "property": "(concentration) and Systems (blood",
    "context": "s.CD34/100 cells:NFr:Pt:Bld^BPU:Qn: ✓ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 8125-7: Cells.CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: C",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "51162-6": {
    "loincCode": "51162-6",
    "context": "Blood, Bone Marrow, or Blood Product ❏ 33023-3: Cells.CD34/100 cells:NFr:Pt:Bld^BPU:Qn: ✓ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 8125-7: Cells.CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "57421-0": {
    "loincCode": "57421-0",
    "context": "14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 8125-7: Cells.CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: Cells.CD34:NCnc:Pt:XXX:Qn: ✓ 33030-8: C",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "51166-7": {
    "loincCode": "51166-7",
    "context": "CD34/100 cells:NFr:Pt:Bld:Qn: ❏ 51162-6: Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: Cells.CD34:NCnc:Pt:XXX:Qn: ✓ 33030-8: Cells.CD34:NCnc:Pt:Bld^BPU:Qn: 14136-6, 51164-2, an",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "51164-2": {
    "loincCode": "51164-2",
    "property": "to the unit Property Answer Examp",
    "units": "Property Answer Examp",
    "context": ": Blasts.CD34/100 blasts:NFr:Pt:Bone mar:Qn: ❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: Cells.CD34:NCnc:Pt:XXX:Qn: ✓ 33030-8: Cells.CD34:NCnc:Pt:Bld^BPU:Qn: 14136-6, 51164-2, and 33030-8 are the only terms listed that",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "74838-4": {
    "loincCode": "74838-4",
    "property": "to the unit Property Answer Example Unit or Result(s) A NFr Example: A-3 1 %",
    "units": "Property Answer Example Unit or Result(s) A NFr Example: A-3 1 %",
    "context": "❏ 14136-6: Cells.CD34:NCnc:Pt:Bld:Qn: ❏ 57421-0: Cells.CD34/100 cells:NFr:Pt:Body fld:Qn: ❏ 51166-7: Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: Cells.CD34:NCnc:Pt:XXX:Qn: ✓ 33030-8: Cells.CD34:NCnc:Pt:Bld^BPU:Qn: 14136-6, 51164-2, and 33030-8 are the only terms listed that match the Property (concentration) and Syst",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "33030-8": {
    "loincCode": "33030-8",
    "property": "to the unit Property Answer Example Unit or Result(s) A NFr Example: A-3 1 % (actual/norm) B NCnc 2 Pos/neg C AC",
    "system": "XXX unles",
    "units": "Property Answer Example Unit or Result(s) A NFr Example: A-3 1 % (actual/norm) B NCnc 2 Pos/neg C AC",
    "context": "Blasts.CD34:ACnc:Pt:XXX:Qn: ✓ 51164-2: Blasts.CD34:ACnc:Pt:Bone mar:Qn: ❏ 74838-4: Cells.CD34:NCnc:Pt:XXX:Qn: ✓ 33030-8: Cells.CD34:NCnc:Pt:Bld^BPU:Qn: 14136-6, 51164-2, and 33030-8 are the only terms listed that match the Property (concentration) and Systems (blood, bone marrow, and blood product) of the local term. Note one should not use System XXX unles",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "46722-5": {
    "loincCode": "46722-5",
    "context": "mL G Prid G4 7 % (% of whole) See Section 2.4.3 Scale and Property. 10. Which of the following would be able to have a result of negative or the name of an analyte? ❏ 46722-5: Cells.ZAP70:PrThr:Pt:Bld:Ord: ❏ 10430-7: AE 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain ✓ 86900-8: Plasma cells.monotypic population:Prid:Pt:Bld:Nom:Flow cytometry ❏ 98241-3: CD154 f",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "10430-7": {
    "loincCode": "10430-7",
    "context": "ion 2.4.3 Scale and Property. 10. Which of the following would be able to have a result of negative or the name of an analyte? ❏ 46722-5: Cells.ZAP70:PrThr:Pt:Bld:Ord: ❏ 10430-7: AE 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain ✓ 86900-8: Plasma cells.monotypic population:Prid:Pt:Bld:Nom:Flow cytometry ❏ 98241-3: CD154 function (binding to CD40):PrThr:Pt:T cells",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "86900-8": {
    "loincCode": "86900-8",
    "property": "Prid is for assays that first determine if an analyte is present",
    "context": "rid:Pt:Bone mar:Nom:Flow cytometry Remember that the Property Prid is for assays that first determine if an analyte is present, and if so, classify the analyte. For instance, 86900-8 will result negative if no monotypic plasma cell population is present. If one is present the result will then be the type of monotypic plasma cell, i.e. monotypic kappa plasma",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "98241-3": {
    "loincCode": "98241-3",
    "context": "yte? ❏ 46722-5: Cells.ZAP70:PrThr:Pt:Bld:Ord: ❏ 10430-7: AE 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain ❏ 86900-8: Plasma cells.monotypic population:Prid:Pt:Bld:Nom:Flow cytometry ❏ 98241-3: CD154 function (binding to CD40):PrThr:Pt:T cells:Ord: ❏ 94437-1: HLA-DQA1 Ab.IgG:Prid:Pt:Ser/Plas:Nom:Flow cytometry ❏ 93362-2: Plasma cells.monotypic population:Prid:Pt:Bone",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "94437-1": {
    "loincCode": "94437-1",
    "property": "Prid is for a",
    "context": ":PrThr:Pt:Tiss:Ord:Immune stain ✓ 86900-8: Plasma cells.monotypic population:Prid:Pt:Bld:Nom:Flow cytometry ❏ 98241-3: CD154 function (binding to CD40):PrThr:Pt:T cells:Ord: ✓ 94437-1: HLA-DQA1 Ab.IgG:Prid:Pt:Ser/Plas:Nom:Flow cytometry ✓ 93362-2: Plasma cells.monotypic population:Prid:Pt:Bone mar:Nom:Flow cytometry Remember that the Property Prid is for a",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "93362-2": {
    "loincCode": "93362-2",
    "property": "Prid is for assays that first determine if an analyte is present",
    "context": "ic population:Prid:Pt:Bld:Nom:Flow cytometry ❏ 98241-3: CD154 function (binding to CD40):PrThr:Pt:T cells:Ord: ✓ 94437-1: HLA-DQA1 Ab.IgG:Prid:Pt:Ser/Plas:Nom:Flow cytometry ✓ 93362-2: Plasma cells.monotypic population:Prid:Pt:Bone mar:Nom:Flow cytometry Remember that the Property Prid is for assays that first determine if an analyte is present, and if so,",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "43871-3": {
    "loincCode": "43871-3",
    "component": "Name Pre LOINC Mapping Post LOINC Mapping Example Aspergillus Antibodies by CF and ID 50171 Aspergillus PPT Aspergillus spp. Abs",
    "context": "mponent Mnemonic Component Name Pre LOINC Mapping Post LOINC Mapping Example Aspergillus Antibodies by CF and ID 50171 Aspergillus PPT Aspergillus spp. Abs, Precipitin 43871-3, Aspergillus sp IgA Ab [Presence] in Serum 5052-6, Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) 50175 Cold Agglutinins 50175 ColdAgglutinins Cold Agglutinin",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "5052-6": {
    "loincCode": "5052-6",
    "component": "names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names",
    "system": "The first",
    "context": "Post LOINC Mapping Example Aspergillus Antibodies by CF and ID 50171 Aspergillus PPT Aspergillus spp. Abs, Precipitin 43871-3, Aspergillus sp IgA Ab [Presence] in Serum 5052-6, Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) 50175 Cold Agglutinins 50175 ColdAgglutinins Cold Agglutinins 79156-6 Cold agglutinin [Titer] in Serum by 37 d",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "34962-1": {
    "loincCode": "34962-1",
    "context": "a 0095885 Lymphocyte Subset Panel 2 - CD4 Percent and Absolute 2012857 CD_4Pct % CD4 0095949 Lymphocyte Transplantation CD3 95248 CD3ABPct % CD3+/TCR ab+ 34962-1 2013805 Natural Killer Cell and Natural Killer T-Cell Panel 2013822 NK NKT Interp Natural Killer T- cell Panel Interp LOINC Mapping Guide Cell Markers Page 67 Answe",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "39803-2": {
    "loincCode": "39803-2",
    "component": "names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names",
    "context": "l Interp LOINC Mapping Guide Cell Markers Page 67 Answers to examples Test Code ARUP Current State Reason for mismatch Answers/comments Example 5052-6 2008320 39803-2 component names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names, fraction 3002216 lll89349-5 Plus and minus signs are used",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "97599-5": {
    "loincCode": "97599-5",
    "component": "names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names",
    "context": "age 67 Answers to examples Test Code ARUP Current State Reason for mismatch Answers/comments Example 5052-6 2008320 39803-2 component names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names, fraction 3002216 lll89349-5 Plus and minus signs are used as abbreviations in Components to designate the pre",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "26028-1": {
    "loincCode": "26028-1",
    "component": "names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names",
    "context": "e ARUP Current State Reason for mismatch Answers/comments Example 5052-6 2008320 39803-2 component names look similar 0093420 97599-5 operators - / 0095840 26028-1 abbreviations in names, fraction 3002216 lll89349-5 Plus and minus signs are used as abbreviations in Components to designate the presence or absence of a cell marker.",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "17109-0": {
    "loincCode": "17109-0",
    "context": "or absence of a cell marker. If two or more constituents are measured as one quantity, each constituent will be named followed by a “+” (presence) or “-” (absence). 2004359 17109-0 The CD (Cluster of Differentiation) markers in the LOINC database include all of the single markers and the most commonly reported combinations, e.g., CD11C+CD20C+. Most of the",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "8123-2": {
    "loincCode": "8123-2",
    "context": "nations, e.g., CD11C+CD20C+. Most of these are measuring the number or percent of a population of cells that bear the specific marker(s) of interest, e.g., Cells.CDx. 0095885 8123-2 If results are to be reported as a Fraction in a percentage, the denominator will be per 100 cells of some cell type, i.e. blasts, lymphocytes, leukocytes, Cells.CD3+CD4+, etc",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "8124-0": {
    "loincCode": "8124-0",
    "component": "was not specific In order to fully specify what is being measured",
    "context": "e general “/100 cells” is the most common, however, it is advised to use a more specific LOINC if available.A more specific code for /100 lymphocytes is not available 0095949 8124-0 component was not specific In order to fully specify what is being measured, many newer LOINC terms include the cell marker(s) that define the parent population in the Divisor",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "80722-2": {
    "loincCode": "80722-2",
    "context": "ing term is used to report the percent of cells that do not express CD4 or CD8 out of a population of cells that express CD3 and T-cell receptor (TCR) alpha and beta: 2013805 80722-2 Cell marker panels may include an interpretation field. Available LOINC for these may be searched by words in the panel name and adding Imp (Impression) to the search criteria",
    "sourceFile": "LOINC-Mapping-Guide-Cell-Markers-Version-1.0.pdf"
  },
  "2708-6": {
    "loincCode": "2708-6",
    "component": "Example terms Oxygen saturation (O 2 Hb) (O 2 Hb + HHb) 2708-6 Oxygen saturation in Arterial Blood 2713-6 Oxygen saturation calculated from oxygen partial pressure in Blood 59408-5 Oxygen saturation in Arterial blood by pulse oximetry",
    "context": "This table summarizes the representation of these two concepts in LOINC. Measurement Formula LOINC Component Example terms Oxygen saturation (O 2 Hb) (O 2 Hb + HHb) 2708-6 Oxygen saturation in Arterial Blood 2713-6 Oxygen saturation calculated from oxygen partial pressure in Blood 59408-5 Oxygen saturation in Arterial blood by pulse oximetry",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "2713-6": {
    "loincCode": "2713-6",
    "component": "Example terms Oxygen saturation (O 2 Hb) (O 2 Hb + HHb) 2708-6 Oxygen saturation in Arterial Blood 2713-6 Oxygen saturation calculated from oxygen partial pressure in Blood 59408-5 Oxygen saturation in Arterial blood by pulse oximetry Measured by traditional pulse oximetry Fracti",
    "context": "these two concepts in LOINC. Measurement Formula LOINC Component Example terms Oxygen saturation (O 2 Hb) (O 2 Hb + HHb) 2708-6 Oxygen saturation in Arterial Blood 2713-6 Oxygen saturation calculated from oxygen partial pressure in Blood 59408-5 Oxygen saturation in Arterial blood by pulse oximetry Measured by traditional pulse oximetry Fracti",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "59408-5": {
    "loincCode": "59408-5",
    "context": "e terms Oxygen saturation (O 2 Hb) (O 2 Hb + HHb) 2708-6 Oxygen saturation in Arterial Blood 2713-6 Oxygen saturation calculated from oxygen partial pressure in Blood 59408-5 Oxygen saturation in Arterial blood by pulse oximetry Measured by traditional pulse oximetry Fractional oxyhemoglobin (O 2 Hb)/ (O 2 Hb + HHb + COHb + MetHb + SulfHb) o",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "2714-4": {
    "loincCode": "2714-4",
    "property": "and Sca",
    "context": "y pulse oximetry Measured by traditional pulse oximetry Fractional oxyhemoglobin (O 2 Hb)/ (O 2 Hb + HHb + COHb + MetHb + SulfHb) or Oxyhemoglobin/ Hemoglobin.total 2714-4 Fractional oxyhemoglobin in Arterial blood 19953-9 Fractional oxyhemoglobin in Blood Measured by co-oximetry in the laboratory, or by pulse co-oximetry 3.3 Bilirubin fractions",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "19953-9": {
    "loincCode": "19953-9",
    "property": "and Scale As mentioned",
    "context": "etry Fractional oxyhemoglobin (O 2 Hb)/ (O 2 Hb + HHb + COHb + MetHb + SulfHb) or Oxyhemoglobin/ Hemoglobin.total 2714-4 Fractional oxyhemoglobin in Arterial blood 19953-9 Fractional oxyhemoglobin in Blood Measured by co-oximetry in the laboratory, or by pulse co-oximetry 3.3 Bilirubin fractions The naming of bilirubin fractions has changed over",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "2436-4": {
    "loincCode": "2436-4",
    "context": "e, meaning the mass of an analyte collected or produced over a specific period of time. Based on this information, the following LOINC is the correct choice for your HVA test: 2436-4 Homovanillate: MRat: 24H: Urine: Qn: LCN: Homovanillate [Mass/time] in 24-hour Urine Note three important points related to this example. ● LOINC uses the anionic name homova",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "44906-6": {
    "loincCode": "44906-6",
    "context": "des measurement of creatinine in 24-hour urine, the order would be mapped to the LOINC panel 44906-6 Homovanillate panel - 24 hour Urine ● If you look at the panel children for 44906-6 Homovanillate panel - 24 hour Urine, you will see only mass-based terms. However, as described in the LOINC Users’ Guide section 12.1.5 Substitutions for mass versus substance P",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "13362-9": {
    "loincCode": "13362-9",
    "context": "used for 24-hour urine specimen collections. The Time Aspect XXX means that collection duration is not specified, and that information should be reported elsewhere (e.g., using 13362-9 Collection duration of Urine or 13363-7 Collection duration of Stool). Some labs LOINC Mapping Guide Chemistry Page 52 also use LOINC terms with Time Aspect XXX when they h",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "13363-7": {
    "loincCode": "13363-7",
    "context": "ions. The Time Aspect XXX means that collection duration is not specified, and that information should be reported elsewhere (e.g., using 13362-9 Collection duration of Urine or 13363-7 Collection duration of Stool). Some labs LOINC Mapping Guide Chemistry Page 52 also use LOINC terms with Time Aspect XXX when they have a single result field for measureme",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "70260-5": {
    "loincCode": "70260-5",
    "component": "PROPERTY:TIME_ASPCT:SYSTEM:SCALE_TYP:METHOD_TYP 70260-5 Triglyceride.periton fld/Triglyceride.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn: LOINC Mapping Guide Chemistry Page 53 7 Method Chemistry terms in LOINC tend to not specif",
    "property": "TIME_ASPCT:SYSTEM:SCALE_TYP:METHOD_TYP 70260-5 Triglyceride.periton fld/Triglyceride.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn: LOINC Mapping Guide Chemistry Page 53 7 Method Chemistry terms in LOINC tend to not specif",
    "method": "Chemistry terms in LOINC tend to not specif",
    "system": "SCALE_TYP:METHOD_TYP 70260-5 Triglyceride.periton fld/Triglyceride.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn: LOINC Mapping Guide Chemistry Page 53 7 Method Chemistry terms in LOINC tend to not specif",
    "context": "of the amount of some analyte in peritoneal fluid to the same analyte in serum (or plasma). For example: LOINC_NUM COMPONENT:PROPERTY:TIME_ASPCT:SYSTEM:SCALE_TYP:METHOD_TYP 70260-5 Triglyceride.periton fld/Triglyceride.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn: LOINC Mapping Guide Chemistry Page 53 7 Method Chemistry terms in LOINC tend to not specif",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "60019-7": {
    "loincCode": "60019-7",
    "method": "specifies the reaction as shown in the examples below. Note",
    "context": "c activity. In such cases, the LOINC Method specifies the reaction as shown in the examples below. Note, for each pair of terms, the Method is the only distinguishing factor. 60019-7 Lactate dehydrogenase:CCnc:Pt:Pericard fld:Qn:Reaction:lactate to pyruvate LCN: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate rea",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "60018-9": {
    "loincCode": "60018-9",
    "context": "e dehydrogenase:CCnc:Pt:Pericard fld:Qn:Reaction:lactate to pyruvate LCN: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction 60018-9 Lactate dehydrogenase:CCnc:Pt:Pericard fld:Qn:Reaction:pyruvate to lactate LCN: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate rea",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "76614-7": {
    "loincCode": "76614-7",
    "context": "e dehydrogenase:CCnc:Pt:Pericard fld:Qn:Reaction:pyruvate to lactate LCN: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction 76614-7 Lysosomal acid lipase:CCnt:Pt:Fibroblasts:Qn:4-MU-oleate substrate LCN: Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate 76615-4 Lysosomal",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "76615-4": {
    "loincCode": "76615-4",
    "context": "reaction 76614-7 Lysosomal acid lipase:CCnt:Pt:Fibroblasts:Qn:4-MU-oleate substrate LCN: Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate 76615-4 Lysosomal acid lipase:CCnt:Pt:Fibroblasts:Qn:4-MU-palmitate substrate LCN: Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate 7.3 Detecti",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "87706-8": {
    "loincCode": "87706-8",
    "context": "th specific detection limit ​Methods​ are no longer recommended for use. Instead, we encourage reporting individual results using a more generic code along with a second LOINC (​87706-8​ ​Laboratory device Detection limit​) to report the detection limit as a separate observation. 2.6 Citations We cite various articles, websites, and online resources in this gu",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "19550-3": {
    "loincCode": "19550-3",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustm",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustm",
    "context": "ee Phen Phenytoin - Percent Free LOINC Mapping Guide Chemistry Page 72 Answers to examples Test Number ARUP Current State Reason for mismatch Answers/Comments Example 19550-3 0050640 2871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustm",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "2871-2": {
    "loincCode": "2871-2",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829",
    "context": "Percent Free LOINC Mapping Guide Chemistry Page 72 Answers to examples Test Number ARUP Current State Reason for mismatch Answers/Comments Example 19550-3 0050640 2871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "15061-5": {
    "loincCode": "15061-5",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "context": "72 Answers to examples Test Number ARUP Current State Reason for mismatch Answers/Comments Example 19550-3 0050640 2871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjus",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "12180-6": {
    "loincCode": "12180-6",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "context": "ent State Reason for mismatch Answers/Comments Example 19550-3 0050640 2871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than obser",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "19072-8": {
    "loincCode": "19072-8",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "context": "/Comments Example 19550-3 0050640 2871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 00201",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "13829-7": {
    "loincCode": "13829-7",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "context": "871-2 general mapping principles, method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "1558-6": {
    "loincCode": "1558-6",
    "component": "names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "method": "0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators",
    "context": "method 0050227 15061-5 component names that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin n",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "93794-6": {
    "loincCode": "93794-6",
    "context": "es that are similar 0020135 12180-6 challenge/adjustment 0020135 19072-8 challenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 v",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "2950-4": {
    "loincCode": "2950-4",
    "context": "hallenge/adjustment 0020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 b",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "3084-1": {
    "loincCode": "3084-1",
    "context": "020461 13829-7 operators, ratio 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 00",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "1989-3": {
    "loincCode": "1989-3",
    "context": "o 0020542 1558-6 challenge/adjustment 0020542 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractio",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "49054-0": {
    "loincCode": "49054-0",
    "context": "42 93794-6 order code rather than observation code challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractions 0090141 3968-5 Free vs Total 0090141 3969",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "62292-8": {
    "loincCode": "62292-8",
    "context": "ode challenge/adjustment 0020154 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractions 0090141 3968-5 Free vs Total 0090141 3969-3 Free vs Total 0090141 10548-6 Free vs Tot",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "1968-7": {
    "loincCode": "1968-7",
    "context": "54 2950-4 SCnc 0020026 3084-1 anion vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractions 0090141 3968-5 Free vs Total 0090141 3969-3 Free vs Total 0090141 10548-6 Free vs Total",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "1975-2": {
    "loincCode": "1975-2",
    "context": "n vs acid 2002348 1989-3 vitamin names, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractions 0090141 3968-5 Free vs Total 0090141 3969-3 Free vs Total 0090141 10548-6 Free vs Total",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "3968-5": {
    "loincCode": "3968-5",
    "context": "mes, related names 2002348 49054-0 vitamin names, related names 2002348 62292-8 using + or & 0020426 1968-7 bilirubin fractions 0020426 1975-2 bilirubin fractions 0090141 3968-5 Free vs Total 0090141 3969-3 Free vs Total 0090141 10548-6 Free vs Total",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "3969-3": {
    "loincCode": "3969-3",
    "component": "for the free concentration of a drug is represented as the drug name plus a dot (“.”) and the word “free”. For",
    "method": ">150 ng/mL 90141 Phenytoin",
    "context": "64 Answers to examples Test Number ARUP Current State Reason for mismatch Answers and Comments Example 19550-3 Methadone [Presence] in Urine by Screen method 90141 3969-3 Phenytoin Free [Mass/volume] in Serum or Plasma The Component for the free concentration of a drug is represented as the drug name plus a dot (“.”) and the word “free”. For",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "10548-6": {
    "loincCode": "10548-6",
    "method": ">150 ng/mL 90141 Phenytoin",
    "context": "hadone [Presence] in Urine 70148-2 Methadone [Presence] in Urine by Screen method >150 ng/mL 90141 Phenytoin, Free and Total 90125 Phenytoin Free Phenytoin - Free Level 10548-6 Phenytoin Free/Phenytoin.total in Serum or Plasma 3969-3 Phenytoin Free [Mass/volume] in Serum or Plasma 2010460 Phencyclidine (PCP), Serum or Plasma, 2010461 PCP_SP Phe",
    "sourceFile": "LOINC-Mapping-Guide-Chemistry-Version-1.0.pdf"
  },
  "19261-7": {
    "loincCode": "19261-7",
    "component": "is the drug class. For example",
    "method": "However",
    "context": "ying which one, the LOINC Component is the drug class. For example, the Component Amphetamines in the following term represents any drug that is classified as an amphetamine: 19261-7 Amphetamines: PrThr: Pt: Urine: Ord: Screen LCN: Amphetamines [Presence] in Urine by Screen method However, different laboratories may have a test targeting different types of",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19262-5": {
    "loincCode": "19262-5",
    "method": "Nominal These two terms would be used together to report which amph",
    "context": "ary to indicate which drugs the assay is designed to detect. LOINC terms with “tested for” in the Component, such as the following, indicate the types of amphetamines tested. 19262-5 Amphetamines tested for: Prid: Pt: Urine: Nom:Screen LCN: Amphetamines tested for in Urine by Screen method Nominal These two terms would be used together to report which amph",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19348-2": {
    "loincCode": "19348-2",
    "method": "is an example of this approach. 2.4.2 List the Value of the Cutoff with the Analyte The second way cutoffs are",
    "context": "or the same analyte but is not specified in the LOINC. The LOINC may also be mapped to results with different cutoffs established by different laboratories for an analyte. LOINC 19348-2 Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method is an example of this approach. 2.4.2 List the Value of the Cutoff with the Analyte The second way cutoffs are",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "14308-1": {
    "loincCode": "14308-1",
    "method": ">1000 ng/mL exemplifies these types of terms. The cutoff value",
    "context": "2 List the Value of the Cutoff with the Analyte The second way cutoffs are represented in LOINC terms is to list the exact value for the cutoff with the analyte(s) tested. LOINC 14308-1 Amphetamines [Presence] in Urine by Screen method >1000 ng/mL exemplifies these types of terms. The cutoff value, in this case > 1000 ng/mL, is the point where a positive result",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "8151-3": {
    "loincCode": "8151-3",
    "context": "s cutoff values for each type of test specified in its protocols. SAMHSA may be used in conjunction with confirmatory or screening methods in LOINC terms as exemplified in LOINC 8151-3 Amphetamines [Presence] in Urine by SAMHSA confirm method. The Federal Register provides resources and further detail regarding SAMHSA cutoff values for each type of test and an",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "8175-2": {
    "loincCode": "8175-2",
    "method": "• 14312-3 Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL • 70145-8 Cannabinoids [Presence]",
    "context": "n our assay tests for only THC, we can rule out the Cannabinoids LOINC of 70145-8. Customers may be testing specimens that do not use the SAMHSA protocols, thus mapping to LOINC 8175-2 would be incorrect in these cases. That leaves 14312-3 as the best choice. Laboratories may also wish to use LOINC 14312-3 as it provides more detailed information with the cuto",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "14312-3": {
    "loincCode": "14312-3",
    "method": "• 14312-3 Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL • 70145-8 Cannabinoids [Presence] in Urine by Screen method >50 ng/mL It is recommended to use the most spe",
    "context": "do not use the SAMHSA protocols, thus mapping to LOINC 8175-2 would be incorrect in these cases. That leaves 14312-3 as the best choice. Laboratories may also wish to use LOINC 14312-3 as it provides more detailed information with the cutoff value in the term to provide users of these results more clarity about the test details. Another advantage is if the SAM",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "70145-8": {
    "loincCode": "70145-8",
    "method": "• 14312-3 Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL • 70145-8 Cannabinoids [Presence] in Urine by Screen method >50 ng/mL It is recommended to use the most specific LOINC corresponding to our test details. Given our assay tests for only",
    "context": "hod >50 ng/mL It is recommended to use the most specific LOINC corresponding to our test details. Given our assay tests for only THC, we can rule out the Cannabinoids LOINC of 70145-8. Customers may be testing specimens that do not use the SAMHSA protocols, thus mapping to LOINC 8175-2 would be incorrect in these cases. That leaves 14312-3 as the best choice.",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "53838-9": {
    "loincCode": "53838-9",
    "units": "match your units. Based on this information",
    "context": "different Components and Properties. Only one candidate’s units match your units. Based on this information, the following LOINC is the correct choice for your arsenic test: 53838-9 Arsenic.inorganic:MRat:24H:Urine Qn: LCN: Arsenic.inorganic [Mass/time] in 24-hour Urine To understand why the example units are appropriate, let’s look at another search",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19269-0": {
    "loincCode": "19269-0",
    "component": "(examples below)",
    "method": "Prid:Pt:Urine:Nom:* LCN: Amphetamines confirm method [Identifier] in Urine 19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LCN: Amphetamine",
    "context": "tain the specific substance plus “screen method” or “confirm method” in the Component (examples below), or a generic term for reporting the specific Method, also shown below. 19269-0 Amphetamines confirm method:Prid:Pt:Urine:Nom:* LCN: Amphetamines confirm method [Identifier] in Urine 19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LCN: Amphetamine",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19268-2": {
    "loincCode": "19268-2",
    "component": "AND Method of Screen. 3 Resources 3.1 LO",
    "method": "Prid:Pt:Urine:Nom:* LCN: Amphetamines confirm method [Identifier] in Urine 19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LCN: Amphetamines screen method [Identifier] in Urine 85069-3 Lab test method:Type:Pt:Specimen:Nom:* LOINC Mapping Guide Dru",
    "context": "Pt:Urine:Qn ✓ 19266-6 Amphetamines cutoff:MCnc:Pt:Urine:Qn:Screen  19261-7 Amphetamines:PrThr:Pt:Urine:Ord:Screen  19262-5 Amphetamines tested for:Prid:Pt:Urine:Nom:Screen  19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* 19266-6 is the only LOINC listed that accurately includes “cutoff” in the Component AND Method of Screen. 3 Resources 3.1 LO",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "85069-3": {
    "loincCode": "85069-3",
    "method": "[Identifier] in Urine 19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LCN: Amphetamines screen method [Identifier] in Urine 85069-3 Lab test method:Type:Pt:Specimen:Nom:* LOINC Mapping Guide Drug and Toxicology Page 50 LCN: Lab test method [Type] (Note that the asterisk (“*”) is used in the terms above",
    "context": "e:Nom:* LCN: Amphetamines confirm method [Identifier] in Urine 19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LCN: Amphetamines screen method [Identifier] in Urine 85069-3 Lab test method:Type:Pt:Specimen:Nom:* LOINC Mapping Guide Drug and Toxicology Page 50 LCN: Lab test method [Type] (Note that the asterisk (“*”) is used in the terms above",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19296-3": {
    "loincCode": "19296-3",
    "context": "An answer key is provided in the next section. Multiple answers may apply. 1. Which LOINC term best matches the local test? Local test: Presence of opiates in urine  19296-3 Opiates tested for:Prid:Pt:Urine:Nom:Screen  19300-3 Opiates cutoff:MCnc:Pt:Urine:Qn:Confirm  41465-6 Opiates/creatinine:MRto:Pt:Urine:Qn:  21431-2 Opiates:PrThr:Pt:Urine:O",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19300-3": {
    "loincCode": "19300-3",
    "method": "P",
    "context": "ge 58 2.2 Answer Key 1. Which LOINC term best matches the local test? Local test: Presence of opiates in urine  19296-3 Opiates tested for:Prid:Pt:Urine:Nom:Screen  19300-3 Opiates cutoff:MCnc:Pt:Urine:Qn:Confirm  41465-6 Opiates/creatinine:MRto:Pt:Urine:Qn: ✓ 21431-2 Opiates:PrThr:Pt:Urine:Ord:Screen>2000 ng/mL  19302-9 Opiates confirm method:P",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "41465-6": {
    "loincCode": "41465-6",
    "method": "Prid:Pt:Urine:Nom:* 2. Which pair of LOINC term",
    "context": "atches the local test? Local test: Presence of opiates in urine  19296-3 Opiates tested for:Prid:Pt:Urine:Nom:Screen  19300-3 Opiates cutoff:MCnc:Pt:Urine:Qn:Confirm  41465-6 Opiates/creatinine:MRto:Pt:Urine:Qn: ✓ 21431-2 Opiates:PrThr:Pt:Urine:Ord:Screen>2000 ng/mL  19302-9 Opiates confirm method:Prid:Pt:Urine:Nom:* 21431-2 is the only LOINC lis",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "21431-2": {
    "loincCode": "21431-2",
    "component": "Opiates) and Property (PrThr for Presence or Threshold) 2. Which pair of LOINC terms co",
    "property": "(PrThr for Presence or Threshold) 2. Which pair of LOINC terms co",
    "method": "Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing",
    "context": "of opiates in urine  19296-3 Opiates tested for:Prid:Pt:Urine:Nom:Screen  19300-3 Opiates cutoff:MCnc:Pt:Urine:Qn:Confirm  41465-6 Opiates/creatinine:MRto:Pt:Urine:Qn: ✓ 21431-2 Opiates:PrThr:Pt:Urine:Ord:Screen>2000 ng/mL  19302-9 Opiates confirm method:Prid:Pt:Urine:Nom:* 21431-2 is the only LOINC listed that matches the exact analyte being measur",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19302-9": {
    "loincCode": "19302-9",
    "component": "Opiates) and Property (PrThr for Presence",
    "property": "(PrThr for Presence",
    "method": "Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 509",
    "context": ":Pt:Urine:Nom:Screen  19300-3 Opiates cutoff:MCnc:Pt:Urine:Qn:Confirm  41465-6 Opiates/creatinine:MRto:Pt:Urine:Qn: ✓ 21431-2 Opiates:PrThr:Pt:Urine:Ord:Screen>2000 ng/mL  19302-9 Opiates confirm method:Prid:Pt:Urine:Nom:* 21431-2 is the only LOINC listed that matches the exact analyte being measured (Component: Opiates) and Property (PrThr for Presence",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "13587-1": {
    "loincCode": "13587-1",
    "component": "Opiates) and Property (PrThr for Presence or Threshold) 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancom",
    "property": "(PrThr for Presence or Threshold) 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancom",
    "method": "Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancom",
    "context": "s:PrThr:Pt:Urine:Ord:Screen>2000 ng/mL  19302-9 Opiates confirm method:Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancom",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "50938-0": {
    "loincCode": "50938-0",
    "property": "(PrThr for Presence or Threshold) 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Va",
    "method": "Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Va",
    "context": "2-9 Opiates confirm method:Prid:Pt:Urine:Nom:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Va",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "39092-2": {
    "loincCode": "39092-2",
    "context": "m:* 2. Which pair of LOINC terms could be used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn:  409",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "13586-3": {
    "loincCode": "13586-3",
    "context": "used to guide therapeutic drug dosing?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "39796-8": {
    "loincCode": "39796-8",
    "context": "?  13587-1 Vancomycin:MCnc:Pt:Body fld:Qn: and 50938-0 Vancomycin:SCnc:Pt:Body fld:Qn:  39092-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4092-3": {
    "loincCode": "4092-3",
    "context": "Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn:  4089-9 Vancomycin.free:MCnc:Pt:Ser/Plas:Qn: and 4091-5 Vancomycin^random:MCnc:Pt:Ser/Plas:Qn: Peak and trough drug concentration mea",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4090-7": {
    "loincCode": "4090-7",
    "context": "2-2 Vancomycin^peak:MCnc:Pt:CSF:Qn: and 13586-3 Vancomycin:MCnc:Pt:CSF:Qn:  39796-8 Vancomycin^peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn:  4089-9 Vancomycin.free:MCnc:Pt:Ser/Plas:Qn: and 4091-5 Vancomycin^random:MCnc:Pt:Ser/",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4089-9": {
    "loincCode": "4089-9",
    "component": "of a LOINC term that represents the to",
    "context": "peak:SCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn:  4089-9 Vancomycin.free:MCnc:Pt:Ser/Plas:Qn: and 4091-5 Vancomycin^random:MCnc:Pt:Ser/Plas:Qn: Peak and trough drug concentration measurements (with the same units) are used togethe",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4091-5": {
    "loincCode": "4091-5",
    "component": "of a LOINC term that represents the total concentration of Gallium?  Total Gallium",
    "context": "trough:MCnc:Pt:Ser/Plas:Qn: ✓ 4090-7 Vancomycin^peak:MCnc:Pt:Ser/Plas:Qn: and 4092-3 Vancomycin^trough:MCnc:Pt:Ser/Plas:Qn:  4089-9 Vancomycin.free:MCnc:Pt:Ser/Plas:Qn: and 4091-5 Vancomycin^random:MCnc:Pt:Ser/Plas:Qn: Peak and trough drug concentration measurements (with the same units) are used together to determine drug dosing to ensure therapeutic b",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "8150-5": {
    "loincCode": "8150-5",
    "context": "ide Drug and Toxicology Page 60 6. Which LOINC code could be used to indicate the concentration of Amphetamines above which a screening result would be considered positive?  8150-5 Amphetamines:MCnc:Pt:Urine:Qn ✓ 19266-6 Amphetamines cutoff:MCnc:Pt:Urine:Qn:Screen  19261-7 Amphetamines:PrThr:Pt:Urine:Ord:Screen  19262-5 Amphetamines tested for:Prid:Pt:U",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19266-6": {
    "loincCode": "19266-6",
    "component": "AND Method of Screen. 3 Resources 3.1 LOINC website The loinc.org website is the home to everythi",
    "method": "Prid:Pt:Urine:Nom:* 19266-6 is the only LOINC listed that accurately includes “cutoff” in the Component AND Method of Screen. 3 Resources 3.1 LOINC website The loinc.org website is the home to everythi",
    "context": "h LOINC code could be used to indicate the concentration of Amphetamines above which a screening result would be considered positive?  8150-5 Amphetamines:MCnc:Pt:Urine:Qn ✓ 19266-6 Amphetamines cutoff:MCnc:Pt:Urine:Qn:Screen  19261-7 Amphetamines:PrThr:Pt:Urine:Ord:Screen  19262-5 Amphetamines tested for:Prid:Pt:Urine:Nom:Screen  19268-2 Amphetamines s",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "43983-6": {
    "loincCode": "43983-6",
    "method": "Prid:Pt:Urine:Nom:* LOINC M",
    "context": "indicate the threshold for determining a positive Amphetamines screen result?  8150-5 Amphetamines:MCnc:Pt:Urine:Qn:  19266-6 Amphetamines cutoff:MCnc:Pt:Urine:Qn:Screen  43983-6 Amphetamines:PrThr:Pt:Urine:Ord:Screen>500 ng/mL  19262-5 Amphetamines tested for:Prid:Pt:Urine:Nom:Screen  19268-2 Amphetamines screen method:Prid:Pt:Urine:Nom:* LOINC M",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "3773-9": {
    "loincCode": "3773-9",
    "component": "Name Component Mnemonic Pre LOINC Post LOINC Example Drug Profile",
    "method": ">150 ng/mL 90141 Phenytoin",
    "context": "t Number Component Name Component Mnemonic Pre LOINC Post LOINC Example Drug Profile, Screen with Reflex to Quantitation 92199 CDU Methadone Methadone, Urn, Screen 3773-9 Methadone [Presence] in Urine 70148-2 Methadone [Presence] in Urine by Screen method >150 ng/mL 90141 Phenytoin, Free and Total 90125 Phenytoin Free Phenytoin - Free Le",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "70148-2": {
    "loincCode": "70148-2",
    "method": ">150 ng/mL 90141 Phenytoin",
    "context": "nemonic Pre LOINC Post LOINC Example Drug Profile, Screen with Reflex to Quantitation 92199 CDU Methadone Methadone, Urn, Screen 3773-9 Methadone [Presence] in Urine 70148-2 Methadone [Presence] in Urine by Screen method >150 ng/mL 90141 Phenytoin, Free and Total 90125 Phenytoin Free Phenytoin - Free Level 10548-6 Phenytoin Free/Phenytoin.to",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "3934-7": {
    "loincCode": "3934-7",
    "context": "a drug will have “free & total” in the Component, and Divisors that represent the total form of a drug will have the drug name plus a dot (“.”) and the word “total”. 2010460 3934-7 Phencyclidine [Mass/volume] in Serum or Plasma LOINC uses the generic name for drugs as the Component, and brand names for drugs will often be found in the list of related n",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "70140-9": {
    "loincCode": "70140-9",
    "method": "70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel",
    "context": "or Plasma 3934-7 Phencyclidine [Mass/volume] in Serum or Plasma 90448 Drugs of Abuse 7 Panel, Urine - Screen Only 90383 CD Benzodiazep Benzodiazepine s, Urn, Screen 70140-9 Benzodiazepines [Mass/volume] in Urine by Screen method 70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel, Urine - Sc",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "70141-7": {
    "loincCode": "70141-7",
    "method": "70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel",
    "context": "a 90448 Drugs of Abuse 7 Panel, Urine - Screen Only 90383 CD Benzodiazep Benzodiazepine s, Urn, Screen 70140-9 Benzodiazepines [Mass/volume] in Urine by Screen method 70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel, Urine - Screen Only 90398 CD Cannabinoid THC, Urn, Screen 21556-6 Tetrahy",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "21556-6": {
    "loincCode": "21556-6",
    "method": "70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel",
    "context": "method 70141-7 Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL 90448 Drugs of Abuse 7 Panel, Urine - Screen Only 90398 CD Cannabinoid THC, Urn, Screen 21556-6 Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL 70144-1 Cannabinoids [Presence] in Urine by Screen method >20 ng/mL 90315 Tobramycin, Peak Level 903",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "70144-1": {
    "loincCode": "70144-1",
    "method": ">20 ng/mL 70144-1 Cannabinoids [Presence] in Urine by Screen method >20 ng/mL 90315 Tobramycin",
    "context": "L 90448 Drugs of Abuse 7 Panel, Urine - Screen Only 90398 CD Cannabinoid THC, Urn, Screen 21556-6 Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL 70144-1 Cannabinoids [Presence] in Urine by Screen method >20 ng/mL 90315 Tobramycin, Peak Level 90315 Tobramycin Pk Tobramycin Peak 4057-6 Tobramycin [Mass/volume] in Serum or",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4057-6": {
    "loincCode": "4057-6",
    "method": ">20 ng/mL 70144-1 Cannabinoids [Presence] in Urine by Screen method >20 ng/mL 90315 Tobramycin",
    "context": "inciples are: 1. Map to the most specific LOINC term possible based on the available information; and 2. Do not overspecify by assuming information that is not known. 90315 4057-6 Tobramycin [Mass/volume] in Serum or Plasma -- peak Knowing the peak and trough levels of a medication is important in the context of therapeutic drug monitoring. Peak level",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4087-3": {
    "loincCode": "4087-3",
    "context": "ass/volume] in Serum or Plasma --peak 4057-6 Tobramycin [Mass/volume] in Serum or Plasma --peak 99310 Valproic Acid, Free and Total 99308 VPA Total Valproic Acid, Total 4087-3 Valproate Free [Mass/volume] in Serum or Plasma 4087-3 Valproate Free [Mass/volume] in Serum or Plasma 2010075 Amphetamines, Urine, Quantitative 2010081 MDEA_U MD",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "27085-0": {
    "loincCode": "27085-0",
    "context": "[Mass/volume] in Serum or Plasma 4087-3 Valproate Free [Mass/volume] in Serum or Plasma 2010075 Amphetamines, Urine, Quantitative 2010081 MDEA_U MDEA, Urn, Quant 27085-0 Methylenedioxyethylam phetamine [Mass/volume] in Urine 27085-0 Methylenedioxyethylamphetami ne [Mass/volume] in Urine LOINC Mapping Guide Drug and Toxicology Page 64 Answ",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "3390-2": {
    "loincCode": "3390-2",
    "method": "Roughly one quarter of existing drug and toxicology terms in LOINC represent tests that have a qualitativ",
    "context": "so sometimes included as related names. Drugs of abuse or recreational drugs often have “street names”, and these are also included as related names as much as possible. 90448 3390-2 Benzodiazepines [Presence] in Urine Level of specificity in method Roughly one quarter of existing drug and toxicology terms in LOINC represent tests that have a qualitativ",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "18282-4": {
    "loincCode": "18282-4",
    "component": "in the Drug/Tox Class is one that represents the cutoff level fo",
    "method": "Level of specificity in method A unique type of Component in the Drug/Tox Class is one that represents the cutoff level fo",
    "context": "ssible based on the available information; and 2. Do not overspecify by assuming information that is not known. LOINC Mapping Guide Drug and Toxicology Page 65 90448 18282-4 Cannabinoids [Presence] in Urine by Screen method Level of specificity in method A unique type of Component in the Drug/Tox Class is one that represents the cutoff level fo",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "4086-5": {
    "loincCode": "4086-5",
    "component": "for the free concentration of a drug is represented as the drug name plus a dot (“.”) and the word “free”. For examp",
    "context": "will include that information in the Challenge subpart of the Component. If peak or trough is not specific, then the test represents a random point in time measurement. 99310 4086-5 Valproate [Mass/volume] in Serum or Plasma The Component for the free concentration of a drug is represented as the drug name plus a dot (“.”) and the word “free”. For examp",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19570-1": {
    "loincCode": "19570-1",
    "component": "LOINC uses the generic name for drugs as the Component",
    "context": ", and Divisors that represent the total form of a drug will have the drug name plus a dot (“.”) and the word “total”. LOINC Mapping Guide Drug and Toxicology Page 66 2010075 19570-1 Methylenedioxymetha mpheta mine [Mass/volume] in Urine incorrect component LOINC uses the generic name for drugs as the Component, and brand names for drugs will often be fo",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "3122-9": {
    "loincCode": "3122-9",
    "property": "based on the reporting units of measure. Breaking down the units of measure into the",
    "units": "of measure. Breaking down the units of measure into the",
    "context": "cific analyte being measured. Use caution when looking at the Component, as terms with seemingly similar Components could potentially represent very different concepts. 80421 3122-9 Vanillylmandelate [Mass/time] in 24 hour Urine You can figure out the correct Property based on the reporting units of measure. Breaking down the units of measure into the",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "30571-4": {
    "loincCode": "30571-4",
    "property": "will be mass-based (ug) and a rate (per 24 hours)",
    "units": "of measure into the individual parts",
    "context": "units of measure into the individual parts, ug and 24 hours, tells you that the correct LOINC Property will be mass-based (ug) and a rate (per 24 hours), respectively. 80421 30571-4 Vanillylmandelate/Creat inine [Mass Ratio] in 24 hour Urine The fraction and ratio Properties in LOINC are often confused by users. Both typically have a numerator and denom",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "9624-8": {
    "loincCode": "9624-8",
    "property": "will be MRto (mass ratio) or SRto (substance ratio)",
    "system": "The two most important overarching principles are: 1. Map to the most specific LOINC term possible",
    "context": "if they match, then the Property will be MRto (mass ratio) or SRto (substance ratio), for example, and if they don’t match, you know that the Property has to be Ratio. 80421 9624-8 Vanillylmandelate [Mass/volume] in Urine Level of specificity in system The two most important overarching principles are: 1. Map to the most specific LOINC term possible",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "2666-6": {
    "loincCode": "2666-6",
    "system": "For many types of tests",
    "context": "rm possible based on the available information; and 2. Do not overspecify by assuming information that is not known. LOINC Mapping Guide Drug and Toxicology Page 67 80216 2666-6 Norepinephrine [Mass/volume] in Plasma Level of specificity in system For many types of tests, the distinction between plasma and serum is irrelevant. When testing on serum",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "27024-9": {
    "loincCode": "27024-9",
    "method": "Ninety percent of drug and toxicology LOINC terms have one of the ten System values: Urine",
    "system": "values: Urine",
    "context": "rinciples are: 1. Map to the most specific LOINC term possible based on the available information; and 2. Do not overspecify by assuming information that is not known. 92316 27024-9 Cannabinoids [Mass/mass] in Meconium Level of specificity in method Ninety percent of drug and toxicology LOINC terms have one of the ten System values: Urine, Ser/Plas",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "19295-5": {
    "loincCode": "19295-5",
    "component": "The LOINC Scale and Property axes are closely related. The Scale represents a higher level categorization o",
    "property": "axes are closely related. The Scale represents a higher level categorization o",
    "method": "Incorrect component The LOINC Scale and Property axes are closely related. The Scale represents a higher level categorization o",
    "context": "nciples are: 1. Map to the most specific LOINC term possible based on the available information; and 2. Do not overspecify by assuming information that is not known. 2005096 19295-5 Opiates [Presences] in Urine by Screen method Incorrect component The LOINC Scale and Property axes are closely related. The Scale represents a higher level categorization o",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "3893-5": {
    "loincCode": "3893-5",
    "context": "eing measured. Use caution when looking at the Component, as terms with seemingly similar Components could potentially represent very different concepts. 92354 3893-5 oxyCODONE [Mass/volume] in Serum or Plasma All LOINC Components are case insensitive. However, some LOINCs, typically those containing drug names, may use tall man lettering",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "20578-1": {
    "loincCode": "20578-1",
    "component": ". If peak or trough is not specific",
    "context": "from the Institute for Safe Medication Practices. The casing does not imply any meaning; it simply draws attention to the unique characters in drugs with similar names. 90285 20578-1 Vancomycin [Mass/volume] in Serum or Plasma Peak and trough tests will include that information in the Challenge subpart of the Component . If peak or trough is not specific",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "35107-2": {
    "loincCode": "35107-2",
    "component": ". If peak or trough is not specific",
    "context": "ill include that information in the Challenge subpart of the Component . If peak or trough is not specific, then the test represents a random point in time measurement. 3002508 35107-2 Norclobazam [Mass/volume] in Serum or Plasma In some cases, an assay measures two or more analytes but does not distinguish between the two when reporting the result. For ex",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "58430-0": {
    "loincCode": "58430-0",
    "method": "(“&”). In LOINC",
    "context": "asured together. Examples of combinations of analytes in the Drug/Tox Class include Imipramine+Desipramine, Amitriptyline+Nortriptyline, and Cocaine+Benzoylecgonine. 2005103 58430-0 oxyCODONE+oxyMOR phone [Presence] in Urine by Screen method (“&”). In LOINC, the “+” indicates that the test does NOT differentiate between the analytes when reporting the",
    "sourceFile": "LOINC-Mapping-Guide-Drug-and-Toxicology-Version-1.0.pdf"
  },
  "40578-7": {
    "loincCode": "40578-7",
    "context": "t to the one(s) that have mg/dL unit. Another factor is knowing that you are looking for mass concentration MCNC, and not Arbitrary concentration (ACNC). Note that LOINC codes: 40578-7 and 40581-1 have the same value in all six axes of the LOINC FSN, except for the Method. This is another item that helps differentiate between two similar descriptions. 3.3 Qua",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "40581-1": {
    "loincCode": "40581-1",
    "context": "(s) that have mg/dL unit. Another factor is knowing that you are looking for mass concentration MCNC, and not Arbitrary concentration (ACNC). Note that LOINC codes: 40578-7 and 40581-1 have the same value in all six axes of the LOINC FSN, except for the Method. This is another item that helps differentiate between two similar descriptions. 3.3 Qualitative Hem",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "63312-3": {
    "loincCode": "63312-3",
    "property": "Usage notes Examples Ord PrThr Whether or not an analyte is present",
    "context": "codes with this System. Scale Property Usage notes Examples Ord PrThr Whether or not an analyte is present, or the graded amount of analyte present (e.g., Present/Absent) 63312-3 Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay Nom Prid Whether an analyte is present and if so, the type 11070-0 Microscopic observation [Identifier]",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "11070-0": {
    "loincCode": "11070-0",
    "component": "is present in this",
    "context": "alyte present (e.g., Present/Absent) 63312-3 Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay Nom Prid Whether an analyte is present and if so, the type 11070-0 Microscopic observation [Identifier] in Urine by Cyto stain Nom Type The analyte is known to be present and this code answers which “type” of the component is present in this",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "49316-3": {
    "loincCode": "49316-3",
    "context": "ient 882-1 ABO and Rh group [Type] in Blood Nom Imp An overall interpretation of two or more results, where the interpretation text is typically drawn from a predefined list 49316-3 Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Nar Imp An overall interpretation of two or more results, where the interpretation is provided as narrative fr",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "59466-3": {
    "loincCode": "59466-3",
    "system": "values",
    "context": "in pattern [Interpretation] in Blood by Electrophoresis Nar Imp An overall interpretation of two or more results, where the interpretation is provided as narrative free text 59466-3 Hematologist review [Interp] LOINC Mapping Guide Hematology and Serology Page 48 RBC 4.80% Body fld 4.40% Used for body fluid specimens that are not named System values",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "96049-2": {
    "loincCode": "96049-2",
    "method": "Method is the only optional LOINC axis of a fully specified LOINC term. In the d",
    "context": "on values from both serum from the patient and blood from the donor. In hematology, combined Systems like this most often apply to B and T cell crossmatch terms. For example: 96049-2 B cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC) 6 Method Method is the only optional LOINC axis of a fully specified LOINC term. In the d",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "79156-6": {
    "loincCode": "79156-6",
    "context": "Aspergillus sp IgA Ab [Presence] in Serum 5052-6, Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) 50175 Cold Agglutinins 50175 ColdAgglutinins Cold Agglutinins 79156-6 Cold agglutinin [Titer] in Serum by 37 degree C incubation --1 hour post incubation 79156-6 Cold agglutinin [Titer] in Serum by 37 degree C incubation --1 hour post incubat",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "56888-1": {
    "loincCode": "56888-1",
    "system": "The first",
    "context": "hod, challenge, system The first, second and third rows are examples of a challenge within an assay procedure, indicating measurement after some process or additive. 2012674 56888-1 In LOINC, the “+” indicates that the test does NOT differentiate between the analytes when reporting the result, and the “&” indicates that it does differentiate. 2013107 6",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "29893-5": {
    "loincCode": "29893-5",
    "context": "l Option # LOINC term(s) Example results 1 - Report the three individual results 18396-2​ ​HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 29893-5​ ​HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 30361-0​ ​HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 2 - Repor",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "29538-6": {
    "loincCode": "29538-6",
    "context": "597 Arbovirus Antibodies, IgG and IgM, CSF 50239 WestNileIgM CSF West Nile Virus Antibody IgM CSF 29538-6 West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid 29538-6 West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid 3001962 21-Hydroxylase Autoantibodies, Serum 3001963 21 OH Ab 21-Hydroxylase Autoantibody 85363-0 21- Hydr",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "85363-0": {
    "loincCode": "85363-0",
    "property": "of ACnc. 3001962 85363-0 The Ord scale is usually often associated with the Property PrThr (Presence or Threshold)",
    "units": "per volume",
    "context": "eported as various arbitrary units per volume, international units per volume (and units such as Bethesda units/volume), all of which map to the LOINC Property of ACnc. 3001962 85363-0 The Ord scale is usually often associated with the Property PrThr (Presence or Threshold), meaning either the actual presence or absence of an analyte or that the amount of an",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "27812-7": {
    "loincCode": "27812-7",
    "context": "ty PrThr (Presence or Threshold), meaning either the actual presence or absence of an analyte or that the amount of analyte detected is over some predetermined threshold. 30015 27812-7 A set of uncommonly used but often misunderstood Properties are those starting with “Rel” (relative). These are used when the two analytes being compared are measured in two d",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "53622-7": {
    "loincCode": "53622-7",
    "method": "53622-7 von Willebrand factor (vWf) cleaving protease actual/norma",
    "context": "different systems, for example, serum and CSF, or patient and control. The two analytes are often the same, e.g., a relative ratio of glucose in CSF to glucose in serum. 30056 53622-7 A set of uncommonly used but often misunderstood Properties are those starting with “Rel” (relative). These are used when the two analytes being compared are measured in two d",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "3271-4": {
    "loincCode": "3271-4",
    "method": "30144 Heparin Anti-Xa",
    "context": "Heparin Anti-Xa, Low Molecular Weight Heparin 30144 Hep Anti Xa LMW Heparin Anti-Xa Lmwh 3271-4 LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method 3271-4 LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method 30143 Heparin Anti-Xa, Unfractionated 30143 Hep Anti Xa Unf Heparin Anti-Xa Unfractionated 327",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "3274-8": {
    "loincCode": "3274-8",
    "component": "Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component)",
    "method": "30143 Heparin Anti-Xa",
    "context": "ent and control. The two analytes are often the same, e.g., a relative ratio of glucose in CSF to glucose in serum. LOINC Mapping Guide Hematology and Serology Page 68 30144 3274-8 component Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method.",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "27821-8": {
    "loincCode": "27821-8",
    "method": "3274-8 Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method 98894 Protein S Free",
    "context": "8 Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method. 98894 27821-8 Free vs Total 30112 27823-4 LOINC will avoid use of the word “total” in laboratory test names, except when denoting the denominator of a fraction. 51162 3181-5 Key in",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "27823-4": {
    "loincCode": "27823-4",
    "context": "choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method. 98894 27821-8 Free vs Total 30112 27823-4 LOINC will avoid use of the word “total” in laboratory test names, except when denoting the denominator of a fraction. 51162 3181-5 Key information necessary for choosing",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "3181-5": {
    "loincCode": "3181-5",
    "context": "98894 27821-8 Free vs Total 30112 27823-4 LOINC will avoid use of the word “total” in laboratory test names, except when denoting the denominator of a fraction. 51162 3181-5 Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method. 2013590",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "43597-4": {
    "loincCode": "43597-4",
    "component": "Map to the most specific LOINC term possible based on the available info",
    "context": "Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method. 2013590 43597-4 For each LOINC term, these are assembled into a list called “Related Names”. 50707 6969-0 component Map to the most specific LOINC term possible based on the available info",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "48404-8": {
    "loincCode": "48404-8",
    "context": "or Plasma by Immunoblot 43597-4 Inner ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot 50707 MPO/PR3 ANCA) Antibodies 50526 MPO IgG Myeloperoxidase (MPO) Ab, IgG 48404-8 Myeloperoxidase IgG Ab [Units/volume] in Serum 48404-8 Myeloperoxidase IgG Ab [Units/volume] in Serum LOINC Mapping Guide Hematology and Serology Page 66 50707 MPO/PR3",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "48408-9": {
    "loincCode": "48408-9",
    "context": "ng Guide Hematology and Serology Page 66 50707 MPO/PR3 ANCA) Antibodies 50527 PR3 IgG Serine Proteinase 3 (PR3) Ab, IgG 48408-9 Proteinase 3 IgG Ab [Units/volume] in Serum 48408-9 Proteinase 3 IgG Ab [Units/volume] in Serum 51069 Influenza A & B Virus Antibodies, IgG & IgM 51074 Influenza A IgG I□nfluenza A Virus Antibody IgG 47313-2 Influenza virus",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "47313-2": {
    "loincCode": "47313-2",
    "context": "lume] in Serum 48408-9 Proteinase 3 IgG Ab [Units/volume] in Serum 51069 Influenza A & B Virus Antibodies, IgG & IgM 51074 Influenza A IgG I□nfluenza A Virus Antibody IgG 47313-2 Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay 47313-2 Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay 50091 Bartonella henselae Antibod",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "6954-2": {
    "loincCode": "6954-2",
    "context": "name of the analyte (Component), the specimen type (System), and if relevant, the Method. Map to the most specific LOINC term possible based on the available information. 50091 6954-2 Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if relevant, the Method.",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "5098-9": {
    "loincCode": "5098-9",
    "system": "The first",
    "context": "LOINC Mapping Guide Hematology and Serology Page 67 Answers to examples Test Number ARUP Current State Reason for mismatch Answers/Comments Example 5052-6 50175 5098-9 specificity of method, challenge, system The first, second and third rows are examples of a challenge within an assay procedure, indicating measurement after some process or ad",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "68961-2": {
    "loincCode": "68961-2",
    "method": "In general",
    "context": "1 In LOINC, the “+” indicates that the test does NOT differentiate between the analytes when reporting the result, and the “&” indicates that it does differentiate. 2013107 68961-2 method In general, when the specific method used has a clinically significant impact on interpreting the results for a particular analyte, LOINC will specify the Method in its t",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "39573-1": {
    "loincCode": "39573-1",
    "property": "in the Hematology domain is ACnc (arbitrary concentration)",
    "method": "used has a clinically significant impact on interpreting the results for a particular analyte",
    "context": "hen the specific method used has a clinically significant impact on interpreting the results for a particular analyte, LOINC will specify the Method in its term name. 2001597 39573-1 index value vs arbU/ml The next most common quantitative Property in the Hematology domain is ACnc (arbitrary concentration), reflective of the numerous coagulation tests report",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "6969-0": {
    "loincCode": "6969-0",
    "component": "Map to the most specific LOINC term possible based on the available information 50707 6968-2 component Map to the most specific LOINC term possible based on the avai",
    "context": "(Component), the specimen type (System), and if relevant, the Method. 2013590 43597-4 For each LOINC term, these are assembled into a list called “Related Names”. 50707 6969-0 component Map to the most specific LOINC term possible based on the available information 50707 6968-2 component Map to the most specific LOINC term possible based on the avai",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "6968-2": {
    "loincCode": "6968-2",
    "component": "Map to the most specific LOINC term possible based on the available information 50707 6968-2 component Map to the most specific LOINC term possible based on the available information 51069 31437-7 specificity of method and system Key information necessary for choosi",
    "method": "and system Key information necessary for choosi",
    "system": "Key information necessary for choosi",
    "context": "term, these are assembled into a list called “Related Names”. 50707 6969-0 component Map to the most specific LOINC term possible based on the available information 50707 6968-2 component Map to the most specific LOINC term possible based on the available information 51069 31437-7 specificity of method and system Key information necessary for choosi",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "31437-7": {
    "loincCode": "31437-7",
    "component": "Map to the most specific LOINC term possible based on the available information 51069 31437-7 specificity of method and system Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component)",
    "method": "and system Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component)",
    "system": "Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component)",
    "context": "pecific LOINC term possible based on the available information 50707 6968-2 component Map to the most specific LOINC term possible based on the available information 51069 31437-7 specificity of method and system Key information necessary for choosing the correct LOINC term includes the name of the analyte (Component), the specimen type (System), and if",
    "sourceFile": "LOINC-Mapping-Guide-Hematology-Serology-Version-1.0.pdf"
  },
  "2015-02": {
    "loincCode": "2015-02",
    "context": "the phenotype level. The term allele is usually applied to a genetic variant that does not cause a disease. 4 2015 Supporting interoperability of genetic data with LOINC. (2015-02-05) Journal of the American Medical Informatics Association : JAMIA Jamalynne Deckard, Clement J McDonald, Daniel J Vreeman LOINC Mapping Guide Molecular Pathology Page 42",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "95770-4": {
    "loincCode": "95770-4",
    "method": "76037-1 GALT gene f",
    "context": "disease but most often to a specific gene. (Nearly half of the MOLPATH codes in LOINC version 2.72 contain a gene name followed by either full or targeted mutation analysis.) 95770-4 GALT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen LCN: GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 76037-1 GALT gene f",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "76037-1": {
    "loincCode": "76037-1",
    "method": "76037-1 GALT gene full mutation analysis: Find:Pt:Bld/Tiss:Doc:Molgen LCN: GALT gene full mutation analysis in Blood or Tissue by Sequencing The original model uses a distinct",
    "context": "alysis.) 95770-4 GALT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen LCN: GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 76037-1 GALT gene full mutation analysis: Find:Pt:Bld/Tiss:Doc:Molgen LCN: GALT gene full mutation analysis in Blood or Tissue by Sequencing The original model uses a distinct, pre-co",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "81247-9": {
    "loincCode": "81247-9",
    "component": "Names As molecula",
    "context": "n LOINC mappings and better interoperability. The following are examples of pre-coordinated LOINC codes. The following are examples of generic model LOINC codes. (The panel “81247-9 Master HL7 genetic variant reporting panel” includes these panel children.) LOINC Mapping Guide Molecular Pathology Page 43 2.2 Gene and Variant Component Names As molecula",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "36908-2": {
    "loincCode": "36908-2",
    "context": "ynonyms: breast cancer risk gene) For each such targeted mutation analysis, we recommend reporting the mutations that were tested using an additional LOINC code, such as LOINC 36908-2 (Gene mutations tested for) or gene-specific companion LOINC observation codes with the words “mutations tested for.” LOINC Mapping Guide Molecular Pathology Page 47 <gene",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "978-3": {
    "loincCode": "978-3",
    "context": "ecomm. of the Int. Standing Comm., Memphis, Tenn., October 1994. Published in coll. with 'Cytogen. & Cell Gen.' Plus fold-out: 'The Normal Human Karyotype G- and R-bands' ISBN: 978-3-8055-6226-3 LOINC Mapping Guide Molecular Pathology Page 50 (Synonyms: SCL/TAL1 interrupting locus, T-cell acute lymphoblastic leukemia, ALL, T- ALL, TAL-1 deletions) inv(",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "8055-6226": {
    "loincCode": "8055-6226",
    "context": "of the Int. Standing Comm., Memphis, Tenn., October 1994. Published in coll. with 'Cytogen. & Cell Gen.' Plus fold-out: 'The Normal Human Karyotype G- and R-bands' ISBN: 978-3-8055-6226-3 LOINC Mapping Guide Molecular Pathology Page 50 (Synonyms: SCL/TAL1 interrupting locus, T-cell acute lymphoblastic leukemia, ALL, T- ALL, TAL-1 deletions) inv(16)(p13.1;",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "51773-0": {
    "loincCode": "51773-0",
    "component": "Property:Timing:System:Scale:Method) Local test: HEXA gene targeted mutation -Find-Pt-Bld- Doc-Molgen ❏ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutatio",
    "property": "Timing:System:Scale:Method) Local test: HEXA gene targeted mutation -Find-Pt-Bld- Doc-Molgen ❏ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutatio",
    "system": "Scale:Method) Local test: HEXA gene targeted mutation -Find-Pt-Bld- Doc-Molgen ❏ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutatio",
    "context": "alysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 35472-0: HEXA gene.c.1277insTATC:PrThr:Pt:Bld/Tiss:Ord:Molgen 51773-0 is the only term listed that matches the Component (HEXA gene targeted mutation analysis), the Property (Find), the Timing (Pt), the System (Bld/Tiss), the Scale (Doc), and the",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "32632-2": {
    "loincCode": "32632-2",
    "system": "Scale:Method) Local test: HEXA gene targeted mutation -Find-Pt-Bld- Doc-Molgen ❏ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation te",
    "context": ":Scale:Method) Local test: HEXA gene targeted mutation - Find - Pt – Bld/Tiss - Doc – Molgen ✓ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation te",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "76033-0": {
    "loincCode": "76033-0",
    "context": "ss - Doc – Molgen ✓ 51773-0: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 35472-0: HEXA gene.c.1277insTATC:PrThr",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "38900-7": {
    "loincCode": "38900-7",
    "context": "Bld/Tiss:Doc:Molgen ❏ 32632-2: HEXA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 35472-0: HEXA gene.c.1277insTATC:PrThr:Pt:Bld/Tiss:Ord:Molgen 51773-0 is the only term listed that matches the C",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "35472-0": {
    "loincCode": "35472-0",
    "component": "(HEXA gene targeted mutation analysis)",
    "property": "(Find)",
    "context": "rid:Pt:Bld/Tiss:Nom:Molgen ❏ 76033-0 HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing ❏ 38900-7: HEXA gene mutation tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 35472-0: HEXA gene.c.1277insTATC:PrThr:Pt:Bld/Tiss:Ord:Molgen 51773-0 is the only term listed that matches the Component (HEXA gene targeted mutation analysis), the Property (Find),",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21637-4": {
    "loincCode": "21637-4",
    "component": "– Analytes are differ",
    "method": "(Molgen). See Section 2 Choosing the Right LOINC Term (Mapping). 3. Why is the LOINC below a poor choice for the local test? LOINC: 21637-4: BRCA1gene.c.185delAG:PrThr:Pt:Bld/Tiss:Ord:Molgen Local test: BRCA1 gene targeted mutation analysis - Prid - Pt - Bld/Tiss - Nom – Molgen ✓ Component – Analytes are differ",
    "context": "s), the Scale (Doc), and the Method (Molgen). See Section 2 Choosing the Right LOINC Term (Mapping). 3. Why is the LOINC below a poor choice for the local test? LOINC: 21637-4: BRCA1gene.c.185delAG:PrThr:Pt:Bld/Tiss:Ord:Molgen Local test: BRCA1 gene targeted mutation analysis - Prid - Pt - Bld/Tiss - Nom – Molgen ✓ Component – Analytes are differ",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "79401-6": {
    "loincCode": "79401-6",
    "component": "Property:Timing:System:Scale:Method) Local test: HBB full gene - Prid - Pt - Bld/Tiss - Nom - Next generation sequencing ❏ 79401-6: HBB gene full mutation analysis: Prid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 77627-8: HBB gene full mutation analysis",
    "property": "Timing:System:Scale:Method) Local test: HBB full gene - Prid - Pt - Bld/Tiss - Nom - Next generation sequencing ❏ 79401-6: HBB gene full mutation analysis: Prid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 77627-8: HBB gene full mutation analysis",
    "system": "Scale:Method) Local test: HBB full gene - Prid - Pt - Bld/Tiss - Nom - Next generation sequencing ❏ 79401-6: HBB gene full mutation analysis: Prid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 77627-8: HBB gene full mutation analysis",
    "context": "options follow this model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: HBB full gene - Prid - Pt - Bld/Tiss - Nom - Next generation sequencing ❏ 79401-6: HBB gene full mutation analysis: Prid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 77627-8: HBB gene full mutation analysis",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21691-1": {
    "loincCode": "21691-1",
    "context": "/Tiss:Nom:Molgen ✓ 77627-8: HBB gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing ❏ 90925-9: HBB gene full mutation analysis:Find:Pt: Amnio fld/CVS:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 21689-5: HBB gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen 77627-8 is the only LOINC listed that ma",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "77627-8": {
    "loincCode": "77627-8",
    "component": "(HBB full gene)",
    "property": "(Prid)",
    "method": "(sequencing). See Section 2.1 Ge",
    "system": "(Bld/Tiss)",
    "context": "- Next generation sequencing ❏ 79401-6: HBB gene full mutation analysis:Prid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ✓ 77627-8: HBB gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing ❏ 90925-9: HBB gene full mutation analysis:Find:Pt: Amnio fld/CVS:Doc:Sequencing ❏ 21691-1: HBB gene mutations",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "90925-9": {
    "loincCode": "90925-9",
    "context": "rid:Pt:Bld/Tiss:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 77627-8: HBB gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing ❏ 90925-9: HBB gene full mutation analysis:Find:Pt: Amnio fld/CVS:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 21689-5: HBB gene targeted mutatio",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21689-5": {
    "loincCode": "21689-5",
    "component": "(HBB full gene)",
    "property": "(Prid)",
    "context": "Bld/Tiss:Nom:Sequencing ❏ 90925-9: HBB gene full mutation analysis:Find:Pt: Amnio fld/CVS:Doc:Sequencing ❏ 21691-1: HBB gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 21689-5: HBB gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen 77627-8 is the only LOINC listed that matches the Component (HBB full gene), Property (Prid), Timing (Pt), Sy",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "49854-3": {
    "loincCode": "49854-3",
    "method": "(sequencing). See Section 2.1 General Mapping Principles. 6. Why is the LOINC below a poor choice for the local test? LOINC: 49854-3: COL5A1 gene+COL5A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen Local test: COL5A1 gene targeted mutation analysis - Find - Pt - Bld/Tiss - Doc – LOINC Ma",
    "system": "(Bld/Tiss)",
    "context": "rid:Pt:Bld/Tiss:Nom:Molgen ❏ 21689-5: HBB gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen 6. Why is the LOINC below a poor choice for the local test? LOINC: 49854-3: COL5A1 gene+COL5A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen Local test: COL5A1 gene targeted mutation analysis Find-Pt-Bld/Tiss-Doc-Molgen ❏ Analytes a",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "41107-4": {
    "loincCode": "41107-4",
    "component": "Property:Timing:System:Scale:Method) Local test: FMR1 gene activation in tissue by Molecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethyl",
    "property": "Timing:System:Scale:Method) Local test: FMR1 gene activation in tissue by Molecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethyl",
    "method": "reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethyl",
    "system": "Scale:Method) Local test: FMR1 gene activation in tissue by Molecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethyl",
    "context": "tions follow this model: LOINC Code: Component:Property:Timing:System:Scale:Method) Local test: FMR1 gene activation in tissue by Molecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethyl",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "66874-9": {
    "loincCode": "66874-9",
    "component": "and Property of the local term. LOINC Mapping Guide Molecular Pathology Page 67 9. Match the Property to the Un",
    "property": "of the local term. LOINC Mapping Guide Molecular Pathology Page 67 9. Match the Property to the Un",
    "method": "reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+",
    "context": "Method) Local test: FMR1 gene activation in tissue by Molecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21759-6": {
    "loincCode": "21759-6",
    "method": "reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ❏ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+full mutation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 369143-0: FMR1",
    "context": "lecular genetics method reported as % ❏ 41107-4: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen ✓ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+full mutation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 369143-0: FMR1",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "66876-4": {
    "loincCode": "66876-4",
    "property": "to t",
    "context": "ysis:Prid:Pt:Bld/Tiss:Nom:Molgen ✓ 66874-9: FMR1 gene activation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+full mutation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 369143-0: FMR1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen 66874-9 is the only term lis",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "369143-0": {
    "loincCode": "369143-0",
    "component": "and Property of the local term. LOINC Map",
    "property": "to the Unit Property Answer Unit A Ratio Example: A-3 1 {CAG_repeats} B Score 2 % C N",
    "units": "Property Answer Unit A Ratio Example: A-3 1 {CAG_repeats} B Score 2 % C N",
    "context": "lgen ❏ 21759-6: FMR1 gene methylation/methylated+unmethylated:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 66876-4: FMR1 gene premutation/premutation+full mutation:NFr:Pt:Bld/Tiss:Qn:Molgen ❏ 369143-0: FMR1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen 9. Match the Property to the Unit Property Answer Unit A Ratio Example: A-3 1 {CAG_repeats} B Score 2 % C N",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "35474-6": {
    "loincCode": "35474-6",
    "component": "Mnemonic Component Name Pre LOINC Mapping Post LOINC Mapping Example Alpha Globin (HBA1 and 2) Seq",
    "method": "51968-6 Discrete variation analysis overall interpretation 2014677 Expanded Carrier",
    "context": "utations tested for in Blood or Tissue by Molecular genetics method Nomina 2014248 Factor V R2 Mutation Detection by PCR 2014251 F5R2 Interp Factor V, R2 - Interpretation 35474-6 Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method 53039-4 Genetic disease analysis overall carrier interpretation 2013341 Apolipoprotein",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "51968-6": {
    "loincCode": "51968-6",
    "component": "Searched by high level \"interpretation\" and then narrowed down to genetic. It was a tossup between 53039-4 and 51968-6. Decided on 51968-6 since it was",
    "method": "51968-6 Discrete variation analysis overall interpretation 2014677 Expanded Carrier Screen by NGS w/FX 2014679 ECSSEQ FX Expanded Carrier SCRN NGS w/FRAG X 53039-4 Genetic disea",
    "context": "MLPA 51415 51968-6 specificity of component Searched by high level \"interpretation\" and then narrowed down to genetic. It was a tossup between 53039-4 and 51968-6. Decided on 51968-6 since it was missing the carrier in the description and the panel had another DTA with carrier that would be closer to 53039-4 2014677 53039-4 specificity of component Search",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "53039-4": {
    "loincCode": "53039-4",
    "component": "Searched by high level \"interpretation\" and then narrowed down to genetic. It was a tossup between 53039-4 and 51968-6. Decided on 51968-6 since it was missing the carrier in the description and the panel had another DTA with carrier that would be closer to 53039-4 2014677 53039-4",
    "method": "51968-6 Discrete variation analysis overall interpretation 2014677 Expanded Carrier Screen by NGS w/FX 2014679 ECSSEQ FX Expanded Carrier SCRN NGS w/FRAG X 53039-4 Genetic disease analysis overall carrier interpretation 53039-4 Genetic disease analysis overall carrier interpretation 2014680 Expanded Carrier Screen by NGS 2014682",
    "context": "53039-4 and 51968-6. Decided on 51968-6 since it was missing the carrier in the description and the panel had another DTA with carrier that would be closer to 53039-4 2014677 53039-4 specificity of component Searched for high level for carrier with 38 results. Narrowed it down to screen with 9 results back. All of the nine were too specific and did not matc",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "49705-7": {
    "loincCode": "49705-7",
    "method": "35297-1 LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular gene",
    "context": "erpretation 53039-4 Genetic disease analysis overall carrier interpretation 3000304 LMNA Full Gene Sequencing for DCM 3000307 LMNA Var Path LMNA Variant Pathogenicity 49705-7 LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 35297-1 LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular gene",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "35297-1": {
    "loincCode": "35297-1",
    "component": "component (findings vs clinical significance) Decided to go with 35297-1 due to the identifier tag. 3001957 53037-8 specificity of component component (interp vs clinical significance) 3003800 43399-5 Could be blood ro BM but could not fin",
    "method": "35297-1 LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 3001957 Gamma Globin (HBG1 and HBG2) Sequencing 3002039 HBG Interp HBG FGS",
    "context": "ed ngs and carrier with only 3 hits. Results were too specific. 3000304 53037-8 specificity of component component (findings vs clinical significance) Decided to go with 35297-1 due to the identifier tag. 3001957 53037-8 specificity of component component (interp vs clinical significance) 3003800 43399-5 Could be blood ro BM but could not fin",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "43399-5": {
    "loincCode": "43399-5",
    "component": "component (interp vs clinical significance) 3003800 43399-5 Could be blood ro BM but could not find one for both in Relma. Selected blood or tissue option 3002956 81258-6 component (gene specific vs generic) 3002956 88519-4",
    "method": "43399-5 JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method",
    "context": "617F Qual w/Rflx CALR w/Rflx MPL 3004048 JAK2 QUAL Int JAK2 QUAL Mutation by PCR 43399-5 JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method 43399-5 JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method 3002956 KIT (D816V)Mutation by ddPCR Quant 3002962 KIT D816V VAF KIT D816V Variant Alle",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "88519-4": {
    "loincCode": "88519-4",
    "component": "(gene specific vs generic) 3002956 88519-4 component (findings vs qual result) Went with 55201-8 thinking it might be more specific. LOINC Mapping Guide Molecular Pathology Page 76 30133 21668-9 component (genotyp",
    "method": "3002956 KIT (D816V)Mutation by ddPCR Quant 3002962 KIT D816V VAF KIT D816V Variant Allele Frequency 88519-4 KIT gene c.2447A>T[Presence] in Blood or Tissue by Molecular geneticsmethod 88519-4 KIT gene c.2447A>T[Presence] in Blood or Tissue by Molecular genetics method 3002956",
    "context": "6V)Mutation by ddPCR Quant 3002962 KIT D816V VAF KIT D816V Variant Allele Frequency 88519-4 KIT gene c.2447A>T[Presence] in Blood or Tissue by Molecular geneticsmethod 88519-4 KIT gene c.2447A>T[Presence] in Blood or Tissue by Molecular genetics method 3002956 KIT (D816V) Mutation by ddPCR Quant 3002963 KIT QNT Interp KIT D816V Mutation by PCR",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "55201-8": {
    "loincCode": "55201-8",
    "component": "(gene specific vs generic) 3002956 88519-4 component (findings vs qual result) Went with 55201-8 thinking it might be more specific. LOINC Mapping Guide Molecular Pathology Page 76 30133 21668-9 component (genotype vs PrThr) Looked at the LTD to see if I could get any",
    "method": "3002956 KIT (D816V) Mutation by ddPCR Quant 3002963 KIT QNT Interp KIT D816V Mutation by PCR 53039-4 Genetic disease analysis overall carrier interpretation 55201-8 KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 30133 Thrombosis",
    "context": "tics method 3002956 KIT (D816V) Mutation by ddPCR Quant 3002963 KIT QNT Interp KIT D816V Mutation by PCR 53039-4 Genetic disease analysis overall carrier interpretation 55201-8 KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 30133 Thrombosis, Common Etiologies 0030194 FACV Reflex Factor V Leiden by PCR 21667-1",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21667-1": {
    "loincCode": "21667-1",
    "method": "30133 Thrombosis",
    "context": "55201-8 KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 30133 Thrombosis, Common Etiologies 0030194 FACV Reflex Factor V Leiden by PCR 21667-1 F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 91712-0 F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetic",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "91712-0": {
    "loincCode": "91712-0",
    "method": "Nominal 91712-0 F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal 97720 Factor V Leiden (F5) R506Q Mutation 0097720 FACV Factor V Leiden (F5) R506Q M",
    "context": "mbosis, Common Etiologies 0030194 FACV Reflex Factor V Leiden by PCR 21667-1 F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal 91712-0 F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal 97720 Factor V Leiden (F5) R506Q Mutation 0097720 FACV Factor V Leiden (F5) R506Q M",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21668-9": {
    "loincCode": "21668-9",
    "component": "(findings vs qual result) Went with 55201-8 thinking it might be more specific. LOINC Mapping Guide Molecular Pathology Page 76 30133 21668-9 component (genotype vs PrThr) Looked at the LTD to see if I could get any additional information. Saw a blurb in the the Interp data: Cause: A deleterious F5 gene mutation R50",
    "method": "Nominal 97720 Factor V Leiden (F5) R506Q Mutation 0097720 FACV Factor V Leiden (F5) R506Q Mutation 21668-9 F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method 21668-9 F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method",
    "context": "the the Interp data: Cause: A deleterious F5 gene mutation R506Q (1691G>A). Note: Standardized nomenclature for the Factor V Leiden Mutation is c.1601G>A (p.Arg534Gln). 97720 21668-9 2014248 41103-3 specificity of component component (gene specific vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21669-7": {
    "loincCode": "21669-7",
    "method": "LOINC Mapping Guide Molecular Pathology Page 73 2014248 Factor V R2 Mutation Detection by PCR 2014249 F5R2 DNA Factor V",
    "context": "Mutation Detection by PCR 2014249 F5R2 DNA Factor V, R2 Mutation Detection 21669-7 F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal 21669-7 F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nomina 2014248 Factor V R2 Mutation Detection by PCR 2014251 F5R2 Interp Factor V, R2 - Inter",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "34734-4": {
    "loincCode": "34734-4",
    "component": "34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X",
    "method": "Nominal 21619-2 APOEgene mutations found [Identifier] in Blood or Tissue",
    "context": "ic vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X, FX.... With no luck. Looked more into the Fragile X nomenclatu",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "21619-2": {
    "loincCode": "21619-2",
    "component": "34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X",
    "method": "Nominal 21619-2 APOEgene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nomina 2011241 Duchenne/Becker MD DelDup w/Rflx to Seq 2011243 DMD REFLEX MLP Duch",
    "context": "findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X, FX.... With no luck. Looked more into the Fragile X nomenclature and noticed the FMR1 designation.",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "75385-5": {
    "loincCode": "75385-5",
    "component": "34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X",
    "method": "Nomina 2011241 Duchenne/Becker MD DelDup w/Rflx to Seq 2011243 DMD REFLEX MLP Duchenne/Becker MD (DMD) DelDup MLPA 75385-5 DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA 75385-5 DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA 300",
    "context": "ions Went with the more generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X, FX.... With no luck. Looked more into the Fragile X nomenclature and noticed the FMR1 designation. Searched for FMR1",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "45321-7": {
    "loincCode": "45321-7",
    "component": "34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X",
    "method": "36913-2 FMR1 gene targeted mutation analysis in Blood or Tissue by Molec",
    "context": "e generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X, FX.... With no luck. Looked more into the Fragile X nomenclature and noticed the FMR1 designation. Searched for FMR1 and returned 12 hits.",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "36913-2": {
    "loincCode": "36913-2",
    "method": "36913-2 FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 2005025 BCR-ABL1",
    "context": "er Screen 3 Disord w/Rflx 0050556 FX Allele 1 Fragile X Allele 1 45321-7 FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method 36913-2 FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 2005025 BCR-ABL1, Minor, Quant (Internal only) 2005008 BCR Min Ratio BCR-ABL1/ABL1, M",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "69381-2": {
    "loincCode": "69381-2",
    "method": "2005025 BCR-ABL1",
    "context": "ion analysis in Blood or Tissue by Molecular genetics method 2005025 BCR-ABL1, Minor, Quant (Internal only) 2005008 BCR Min Ratio BCR-ABL1/ABL1, Minor (p190) Quant Ratio 69381-2 t(9;22)(q34.1;q11)( ABL1,BCR) b2a2 fusion transcript/control transcript (International 69381-2 t(9;22)(q34.1;q11)( ABL1,BCR) b2a2 fusion transcript/control transcript (In",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "59266-7": {
    "loincCode": "59266-7",
    "component": "Had trouble deciduing between 38413-1 and 75391-13. The difference were the systems. Decided on 38413-1 since I consider Amniocytes a type of tissue. 0051265 59266-7 component Looked at the dta more closely and it was a specimen dta. Searched for MCC specimen and it was the only hit.",
    "method": "59266-7 Maternal cell contamination [Identifier] in Specimen Nominal LOINC Mapping Guide Molecular Pathology Page 75 Answers to examples Test Number ARUP Current State R",
    "context": "3) 2Mutations Fetal 0050548 MCC Fetal Maternal Contamination Study Fetal Spec 38413-1FGFR3gene targeted mutation analysis in Blood or Tissue by Molecular genetics method 59266-7 Maternal cell contamination [Identifier] in Specimen Nominal LOINC Mapping Guide Molecular Pathology Page 75 Answers to examples Test Number ARUP Current State R",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "87730-8": {
    "loincCode": "87730-8",
    "component": "Searched by high level \"inter",
    "context": "in Specimen Nominal LOINC Mapping Guide Molecular Pathology Page 75 Answers to examples Test Number ARUP Current State Reason for mismatch Comments Example 87730-8 HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing is close, but we reflex to MLPA 51415 51968-6 specificity of component Searched by high level \"inter",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "53037-8": {
    "loincCode": "53037-8",
    "component": "Searched NGS with over 300 hits. Searched ngs and carrier with only 3 hits. Results were too specific. 3000304 53037-8 specificity of component component (findings vs clinical significance) Decided to go with 35297-1 due to the identifier tag. 3001957 53037-8 specificity of component compon",
    "context": "ays interpretation. 2014680 53039-4 specificity of component Searched NGS with over 300 hits. Searched ngs and carrier with only 3 hits. Results were too specific. 3000304 53037-8 specificity of component component (findings vs clinical significance) Decided to go with 35297-1 due to the identifier tag. 3001957 53037-8 specificity of component compon",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "81258-6": {
    "loincCode": "81258-6",
    "component": "(interp vs clinical significance) 3003800 43399-5 Could be blood ro BM but could not find one for both in Relma. Selected blood or tissue option 3002956 81258-6 component (gene specific vs generic) 3002956 88519-4 component (findings vs qual result) Went with 55201-8 thinking it might be more specific. LOINC Mapping Guide M",
    "context": "component (interp vs clinical significance) 3003800 43399-5 Could be blood ro BM but could not find one for both in Relma. Selected blood or tissue option 3002956 81258-6 component (gene specific vs generic) 3002956 88519-4 component (findings vs qual result) Went with 55201-8 thinking it might be more specific. LOINC Mapping Guide M",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "41103-3": {
    "loincCode": "41103-3",
    "component": "component (gene specific vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact",
    "context": "ause: A deleterious F5 gene mutation R506Q (1691G>A). Note: Standardized nomenclature for the Factor V Leiden Mutation is c.1601G>A (p.Arg534Gln). 97720 21668-9 2014248 41103-3 specificity of component component (gene specific vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "42315-2": {
    "loincCode": "42315-2",
    "component": "(gene specific vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X",
    "context": "omponent component (gene specific vs generic) 2014248 35474-6 findings vs impressions Went with the more generic LOINC since I couldn't quite find an exact match. 2013341 42315-2 specificity of component 34734-4 was deprecated and mapped to 21619-2 2011241 75385-5 3000258 45321-7 component Tried to search Fragile X, FX.... With no luck. Looked mo",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "52132-8": {
    "loincCode": "52132-8",
    "component": "Search with \"ratio bcr minor\" returns 11 hits. Differences being the fusion transcript and the property. How do we tell which fusion transcript? B2a2",
    "context": "ith no luck. Looked more into the Fragile X nomenclature and noticed the FMR1 designation. Searched for FMR1 and returned 12 hits. Went with the more general LOINC??? 2005025 52132-8 component Search with \"ratio bcr minor\" returns 11 hits. Differences being the fusion transcript and the property. How do we tell which fusion transcript? B2a2, b1a1, b3a1? P",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "38413-1": {
    "loincCode": "38413-1",
    "component": "Had trouble deciduing between 38413-1 and 75391-13. The difference were the systems. Decided on 38413-1 since I consider Amniocytes a type of tissue.",
    "context": "t? B2a2, b1a1, b3a1? Package insert? 51265 38413-1 specificity of component Had trouble deciduing between 38413-1 and 75391-13. The difference were the systems. Decided on 38413-1 since I consider Amniocytes a type of tissue. 0051265 59266-7 component Looked at the dta more closely and it was a specimen dta. Searched for MCC specimen and it was the onl",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "75391-13": {
    "loincCode": "75391-13",
    "component": "Had trouble deciduing between 38413-1 and 75391-13. The difference were the systems. Decided on 38413-1 since I consider Amniocytes a type of tissue. 0051265 59266-7 component Looked at the dta more closely and it was a spe",
    "context": "and the property. How do we tell which fusion transcript? B2a2, b1a1, b3a1? Package insert? 51265 38413-1 specificity of component Had trouble deciduing between 38413-1 and 75391-13. The difference were the systems. Decided on 38413-1 since I consider Amniocytes a type of tissue. 0051265 59266-7 component Looked at the dta more closely and it was a spe",
    "sourceFile": "LOINC-Mapping-Guide-Molecular-Pathology-Version-1.0.pdf"
  },
  "8014-3": {
    "loincCode": "8014-3",
    "context": "ples because at the current time, v2 is widely used in laboratory result reporting. The LOINC code in each example links to the web page with details for that term. OBX|1|NM|​8014-3​^Rubella virus IgG Ab [Units/​volume] in Serum^LN^RUB IGG^Rubella IgG Serum^L||18|IU/mL|<10|P|... The table below provides a brief overview of the field definitions in an HL7",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "10729-2": {
    "loincCode": "10729-2",
    "component": "{Class or name of organism} identified Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method Microscopy.light Examples: 10729-2​ Trypanosoma sp identified: Prid: Pt: Bld: Nom: Microscopy.light LCN: ​Trypanosoma sp identified in Blood by Light microscopy OBX|1|CE|​10729-2​^Trypanosoma sp identified in",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method Microscopy.light Examples: 10729-2​ Trypanosoma sp identified: Prid: Pt: Bld: Nom: Microscopy.light LCN: ​Trypanosoma sp identified in Blood by Light microscopy OBX|1|CE|​10729-2​^Trypanosoma sp identified in",
    "method": "Microscopy.light Examples: 10729-2​ Trypanosoma sp identified: Prid: Pt: Bld: Nom: Microscopy.light LCN: ​Trypanosoma sp identified in Blood by Light microscopy OBX|1|CE|​10729-2​^Trypanosoma sp identified in",
    "system": "{Specimen type} Scale Nom Method Microscopy.light Examples: 10729-2​ Trypanosoma sp identified: Prid: Pt: Bld: Nom: Microscopy.light LCN: ​Trypanosoma sp identified in Blood by Light microscopy OBX|1|CE|​10729-2​^Trypanosoma sp identified in",
    "context": "rm. Note that the LCN is italicized, both when the LOINC code and name pairs are presented separately (as below) as well as when they are included within a paragraph of text. 10729-2​ Trypanosoma sp identified: Prid: Pt: Bld: Nom: Microscopy.light LCN: ​Trypanosoma sp identified in Blood by Light microscopy 2.5 Key points and Evolving models Specific point",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "20457-8": {
    "loincCode": "20457-8",
    "component": "{Class or name of organism} Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Microscopy.light Example: 20457-8​ Fungi.filamentous: PrThr: Pt: Urine sed: Ord: Microscopy.light LCN: ​ Fungi.filamentous [Presence] in Urine sediment by Light microscopy OBX|1|CE|​20457-8​^Fungi.filamentous",
    "property": "PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Microscopy.light Example: 20457-8​ Fungi.filamentous: PrThr: Pt: Urine sed: Ord: Microscopy.light LCN: ​ Fungi.filamentous [Presence] in Urine sediment by Light microscopy OBX|1|CE|​20457-8​^Fungi.filamentous",
    "method": "Microscopy.light Example: 20457-8​ Fungi.filamentous: PrThr: Pt: Urine sed: Ord: Microscopy.light LCN: ​ Fungi.filamentous [Presence] in Urine sediment by Light microscopy OBX|1|CE|​20457-8​^Fungi.filamentous",
    "system": "{Specimen type} Scale Ord Method Microscopy.light Example: 20457-8​ Fungi.filamentous: PrThr: Pt: Urine sed: Ord: Microscopy.light LCN: ​ Fungi.filamentous [Presence] in Urine sediment by Light microscopy OBX|1|CE|​20457-8​^Fungi.filamentous",
    "context": "ight Example: 20457-8​ Fungi.filamentous: PrThr: Pt: Urine sed: Ord: Microscopy.light LCN: ​ Fungi.filamentous [Presence] in Urine sediment by Light microscopy OBX|1|CE|​20457-8​^Fungi.filamentous [Presence] in Urine sediment by Light microscopy^LN|1|LA11882-0^Detected^LN|||... 3.2 Stains LOINC includes terms for a variety of stains that aid in the i",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "11480-1": {
    "loincCode": "11480-1",
    "component": "Microscopic observation Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Name of stain} Examples: 11480-1​ Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Urine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Name of stain} Examples: 11480-1​ Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Urine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast",
    "method": "{Name of stain} Examples: 11480-1​ Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Urine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast",
    "system": "{Specimen type} Scale Nom Method {Name of stain} Examples: 11480-1​ Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Urine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast",
    "context": "c fluid by Acid fast stain 27112-2​ Microscopic observation:Prid:Pt:Body fld:Nom:Gram stain LCN: ​Microscopic observation [Identifier] in Body fluid by Gram stain OBX|1|CE|​11480-1​^Microscopic observation [Identifier] in Urine by Acid fast stain^LN|1|LA20996-7^Mycobacterium tuberculosis^LN||... Guide for Using LOINC Microbiology Terms ​• 19 KEY POIN",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "11476-9": {
    "loincCode": "11476-9",
    "context": "ethod {Name of stain} Examples: 11480-1​ Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Urine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast fld:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Gastric fluid by Acid fast stain 27112-2​ Microscopic observation:P",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "27112-2": {
    "loincCode": "27112-2",
    "context": "rine by Acid fast stain 11476-9​ Microscopic observation:Prid:Pt:Gast fld:Nom:Acid fast stain LCN: ​Microscopic observation [Identifier] in Gastric fluid by Acid fast stain 27112-2​ Microscopic observation:Prid:Pt:Body fld:Nom:Gram stain LCN: ​Microscopic observation [Identifier] in Body fluid by Gram stain OBX|1|CE|​11480-1​^Microscopic observation [Ide",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "23597-8": {
    "loincCode": "23597-8",
    "component": "{Name of organism} Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Name of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:",
    "property": "PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Name of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:",
    "method": "{Name of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:",
    "system": "{Specimen type} Scale Ord Method {Name of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:",
    "context": "LOINC name follows this pattern: Component {Name of organism} Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Name of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "20781-1": {
    "loincCode": "20781-1",
    "context": "me of stain} Examples: 23597-8​ Dermatophilus congolensis:PrThr:Pt:Exudate:Ord:Methylene blue LCN: ​Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain 20781-1​ Cryptosporidium sp:PrThr:Pt:Stool:Ord:Acid fast stain LCN: ​Cryptosporidium sp [Presence] in Stool by Acid fast stain OBX|1|CE|​23597-8​^Dermatophilus congolensis [Presence",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "6470-9": {
    "loincCode": "6470-9",
    "property": "Prid Guide for Using LOINC Microbiology Terms ​• 21 Time Aspect {Time value} System {Specimen type} Scale Nom Method Wet preparation Examples: 6470-9​ Microscopic observation:Prid:Pt:Stool:Nom:Wet preparation LCN: ​Microscopic observation [Identifier] in Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body",
    "method": "Wet preparation Examples: 6470-9​ Microscopic observation:Prid:Pt:Stool:Nom:Wet preparation LCN: ​Microscopic observation [Identifier] in Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body",
    "system": "{Specimen type} Scale Nom Method Wet preparation Examples: 6470-9​ Microscopic observation:Prid:Pt:Stool:Nom:Wet preparation LCN: ​Microscopic observation [Identifier] in Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body",
    "context": "r] in Body fluid by KOH preparation 10733-4​ Trypanosoma sp identified:Prid:Pt:Bld:Nom:Wet preparation LCN: ​Trypanosoma sp identified in Blood by Wet preparation OBX|1|CE|​6470-9​^Microscopic observation [Identifier] in Stool by Wet preparation^LN|1|LA28390-5^Enterobius vermicularis^LN||... 3.3.2 Wet or KOH preparations that help identify the presence",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "68383-9": {
    "loincCode": "68383-9",
    "method": "Wet preparation Examples: 6470-9​ Microscopic observation:Prid:Pt:Stool:Nom:Wet preparation LCN: ​Microscopic observation [Identifier] in Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body fld:Nom:KOH preparation LCN: ​Microscopic observation [Identifier] in Body fluid by KOH preparation 10733-4​ Trypanosoma sp identified:Pr",
    "context": "Method Wet preparation Examples: 6470-9​ Microscopic observation:Prid:Pt:Stool:Nom:Wet preparation LCN: ​Microscopic observation [Identifier] in Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body fld:Nom:KOH preparation LCN: ​Microscopic observation [Identifier] in Body fluid by KOH preparation 10733-4​ Trypanosoma sp identified:Pr",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "10733-4": {
    "loincCode": "10733-4",
    "context": "n Stool by Wet preparation 68383-9​ Microscopic observation:Prid:Pt:Body fld:Nom:KOH preparation LCN: ​Microscopic observation [Identifier] in Body fluid by KOH preparation 10733-4​ Trypanosoma sp identified:Prid:Pt:Bld:Nom:Wet preparation LCN: ​Trypanosoma sp identified in Blood by Wet preparation OBX|1|CE|​6470-9​^Microscopic observation [Identifier] i",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "23520-0": {
    "loincCode": "23520-0",
    "method": "Wet preparation KOH preparation Guide for Using LOINC Microbiology Terms ​• 22 Examples: 23520-0​ Trypanosoma evansi:PrThr:Pt:Asp:Ord:Wet preparation LCN: ​Trypanosoma evansi [Presence] in Aspirate by Wet preparation 55303-2​ Fungus:PrThr:Pt:Skin:Ord:KOH preparation LCN:",
    "system": "{Specimen type} Scale Ord Method Wet preparation KOH preparation Guide for Using LOINC Microbiology Terms ​• 22 Examples: 23520-0​ Trypanosoma evansi:PrThr:Pt:Asp:Ord:Wet preparation LCN: ​Trypanosoma evansi [Presence] in Aspirate by Wet preparation 55303-2​ Fungus:PrThr:Pt:Skin:Ord:KOH preparation LCN:",
    "context": "ty PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Wet preparation KOH preparation Guide for Using LOINC Microbiology Terms ​• 22 Examples: 23520-0​ Trypanosoma evansi:PrThr:Pt:Asp:Ord:Wet preparation LCN: ​Trypanosoma evansi [Presence] in Aspirate by Wet preparation 55303-2​ Fungus:PrThr:Pt:Skin:Ord:KOH preparation LCN:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "55303-2": {
    "loincCode": "55303-2",
    "context": "Fungus [Presence] in Skin by KOH preparation 55320-6​ Yeast:PrThr:Pt:Bronchial:Ord:KOH preparation LCN: ​Yeast [Presence] in Bronchial specimen by KOH preparation OBX|1|CE|​55303-2​^Fungus [Presence] in Skin by KOH preparation^LN||LA20667-4^None seen^LN|... 3.4 Thick and thin films Thin and thick films are smears made from blood, and are used to identif",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "55320-6": {
    "loincCode": "55320-6",
    "context": "ion LCN: ​Trypanosoma evansi [Presence] in Aspirate by Wet preparation 55303-2​ Fungus:PrThr:Pt:Skin:Ord:KOH preparation LCN: ​Fungus [Presence] in Skin by KOH preparation 55320-6​ Yeast:PrThr:Pt:Bronchial:Ord:KOH preparation LCN: ​Yeast [Presence] in Bronchial specimen by KOH preparation OBX|1|CE|​55303-2​^Fungus [Presence] in Skin by KOH preparation^L",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "10664-1": {
    "loincCode": "10664-1",
    "component": "{Class or name of organism} identified Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method Thin film Thick film Examples: 10664-1​ Filaria identified:Prid:Pt:Bld:Nom:Thin film LCN: ​Filaria identified in Blood by Thin film Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method Thin film Thick film Examples: 10664-1​ Filaria identified:Prid:Pt:Bld:Nom:Thin film LCN: ​Filaria identified in Blood by Thin film Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified",
    "method": "Thin film Thick film Examples: 10664-1​ Filaria identified:Prid:Pt:Bld:Nom:Thin film LCN: ​Filaria identified in Blood by Thin film Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified",
    "system": "{Specimen type} Scale Nom Method Thin film Thick film Examples: 10664-1​ Filaria identified:Prid:Pt:Bld:Nom:Thin film LCN: ​Filaria identified in Blood by Thin film Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified",
    "context": "tern: Component {Class or name of organism} identified Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method Thin film Thick film Examples: 10664-1​ Filaria identified:Prid:Pt:Bld:Nom:Thin film LCN: ​Filaria identified in Blood by Thin film Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "637-9": {
    "loincCode": "637-9",
    "context": "Guide for Using LOINC Microbiology Terms ​• 23 637-9​ Plasmodium sp identified:Prid:Pt:Bld:Nom:Thick film LCN: ​Plasmodium sp identified in Blood by Thick film OBX|1|CE|​637-9​^Plasmodium sp identified in Blood by Thick film^LN||LA18496-2^Plasmodium falciparum^LN|... Note that there are a few LOINC terms with the ​Methods​ ​Malaria smear ​and ​Malar",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "51587-4": {
    "loincCode": "51587-4",
    "context": "sing of updating in order to align with the model described above. There are also some parasitology terms that follow the general light microscopy model described above, such as 51587-4​ ​Plasmodium sp [Presence] in Blood by Light microscopy​, to report the presence of any Plasmodium species, and ​32206-5​ Plasmodium sp identified in Blood by Light microscopy​,",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "32206-5": {
    "loincCode": "32206-5",
    "context": "general light microscopy model described above, such as 51587-4​ ​Plasmodium sp [Presence] in Blood by Light microscopy​, to report the presence of any Plasmodium species, and ​32206-5​ Plasmodium sp identified in Blood by Light microscopy​, to report the specific species of Plasmodium that was identified, that may be used when the specific type of smear is no",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "43227-8": {
    "loincCode": "43227-8",
    "component": "Ova & parasites identified Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:",
    "method": "{Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:",
    "system": "{Specimen type} Scale Nom Method {Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:",
    "context": "ons follow this pattern: Component Ova & parasites identified Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "10702-9": {
    "loincCode": "10702-9",
    "method": "{Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:Nom:Immune stain Guide for Using LOINC Microbiology Terms ​• 24 LCN: ​Ova and parasites identified in Stool by Immune stain OBX|1",
    "context": "Nom Method {Name of stain} Examples: 43227-8​ Ova & parasites identified:Prid:Pt:Stool:Nom:Trichrome stain LCN: ​Ova and parasites identified in Stool by Trichrome stain 10702-9​ Ova & parasites identified:Prid:Pt:Stool:Nom:Immune stain Guide for Using LOINC Microbiology Terms ​• 24 LCN: ​Ova and parasites identified in Stool by Immune stain OBX|1",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "625-4": {
    "loincCode": "625-4",
    "context": "distinguish specimen-specific techniques in the ​Method​, because the ​System​ provides information about the specimen for which the culture is optimized. For example, the term ​625-4​ ​Bacteria identified in Stool by Culture​ is used to represent a culture optimized for the growth of pathogens in stool, and ​6331-3​ ​Campylobacter sp identified in Stool by Or",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "6331-3": {
    "loincCode": "6331-3",
    "context": "culture is optimized. For example, the term ​625-4​ ​Bacteria identified in Stool by Culture​ is used to represent a culture optimized for the growth of pathogens in stool, and ​6331-3​ ​Campylobacter sp identified in Stool by Organism specific culture ​for a culture that specifically promotes the growth of Campylobacter species in stool. In both cases, the LO",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "17928-3": {
    "loincCode": "17928-3",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Guide for Using LOINC Microbiology Terms ​• 29 Scale Nom Method {Type of culture} Examples: 17928-3​ Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identi",
    "method": "{Type of culture} Examples: 17928-3​ Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identi",
    "system": "{Specimen type} Guide for Using LOINC Microbiology Terms ​• 29 Scale Nom Method {Type of culture} Examples: 17928-3​ Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identi",
    "context": "type of organism, such as growth of a fungus on a routine aerobic bacterial culture, the result would still be reported using the term for the test that was done, in this case, ​17928-3​ ​Bacteria identified in Blood by Aerobe culture​. The fact that the result is a fungus does not change the fact that the assay was optimized for bacteria, which is what the LOI",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "569-4": {
    "loincCode": "569-4",
    "method": "{Type of culture} Examples: 17928-3​ Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identified in Cerebrospinal fluid by Culture 14451-9​ Virus identified:Prid:Pt:Eye:Nom:Culture LCN:​ Virus identified",
    "context": "rms ​• 29 Scale Nom Method {Type of culture} Examples: 17928-3​ Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identified in Cerebrospinal fluid by Culture 14451-9​ Virus identified:Prid:Pt:Eye:Nom:Culture LCN:​ Virus identified",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "14451-9": {
    "loincCode": "14451-9",
    "context": "bic culture LCN: ​Bacteria identified in Blood by Aerobe culture 569-4​ Fungus identified:Prid:Pt:CSF:Nom:Culture LCN: ​Fungus identified in Cerebrospinal fluid by Culture 14451-9​ Virus identified:Prid:Pt:Eye:Nom:Culture LCN:​ Virus identified in Eye by Culture OBX|1|CE|​17928-3​^Bacteria identified in Blood by Aerobe culture^LN|1| LA19246-0^ Staphylo",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "45095-7": {
    "loincCode": "45095-7",
    "component": "{Name of organism} Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Organism specific culture Examples: 45095-7​ Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture LCN: ​Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture 562-9​ Clostridi",
    "property": "PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Organism specific culture Examples: 45095-7​ Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture LCN: ​Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture 562-9​ Clostridi",
    "method": "Organism specific culture Examples: 45095-7​ Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture LCN: ​Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture 562-9​ Clostridi",
    "system": "{Specimen type} Scale Ord Method Organism specific culture Examples: 45095-7​ Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture LCN: ​Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture 562-9​ Clostridi",
    "context": "ulture 48741-3​ Bordetella pertussis:PrThr:Pt:Nph:Ord:Organism specific culture LCN: ​Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture OBX|1|CE|​45095-7​^Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture^LN|1|LA11882-0^Detected^LN||... 4.3.1.1 Screening cultures for drug-resistant organisms Scr",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "562-9": {
    "loincCode": "562-9",
    "context": "amples: 45095-7​ Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture LCN: ​Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture 562-9​ Clostridioides difficile:PrThr:Pt:Stool:Ord:Organism specific culture LCN:​ Clostridioides difficile [Presence] in Stool by Organism specific culture 48741-3​ Bordetella per",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "48741-3": {
    "loincCode": "48741-3",
    "context": "ecific culture 562-9​ Clostridioides difficile:PrThr:Pt:Stool:Ord:Organism specific culture LCN:​ Clostridioides difficile [Presence] in Stool by Organism specific culture 48741-3​ Bordetella pertussis:PrThr:Pt:Nph:Ord:Organism specific culture LCN: ​Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture OBX|1|CE|​45095-7​^Chlamydia",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "73834-4": {
    "loincCode": "73834-4",
    "property": "PrThr Prid Time Aspect {Time value} System {Specimen type} Scale Ord Nom Method Organism specific culture Examples: 73834-4​ Bacteria.carbapenem resistant identified:Prid:Pt:Anal:Nom:Organism specific culture LCN: ​Bacteria.carbapenem resistant identified in Anal by Organism specific culture 6348",
    "method": "Organism specific culture Examples: 73834-4​ Bacteria.carbapenem resistant identified:Prid:Pt:Anal:Nom:Organism specific culture LCN: ​Bacteria.carbapenem resistant identified in Anal by Organism specific culture 6348",
    "system": "{Specimen type} Scale Ord Nom Method Organism specific culture Examples: 73834-4​ Bacteria.carbapenem resistant identified:Prid:Pt:Anal:Nom:Organism specific culture LCN: ​Bacteria.carbapenem resistant identified in Anal by Organism specific culture 6348",
    "context": "{Name of drug class} resistant isolate Property PrThr Prid Time Aspect {Time value} System {Specimen type} Scale Ord Nom Method Organism specific culture Examples: 73834-4​ Bacteria.carbapenem resistant identified:Prid:Pt:Anal:Nom:Organism specific culture LCN: ​Bacteria.carbapenem resistant identified in Anal by Organism specific culture 6348",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "63480-8": {
    "loincCode": "63480-8",
    "context": "34-4​ Bacteria.carbapenem resistant identified:Prid:Pt:Anal:Nom:Organism specific culture LCN: ​Bacteria.carbapenem resistant identified in Anal by Organism specific culture 63480-8​ Pseudomonas aeruginosa.multidrug resistant isolate:PrThr:Pt:XXX:Ord:Organism specific culture LCN: ​Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Unspecified",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "20955-1": {
    "loincCode": "20955-1",
    "property": "Prid Time Aspect {Time value} Guide for Using LOINC Microbiology Terms ​• 32 System {Specimen type} Scale Nom Method Organism-specific culture Examples: 20955-1​ Salmonella sp identified:Prid:Pt:Stool:Nom:Organism specific culture LCN: ​Salmonella sp identified in Stool by Organism specific culture 43979-4​ Aspergillus sp identified:P",
    "method": "Organism-specific culture Examples: 20955-1​ Salmonella sp identified:Prid:Pt:Stool:Nom:Organism specific culture LCN: ​Salmonella sp identified in Stool by Organism specific culture 43979-4​ Aspergillus sp identified:P",
    "system": "{Specimen type} Scale Nom Method Organism-specific culture Examples: 20955-1​ Salmonella sp identified:Prid:Pt:Stool:Nom:Organism specific culture LCN: ​Salmonella sp identified in Stool by Organism specific culture 43979-4​ Aspergillus sp identified:P",
    "context": "ecific culture 38394-3​ Legionella sp identified:Prid:Pt:Urine:Nom:Organism specific culture LCN: ​Legionella sp identified in Urine by Organism specific culture OBX|1|CE|​20955-1​^Salmonella sp identified in Stool by Organism specific culture^LN|1|LA21329-0^Salmonella typhi^LN|... 4.4 Colony counts A colony count represents the number of colonies for",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "43979-4": {
    "loincCode": "43979-4",
    "context": "ecific culture Examples: 20955-1​ Salmonella sp identified:Prid:Pt:Stool:Nom:Organism specific culture LCN: ​Salmonella sp identified in Stool by Organism specific culture 43979-4​ Aspergillus sp identified:Prid:Pt:XXX:Nom:Organism specific culture LCN: ​Aspergillus sp identified in Unspecified specimen by Organism specific culture 38394-3​ Legionella s",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "38394-3": {
    "loincCode": "38394-3",
    "context": "ic culture 43979-4​ Aspergillus sp identified:Prid:Pt:XXX:Nom:Organism specific culture LCN: ​Aspergillus sp identified in Unspecified specimen by Organism specific culture 38394-3​ Legionella sp identified:Prid:Pt:Urine:Nom:Organism specific culture LCN: ​Legionella sp identified in Urine by Organism specific culture OBX|1|CE|​20955-1​^Salmonella sp id",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "19090-0": {
    "loincCode": "19090-0",
    "method": "Culture Examples: 19090-0​ Colony count:NCnc:Pt:Urine:Qn LCN: ​Colony count [#/volume] in Urine 19101-5​ Fungus colony count:NCnc:Pt:XXX:Qn:Culture LCN: ​Fungus colony count [#/volume] in Unspecified",
    "system": "{Specimen type} Guide for Using LOINC Microbiology Terms ​• 33 Scale Qn Method Culture Examples: 19090-0​ Colony count:NCnc:Pt:Urine:Qn LCN: ​Colony count [#/volume] in Urine 19101-5​ Fungus colony count:NCnc:Pt:XXX:Qn:Culture LCN: ​Fungus colony count [#/volume] in Unspecified",
    "context": "LCN: ​Colony count [#/volume] in Urine 19101-5​ Fungus colony count:NCnc:Pt:XXX:Qn:Culture LCN: ​Fungus colony count [#/volume] in Unspecified specimen by Culture OBX|1|NM|​19090-0​^Colony count [#/volume] in Urine^LN|1|596|/mL|... Guide for Using LOINC Microbiology Terms ​• 34 5 Susceptibility testing Two primary types of susceptibility testing a",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "19101-5": {
    "loincCode": "19101-5",
    "method": "Culture Examples: 19090-0​ Colony count:NCnc:Pt:Urine:Qn LCN: ​Colony count [#/volume] in Urine 19101-5​ Fungus colony count:NCnc:Pt:XXX:Qn:Culture LCN: ​Fungus colony count [#/volume] in Unspecified specimen by Culture OBX|1|NM|​19090-0​^Colony count [#/volume] in Urine^LN|1|59",
    "context": "type} Guide for Using LOINC Microbiology Terms ​• 33 Scale Qn Method Culture Examples: 19090-0​ Colony count:NCnc:Pt:Urine:Qn LCN: ​Colony count [#/volume] in Urine 19101-5​ Fungus colony count:NCnc:Pt:XXX:Qn:Culture LCN: ​Fungus colony count [#/volume] in Unspecified specimen by Culture OBX|1|NM|​19090-0​^Colony count [#/volume] in Urine^LN|1|59",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "98-99": {
    "loincCode": "98-99",
    "context": "24-hour incubation and in accordance with the standardized conditions stated in document M26-A. The MFC is defined as the lowest concentration of an antifungal drug that kills 98-99.9% when compared to the initial inoculum (the sample in the clear wells or tubes).​ 6 9 Balouiri M, Sadiki M, Ibnsouda SK. Methods for ​in vitro​ evaluating antimicrobial activi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "71-79": {
    "loincCode": "71-79",
    "context": "the clear wells or tubes).​ 6 9 Balouiri M, Sadiki M, Ibnsouda SK. Methods for ​in vitro​ evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis 2016;6:71-79. 10 CLSI, Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline, CLSI document M26-A. Clinical and Laboratory Standards Institute, 950 West",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "976-81": {
    "loincCode": "976-81",
    "method": "with 7H9 broth. J Clin Microbiol. 1986 Dec",
    "context": "lace RJ Jr, Nash DR, Steele LC, Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol. 1986 Dec;24(6):976-81. [PMID: ​3097069​] 12 Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Richter SS, Warnock DW (Eds.). Manual of Clinical Microbiology, 11th edition 2015;1220-1221,1286.",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "1220-1221": {
    "loincCode": "1220-1221",
    "method": "MIC Gradient strip Agar diffusion MLC Examples: 700",
    "system": "{Specimen type} Scale Qn Ord OrdQn Method MIC Gradient strip Agar diffusion MLC Examples: 700",
    "context": "ec;24(6):976-81. [PMID: ​3097069​] 12 Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Richter SS, Warnock DW (Eds.). Manual of Clinical Microbiology, 11th edition 2015;1220-1221,1286. Guide for Using LOINC Microbiology Terms ​• 37 System {Specimen type} Scale Qn Ord OrdQn Method MIC Gradient strip Agar diffusion MLC Examples: 700",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "7009-4": {
    "loincCode": "7009-4",
    "method": "MIC Gradient strip Agar diffusion MLC Examples: 7009-4​ Erythromycin:Susc:Pt:Isolate:OrdQn:Gradient strip LCN:​ Erythromycin [Susceptibility] by Gradient strip 6932-8​ Penicillin: Susc: Pt: Isolate: OrdQn: MIC LCN: ​Penicillin [",
    "system": "{Specimen type} Scale Qn Ord OrdQn Method MIC Gradient strip Agar diffusion MLC Examples: 7009-4​ Erythromycin:Susc:Pt:Isolate:OrdQn:Gradient strip LCN:​ Erythromycin [Susceptibility] by Gradient strip 6932-8​ Penicillin: Susc: Pt: Isolate: OrdQn: MIC LCN: ​Penicillin [",
    "context": "[Susceptibility] by Gradient strip 6932-8​ Penicillin: Susc: Pt: Isolate: OrdQn: MIC LCN: ​Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) OBX|1|CE|​7009-4​^Erythromycin Islt Grad strip^LN|1|LA6676-6^Resistant^LN||... As described above, the results for an MIC OrdQn assay can be reported either as quantitative in OBX-5 with an in",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "20373-7": {
    "loincCode": "20373-7",
    "property": "Susc Time Aspect {Time value} System {Specimen type} Scale OrdQn Method Method for slow-growing mycobacteria Example: 20373-7​ Amikacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria LCN:​ Amikacin [Susceptibility] by Method for Slow-growing mycobacteria OBX|1|CE|​20373-7​^Amikacin [Susce",
    "method": "Method for slow-growing mycobacteria Example: 20373-7​ Amikacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria LCN:​ Amikacin [Susceptibility] by Method for Slow-growing mycobacteria OBX|1|CE|​20373-7​^Amikacin [Susce",
    "system": "{Specimen type} Scale OrdQn Method Method for slow-growing mycobacteria Example: 20373-7​ Amikacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria LCN:​ Amikacin [Susceptibility] by Method for Slow-growing mycobacteria OBX|1|CE|​20373-7​^Amikacin [Susce",
    "context": "ria Example: 20373-7​ Amikacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria LCN:​ Amikacin [Susceptibility] by Method for Slow-growing mycobacteria OBX|1|CE|​20373-7​^Amikacin [Susceptibility] by Method for Slow-growing mycobacteria^LN||LA24225-7^Susceptible^LN||... 5.1.3 Viral phenotypic susceptibility testing Viral phenotypic susceptibi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72861-8": {
    "loincCode": "72861-8",
    "property": "Susc Time Aspect {Time value} System Isolate Scale OrdQn Guide for Using LOINC Microbiology Terms ​• 39 Method Phenotyping Example: 72861-8​ Ganciclovir: Susc: Pt: Isolate: OrdQn: Phenotyping LCN:​ Ganciclovir [Susceptibility] by Phenotype method OBX|1|CE|​72861-8​^Ganciclovir [Susceptibility] by Phenotype metho",
    "method": "Phenotyping Example: 72861-8​ Ganciclovir: Susc: Pt: Isolate: OrdQn: Phenotyping LCN:​ Ganciclovir [Susceptibility] by Phenotype method OBX|1|CE|​72861-8​^Ganciclovir [Susceptibility] by Phenotype metho",
    "system": "Isolate Scale OrdQn Guide for Using LOINC Microbiology Terms ​• 39 Method Phenotyping Example: 72861-8​ Ganciclovir: Susc: Pt: Isolate: OrdQn: Phenotyping LCN:​ Ganciclovir [Susceptibility] by Phenotype method OBX|1|CE|​72861-8​^Ganciclovir [Susceptibility] by Phenotype metho",
    "context": "ogy Terms ​• 39 Method Phenotyping Example: 72861-8​ Ganciclovir: Susc: Pt: Isolate: OrdQn: Phenotyping LCN:​ Ganciclovir [Susceptibility] by Phenotype method OBX|1|CE|​72861-8​^Ganciclovir [Susceptibility] by Phenotype method^LN||LA24225-7^Susceptible^LN||... 5.1.4 Susceptibility thresholds based on type of infection (“Breakpoints”) In most cases,",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "31138-1": {
    "loincCode": "31138-1",
    "component": "{Generic name of drug} Property Susc Time Aspect {Time value} System Isolate.{infection type} Scale OrdQn Method MIC Example: 31138-1​ Cefotaxime: Susc: Pt: Isolate.meningitis: OrdQn: MIC LCN: ​Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration OBX|1|CE|​31138-1​^Cefotaxime [Sus",
    "property": "Susc Time Aspect {Time value} System Isolate.{infection type} Scale OrdQn Method MIC Example: 31138-1​ Cefotaxime: Susc: Pt: Isolate.meningitis: OrdQn: MIC LCN: ​Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration OBX|1|CE|​31138-1​^Cefotaxime [Sus",
    "method": "MIC Example: 31138-1​ Cefotaxime: Susc: Pt: Isolate.meningitis: OrdQn: MIC LCN: ​Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration OBX|1|CE|​31138-1​^Cefotaxime [Sus",
    "system": "Isolate.{infection type} Scale OrdQn Method MIC Example: 31138-1​ Cefotaxime: Susc: Pt: Isolate.meningitis: OrdQn: MIC LCN: ​Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration OBX|1|CE|​31138-1​^Cefotaxime [Sus",
    "context": "MIC Example: 31138-1​ Cefotaxime: Susc: Pt: Isolate.meningitis: OrdQn: MIC LCN: ​Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration OBX|1|CE|​31138-1​^Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration^LN||LA6676-6^Resistant^LN||... 5.2 Phenotypic testing for resistance enzymes At the current ti",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85046-1": {
    "loincCode": "85046-1",
    "property": "PrThr Time Aspect {Time value} System Isolate Scale Ord Method Gradient strip ARD Example: 85046-1​ AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD LCN: ​AmpC beta-lactamase by cefoTEtan to cefoT",
    "method": "Gradient strip ARD Example: 85046-1​ AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD LCN: ​AmpC beta-lactamase by cefoTEtan to cefoT",
    "system": "Isolate Scale Ord Method Gradient strip ARD Example: 85046-1​ AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD LCN: ​AmpC beta-lactamase by cefoTEtan to cefoT",
    "context": "me of antimicrobial+name of inhibitor} inhibitory concentration ratio Property PrThr Time Aspect {Time value} System Isolate Scale Ord Method Gradient strip ARD Example: 85046-1​ AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD LCN: ​AmpC beta-lactamase by cefoTEtan to cefoT",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72421-1": {
    "loincCode": "72421-1",
    "method": "Molgen Probe.amp.tar* Non-probe.amp.tar* *Going forward terms with these ​Methods​ may be updated to the Molgen ​Method​ (see discussion above) Examples: 72421-1​ ​Bacterial vancomycin resistance vanB gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Vancomycin resistance vanB gene [Presence] by Molecular method 85827-4​ Bacterial carb",
    "context": "rial carbapenem resistance blaOXA-48-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method OBX|1|CE|​72421-1​^Vancomycin resistance vanB gene [Presence] by NAA with probe detection^LN||LA11882-0^Detected^LN||... 5.3.1.2 Identifying the presence or absence of a resistance-conferring",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85827-4": {
    "loincCode": "85827-4",
    "method": "85827-4​ Bacterial carbapenem resistance blaOXA-48-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method OBX",
    "context": ") Examples: 72421-1​ ​Bacterial vancomycin resistance vanB gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Vancomycin resistance vanB gene [Presence] by Molecular method 85827-4​ Bacterial carbapenem resistance blaOXA-48-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method OBX",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "89372-7": {
    "loincCode": "89372-7",
    "context": "d Molgen Probe* Probe.amp.tar* Non-probe.amp.tar* *Going forward terms with these ​Methods​ may be updated to the Molgen ​Method​ (see discussion above) Examples: 89372-7​ Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation:PrThr:Pt:Isolate/Specimen:Ord:Molgen LCN: ​Mycobacterium tuberculosis complex rpoB gene rifAMPin resis",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "89488-1": {
    "loincCode": "89488-1",
    "component": "{Generic name of drug} Property Susc Time Aspect {Time value} System Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [",
    "property": "Susc Time Aspect {Time value} System Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [",
    "method": "Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [",
    "system": "Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [",
    "context": "ive genes follow the pattern shown below: Component {Generic name of drug} Property Susc Time Aspect {Time value} System Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72854-3": {
    "loincCode": "72854-3",
    "method": "Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [Susceptibility] by Genotype method Guide for Using LOINC Microbiology Terms ​• 47 6 Antigen tests Antigens ar",
    "system": "Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [Susceptibility] by Genotype method Guide for Using LOINC Microbiology Terms ​• 47 6 Antigen tests Antigens ar",
    "context": "lue} System Isolate Scale Ord Method Genotyping Examples: 89488-1​ Isoniazid:Susc:Pt:Isolate/Specimen:Ord:Genotyping LCN: ​Isoniazid [Susceptibility] by Genotype method 72854-3​ Ganciclovir:Susc:Pt:Isolate:Ord:Genotyping LCN: ​Ganciclovir [Susceptibility] by Genotype method Guide for Using LOINC Microbiology Terms ​• 47 6 Antigen tests Antigens ar",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "217-35": {
    "loincCode": "217-35",
    "context": "ctrophoresis step. 17 Darwish IA. Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances. Int J Biomed Sci. 2006 Sep;2(3):217-35. [PMID: ​23674985​] 18 Pedersen JC. Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to infl",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "31754-5": {
    "loincCode": "31754-5",
    "component": "{Name of microorganism} Ag Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by",
    "property": "PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by",
    "method": "{Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by",
    "system": "{Specimen type} Scale Ord Method {Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by",
    "context": "follows: Component {Name of microorganism} Ag Property PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method {Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "43612-1": {
    "loincCode": "43612-1",
    "method": "{Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by Immunofluorescence 48335-4​ Aspergillus sp Ag:PrThr:Pt:Tiss:Ord:Immune stain LCN: ​Aspergillus s",
    "context": "{Specimen type} Scale Ord Method {Method type} or method-less Examples: 31754-5​ Brucella sp Ag: PrThr: Pt: Placenta: Ord: LCN: ​Brucella sp Ag [Presence] in Placenta 43612-1​ Adenovirus Ag:PrThr:Pt:Nose:Ord:IF LCN: ​Adenovirus Ag [Presence] in Nose by Immunofluorescence 48335-4​ Aspergillus sp Ag:PrThr:Pt:Tiss:Ord:Immune stain LCN: ​Aspergillus s",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "48335-4": {
    "loincCode": "48335-4",
    "context": "5-4​ Aspergillus sp Ag:PrThr:Pt:Tiss:Ord:Immune stain LCN: ​Aspergillus sp Ag [Presence] in Tissue by Immune stain Guide for Using LOINC Microbiology Terms ​• 49 OBX|1|CE|​48335-4​^Aspergillus Ag Tiss Ql ImStn^LN|1|LA6577-6^Negative^LN||... 6.3 Identifying the specific subtype of a suspected organism LOINC also contains a small number of terms for assa",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72366-8": {
    "loincCode": "72366-8",
    "component": "{Name of microorganism} Ag Property Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Method type} Example: 72366-8​ Influenza virus A & B Ag: Prid: Pt: Nose: Nom: IA.rapid LCN:​ Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay OBX|1|CE|​72366-8​^​ ​Influenza virus A an",
    "property": "Prid Time Aspect {Time value} System {Specimen type} Scale Nom Method {Method type} Example: 72366-8​ Influenza virus A & B Ag: Prid: Pt: Nose: Nom: IA.rapid LCN:​ Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay OBX|1|CE|​72366-8​^​ ​Influenza virus A an",
    "method": "{Method type} Example: 72366-8​ Influenza virus A & B Ag: Prid: Pt: Nose: Nom: IA.rapid LCN:​ Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay OBX|1|CE|​72366-8​^​ ​Influenza virus A an",
    "system": "{Specimen type} Scale Nom Method {Method type} Example: 72366-8​ Influenza virus A & B Ag: Prid: Pt: Nose: Nom: IA.rapid LCN:​ Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay OBX|1|CE|​72366-8​^​ ​Influenza virus A an",
    "context": "ethod type} Example: 72366-8​ Influenza virus A & B Ag: Prid: Pt: Nose: Nom: IA.rapid LCN:​ Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay OBX|1|CE|​72366-8​^​ ​Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay^LN||LA6577-6^Negative^LN||... 6.4 Quantitative antigen tests Some assays quantify the amount of anti",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9817-8": {
    "loincCode": "9817-8",
    "component": "{Name of microorganism} Ag Property ACnc Titr Time Aspect {Time value} System {Specimen type} Scale Qn Method {Method type} Example: 9817-8​ Cryptococcus sp Ag: Titr: Pt: CSF: Qn: IA LCN: ​Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay OBX|1|NM|​9817-8​^Cryptococcus sp Ag [Titer] in Cerebral",
    "property": "ACnc Titr Time Aspect {Time value} System {Specimen type} Scale Qn Method {Method type} Example: 9817-8​ Cryptococcus sp Ag: Titr: Pt: CSF: Qn: IA LCN: ​Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay OBX|1|NM|​9817-8​^Cryptococcus sp Ag [Titer] in Cerebral",
    "method": "{Method type} Example: 9817-8​ Cryptococcus sp Ag: Titr: Pt: CSF: Qn: IA LCN: ​Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay OBX|1|NM|​9817-8​^Cryptococcus sp Ag [Titer] in Cerebral",
    "system": "{Specimen type} Scale Qn Method {Method type} Example: 9817-8​ Cryptococcus sp Ag: Titr: Pt: CSF: Qn: IA LCN: ​Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay OBX|1|NM|​9817-8​^Cryptococcus sp Ag [Titer] in Cerebral",
    "context": "le Qn Method {Method type} Example: 9817-8​ Cryptococcus sp Ag: Titr: Pt: CSF: Qn: IA LCN: ​Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay OBX|1|NM|​9817-8​^Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay ^LN|1|1:32||... Guide for Using LOINC Microbiology Terms ​• 51 7 Nucleic acid tests Nucleic acid te",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82159-5": {
    "loincCode": "82159-5",
    "context": "x tests which simultaneously look for many different organisms based on their individual genetic targets. Such multiplex tests are often represented in LOINC as panels, such as ​82159-5​ Respiratory pathogens DNA and RNA panel – Nasopharynx by NAA with non-probe detection​, where the panel code is used for the order and the individual children to report the resu",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "87376-0": {
    "loincCode": "87376-0",
    "property": "PrThr Time Aspect {Time value} System {Specimen type} Scale Ord Method Probe Probe.amp.sig Probe.amp.tar Non-probe.amp.tar Examples: 87376-0​ Escherichia coli stx1 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar LCN: ​Escherichia coli stx1 gene [Presence] in Isolate by NAA with probe detection 77959-5​ Yellow fever virus",
    "method": "Probe Probe.amp.sig Probe.amp.tar Non-probe.amp.tar Examples: 87376-0​ Escherichia coli stx1 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar LCN: ​Escherichia coli stx1 gene [Presence] in Isolate by NAA with probe detection 77959-5​ Yellow fever virus",
    "system": "{Specimen type} Scale Ord Method Probe Probe.amp.sig Probe.amp.tar Non-probe.amp.tar Examples: 87376-0​ Escherichia coli stx1 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar LCN: ​Escherichia coli stx1 gene [Presence] in Isolate by NAA with probe detection 77959-5​ Yellow fever virus",
    "context": "spinal fluid by NAA with non-probe detection 77369-7​ HIV 1 RNA:PrThr:Pt:Semen:Ord:Probe.amp.tar LCN: ​HIV 1 RNA [Presence] in Semen by NAA with probe detection OBX|1|CE|​87376-0​^Escherichia coli stx1 gene [Presence] in Isolate by NAA with probe detection^LN|1|LA11882-0^Detected^LN||... 7.4 Identifying the subtype or species of a suspected organism",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "77959-5": {
    "loincCode": "77959-5",
    "context": "mp.tar Examples: 87376-0​ Escherichia coli stx1 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar LCN: ​Escherichia coli stx1 gene [Presence] in Isolate by NAA with probe detection 77959-5​ Yellow fever virus ns5 gene:PrThr:Pt:CSF:Ord:Non-probe.amp.tar Guide for Using LOINC Microbiology Terms ​• 54 LCN: ​Yellow fever virus ns5 gene [Presence] in Cerebral spinal",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "77369-7": {
    "loincCode": "77369-7",
    "context": "Ord:Non-probe.amp.tar Guide for Using LOINC Microbiology Terms ​• 54 LCN: ​Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection 77369-7​ HIV 1 RNA:PrThr:Pt:Semen:Ord:Probe.amp.tar LCN: ​HIV 1 RNA [Presence] in Semen by NAA with probe detection OBX|1|CE|​87376-0​^Escherichia coli stx1 gene [Presence] in Isolate",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72483-1": {
    "loincCode": "72483-1",
    "property": "Prid Type Time Aspect {Time value} System {Specimen type} Scale Nom Method Probe.amp.tar Non-probe.amp.tar Examples: 72483-1​ BK virus subtype:Type:Pt:Ser/Plas:Nom:Probe.amp.tar LCN: ​BK virus subtype in Serum or Plasma by NAA with probe detection Guide for Using LOINC Microbiology Terms ​• 55",
    "method": "Probe.amp.tar Non-probe.amp.tar Examples: 72483-1​ BK virus subtype:Type:Pt:Ser/Plas:Nom:Probe.amp.tar LCN: ​BK virus subtype in Serum or Plasma by NAA with probe detection Guide for Using LOINC Microbiology Terms ​• 55",
    "system": "{Specimen type} Scale Nom Method Probe.amp.tar Non-probe.amp.tar Examples: 72483-1​ BK virus subtype:Type:Pt:Ser/Plas:Nom:Probe.amp.tar LCN: ​BK virus subtype in Serum or Plasma by NAA with probe detection Guide for Using LOINC Microbiology Terms ​• 55",
    "context": "virus 16 & 18+45 E6+E7 mRNA:Prid:Pt:Cvx:Nom:Probe.amp.tar LCN: ​Human papilloma virus 16 and 18+​45 E6+​E7 mRNA [Identifier] in Cervix by NAA with probe detection OBX|1|CE|​72483-1​^BK virus subtype in Serum or Plasma by NAA with probe detection^LN|1|LA19050-6^BK virus subtype II^LN|... 7.5 Multiplex assays Multiplex assays are able to detect or identif",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82354-2": {
    "loincCode": "82354-2",
    "context": "​ BK virus subtype:Type:Pt:Ser/Plas:Nom:Probe.amp.tar LCN: ​BK virus subtype in Serum or Plasma by NAA with probe detection Guide for Using LOINC Microbiology Terms ​• 55 82354-2​ Human papilloma virus 16 & 18+45 E6+E7 mRNA:Prid:Pt:Cvx:Nom:Probe.amp.tar LCN: ​Human papilloma virus 16 and 18+​45 E6+​E7 mRNA [Identifier] in Cervix by NAA with probe detecti",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82160-3": {
    "loincCode": "82160-3",
    "context": "epresents a multiplex panel. Guide for Using LOINC Microbiology Terms ​• 56 82159-5​ ​Respiratory pathogens DNA and RNA panel – Nasopharynx by NAA with non-probe detection 82160-3​ ​Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection 82161-1​ ​Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 821",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82161-1": {
    "loincCode": "82161-1",
    "context": "59-5​ ​Respiratory pathogens DNA and RNA panel – Nasopharynx by NAA with non-probe detection 82160-3​ ​Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection 82161-1​ ​Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82162-9​ ​Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe det",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82162-9": {
    "loincCode": "82162-9",
    "context": "0-3​ ​Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection 82161-1​ ​Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82162-9​ ​Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82163-7​ ​Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe det",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82163-7": {
    "loincCode": "82163-7",
    "context": "coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82162-9​ ​Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82163-7​ ​Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection 82164-5​ ​Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe det",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82164-5": {
    "loincCode": "82164-5",
    "context": "coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82163-7​ ​Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection 82164-5​ ​Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82165-2​ ​Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe det",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82165-2": {
    "loincCode": "82165-2",
    "context": "coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection 82164-5​ ​Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82165-2​ ​Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82166-0​ ​ Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82166-0": {
    "loincCode": "82166-0",
    "context": "coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82165-2​ ​Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82166-0​ ​ Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection 82167-8​ ​Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82167-8": {
    "loincCode": "82167-8",
    "context": "​Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82166-0​ ​ Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection 82167-8​ ​Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82168-6​ ​Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82168-6": {
    "loincCode": "82168-6",
    "context": "​ Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection 82167-8​ ​Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82168-6​ ​Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection 82169-4 ​ ​Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with no",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82169-4": {
    "loincCode": "82169-4",
    "context": "A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82168-6​ ​Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection 82169-4 ​ ​Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82170-2​ ​Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82170-2": {
    "loincCode": "82170-2",
    "context": "H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection 82169-4 ​ ​Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82170-2​ ​Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection 82171-0​ ​Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82171-0": {
    "loincCode": "82171-0",
    "context": "​Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82170-2​ ​Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection 82171-0​ ​Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82172-8​ ​Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82172-8": {
    "loincCode": "82172-8",
    "context": "​Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection 82171-0​ ​Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82172-8​ ​Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82173-6​ ​Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82173-6": {
    "loincCode": "82173-6",
    "context": "ainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82172-8​ ​Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82173-6​ ​Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82174-4​ ​Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82174-4": {
    "loincCode": "82174-4",
    "context": "ainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82173-6​ ​Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82174-4​ ​Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82175-1​ ​Rhinovirus+​Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe det",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82175-1": {
    "loincCode": "82175-1",
    "context": "ainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82174-4​ ​Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82175-1​ ​Rhinovirus+​Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82176-9​ ​Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-pro",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82176-9": {
    "loincCode": "82176-9",
    "context": "nfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection 82175-1​ ​Rhinovirus+​Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82176-9​ ​Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82177-7​ ​Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82177-7": {
    "loincCode": "82177-7",
    "context": "​Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82176-9​ ​Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82177-7​ ​Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection 82178-5​ ​Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe de",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82178-5": {
    "loincCode": "82178-5",
    "context": "ry syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection 82177-7​ ​Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection 82178-5​ ​Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection 82179-3​ ​Bordetella pertussis toxin promoter region [Presence] in Nasopharynx by NAA",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82179-3": {
    "loincCode": "82179-3",
    "context": "asma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection 82178-5​ ​Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection 82179-3​ ​Bordetella pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection Historically, multiplex tests that produced two or three individual res",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "51668-2": {
    "loincCode": "51668-2",
    "context": "hildren for each result. Following is an example of an older LOINC term representing a multiplex assay that produces individual results that are reported together as one: 51668-2​ Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Pseudomonas aeruginosa DNA:Prid:Pt:XXX:Nom:Probe.amp.tar LCN: ​Streptococcus pneumoniae DNA and Haemophilus influenza",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "74424-3": {
    "loincCode": "74424-3",
    "component": "{Name of microorganism} gene or DNA or RNA Property ThreshNum Time Aspect {Time value} System {Specimen type} Scale Qn Method Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:T",
    "property": "ThreshNum Time Aspect {Time value} System {Specimen type} Scale Qn Method Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:T",
    "method": "Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:T",
    "system": "{Specimen type} Scale Qn Method Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:T",
    "context": "ttern: Component {Name of microorganism} gene or DNA or RNA Property ThreshNum Time Aspect {Time value} System {Specimen type} Scale Qn Method Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:T",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85679-9": {
    "loincCode": "85679-9",
    "method": "Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar LCN: ​Haemophilus influenzae bex gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection",
    "context": "Method Probe.amp.tar Examples: 74424-3​ Enterovirus RNA:ThreshNum:Pt:Stool:Qn:Probe.amp.tar LCN: ​Enterovirus RNA [Cycle threshold #] in Stool by NAA with probe detection 85679-9​ Haemophilus influenzae bex gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar LCN: ​Haemophilus influenzae bex gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "20447-9": {
    "loincCode": "20447-9",
    "context": "limit = {#} copies/mL* Probe.amp.tar detection limit = {#} log copies/mL* *Going forward terms with these ​Methods​ are not recommended (see discussion above) Examples: 20447-9​ HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 41497-9​ HIV 1 RNA:LNCnc:Pt:CSF:Qn:Probe.a",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "41497-9": {
    "loincCode": "41497-9",
    "context": "ee discussion above) Examples: 20447-9​ HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 41497-9​ HIV 1 RNA:LNCnc:Pt:CSF:Qn:Probe.amp.tar LCN: ​HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection 48511-0​ HIV 1 RNA:NCnc:Pt:Ser/Plas:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "48511-0": {
    "loincCode": "48511-0",
    "context": "NAA with probe detection 41497-9​ HIV 1 RNA:LNCnc:Pt:CSF:Qn:Probe.amp.tar LCN: ​HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection 48511-0​ HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 50 copies/mL LCN: ​HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection limit = 50 cop",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "43730-1": {
    "loincCode": "43730-1",
    "method": "Probe.amp.tar Probe.amp.tar detection limit = {#} IU/mL* *Going forward terms with this type of ​Method are not recommended (see discussion above) Examples: 43730-1​ Epstein Barr virus DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Epstein Barr virus DNA [Units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method",
    "context": "Qn Method Probe.amp.tar Probe.amp.tar detection limit = {#} IU/mL* *Going forward terms with this type of ​Method are not recommended (see discussion above) Examples: 43730-1​ Epstein Barr virus DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Epstein Barr virus DNA [Units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "74419-3": {
    "loincCode": "74419-3",
    "method": "74419-3​ Parvovirus B19 DNA:LaCnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Parvovirus B19 DNA [log units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method 4",
    "context": "pstein Barr virus DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Epstein Barr virus DNA [Units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method 74419-3​ Parvovirus B19 DNA:LaCnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Parvovirus B19 DNA [log units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method 4",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "49758-6": {
    "loincCode": "49758-6",
    "method": "49758-6​ Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 5 IU/mL LCN: ​Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe de",
    "context": "3​ Parvovirus B19 DNA:LaCnc:Pt:Ser/Plas:Qn:Probe.amp.tar LCN: ​Parvovirus B19 DNA [log units/​volume] (viral load) in Serum or Plasma by Probe and target amplification method 49758-6​ Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 5 IU/mL LCN: ​Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe de",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "2-4": {
    "loincCode": "2-4",
    "context": "icacy Acute and convalescent antibody testing helps confirm a recent infection by comparing antibody levels measured during the active phase of the infection with those measured 2-4 weeks later during the recovery phase. Another example of a paired antibody test is pre- and post-immunization testing, which is done in some clinical circumstances. LOINC creat",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "32843-5": {
    "loincCode": "32843-5",
    "context": "to represent the convalescent or post-immunization specimen. For example, the following term represents the test for Epstein-Barr virus in the acute phase of the illness: 32843-5​ Epstein Barr virus capsid Ab.IgG^1st specimen: ACnc: Pt: Ser: Qn: LCN:​ Epstein Barr virus capsid IgG Ab [Units/​volume] in Serum --1st specimen And this term represents the",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "32844-3": {
    "loincCode": "32844-3",
    "context": "st specimen: ACnc: Pt: Ser: Qn: LCN:​ Epstein Barr virus capsid IgG Ab [Units/​volume] in Serum --1st specimen And this term represents the test in the convalescent phase: 32844-3​ Epstein Barr virus capsid Ab.IgG^2nd specimen: ACnc: Pt: Ser: Qn: LCN: ​Epstein Barr virus capsid IgG Ab [Units/​volume] in Serum --2nd specimen 8.2 LOINC ​Methods​ for antibo",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "11-25": {
    "loincCode": "11-25",
    "context": "emagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus.Methods Mol Biol. 2014;1161:11-25. [PMID: ​24899416​] Guide for Using LOINC Microbiology Terms ​• 64 Line blot Line blots are pre-manufactured immunoblot “strips”, in which membrane strips are pre-coated wi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "81097-8": {
    "loincCode": "81097-8",
    "method": "{Method type} Examples: 81097-8​ West Nile virus Kunjin strain Ab: PrThr: Pt: Ser: Ord: LCN: ​West Nile virus Kunjin strain Ab [Presence] in Serum 83081-0​ Borrelia burgdorferi Ab.IgG+​IgM: PrThr: Pt: Ser:",
    "context": "from: ​http://www.biobest.co.uk/diagnostics/techniques/vnt-virus-neutralisation-tests.html Guide for Using LOINC Microbiology Terms ​• 65 Method {Method type} Examples: 81097-8​ West Nile virus Kunjin strain Ab: PrThr: Pt: Ser: Ord: LCN: ​West Nile virus Kunjin strain Ab [Presence] in Serum 83081-0​ Borrelia burgdorferi Ab.IgG+​IgM: PrThr: Pt: Ser:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "83081-0": {
    "loincCode": "83081-0",
    "method": "{Method type} Examples: 81097-8​ West Nile virus Kunjin strain Ab: PrThr: Pt: Ser: Ord: LCN: ​West Nile virus Kunjin strain Ab [Presence] in Serum 83081-0​ Borrelia burgdorferi Ab.IgG+​IgM: PrThr: Pt: Ser: Ord: IA LCN: ​Borrelia burgdorferi IgG+​IgM Ab [Presence] in Serum by Immunoassay OBX|1|CE|​83081-0​^Borrelia burgdorferi",
    "context": "[Presence] in Serum 83081-0​ Borrelia burgdorferi Ab.IgG+​IgM: PrThr: Pt: Ser: Ord: IA LCN: ​Borrelia burgdorferi IgG+​IgM Ab [Presence] in Serum by Immunoassay OBX|1|CE|​83081-0​^Borrelia burgdorferi IgG+​IgM Ab [Presence] in Serum by Immunoassay^LN|1|LA6577-6^Negative^LN||... 8.4 Quantitative antibody testing Assays that quantify the amount of antib",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "80618-2": {
    "loincCode": "80618-2",
    "component": "{Name of organism} Ab{.antibody class} Property Acnc Titer Time Aspect {Time value} System {Specimen type} Scale Qn Method {Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Q",
    "property": "Acnc Titer Time Aspect {Time value} System {Specimen type} Scale Qn Method {Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Q",
    "method": "{Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Q",
    "system": "{Specimen type} Scale Qn Method {Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Q",
    "context": "fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Qn: Comp fix LCN: ​Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen OBX|1|NM|​80618-2​^Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay^LN|1|25|U/L|... Guide for Using LOINC Microbiology Terms ​• 66 8.5 Reporting the interpretation",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "24176-0": {
    "loincCode": "24176-0",
    "method": "{Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Qn: Comp fix LCN: ​Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen OBX|1|NM|​80618-2​^Zika virus IgM Ab [Unit",
    "context": "Scale Qn Method {Method type} Examples: 80618-2​ Zika virus Ab.IgM: ACnc: Pt: CSF: Qn: IA LCN: ​Zika virus IgM Ab [Units/​volume] in Cerebral spinal fluid by Immunoassay 24176-0​ Adenovirus Ab^2nd specimen: Titr: Pt: Ser: Qn: Comp fix LCN: ​Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen OBX|1|NM|​80618-2​^Zika virus IgM Ab [Unit",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "23979-8": {
    "loincCode": "23979-8",
    "property": "Imp Time Aspect {Time value} System {Specimen type} Scale Nom Nar Method {Method type} Examples: 23979-8​ Borrelia burgdorferi Ab.IgG band pattern: Imp: Pt: CSF: Nom: IB LCN: ​Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot 73560-",
    "method": "{Method type} Examples: 23979-8​ Borrelia burgdorferi Ab.IgG band pattern: Imp: Pt: CSF: Nom: IB LCN: ​Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot 73560-",
    "system": "{Specimen type} Scale Nom Nar Method {Method type} Examples: 23979-8​ Borrelia burgdorferi Ab.IgG band pattern: Imp: Pt: CSF: Nom: IB LCN: ​Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot 73560-",
    "context": "73560-5​ Mumps virus Ab.IgG & IgM: Imp: Pt: Ser: Nom: LCN: ​Mumps virus IgG and IgM [Interpretation] in Serum Guide for Using LOINC Microbiology Terms ​• 67 OBX|1|CE|​23979-8​^Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot^LN|1|LA15256-3^Non-reactive ^LN||... OBX|1|CE|​73560-5​^Mumps virus IgG and I",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "73560-5": {
    "loincCode": "73560-5",
    "context": "erms ​• 67 OBX|1|CE|​23979-8​^Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot^LN|1|LA15256-3^Non-reactive ^LN||... OBX|1|CE|​73560-5​^Mumps virus IgG and IgM [Interpretation] in Serum^LN|1| LA19556-2^Results suggest prior exposure and immunity to mumps, or a convalescent stage of infection^LN||... Note tha",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "56850-1": {
    "loincCode": "56850-1",
    "context": "rt an interpretation across organism-specific panels. In this case, the meaning of the result is understood in the context of the panel. Examples of these general codes include ​56850-1​ ​Interpretation and review of laboratory results​, 59464-8​ ​Microbiologist review of results​, and ​69048-7​ ​Immunologist review of results​. Guide for Using LOINC Micro",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "59464-8": {
    "loincCode": "59464-8",
    "context": "s case, the meaning of the result is understood in the context of the panel. Examples of these general codes include ​56850-1​ ​Interpretation and review of laboratory results​, 59464-8​ ​Microbiologist review of results​, and ​69048-7​ ​Immunologist review of results​. Guide for Using LOINC Microbiology Terms ​• 68 9 Mapping Qualitative Result Values I",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "69048-7": {
    "loincCode": "69048-7",
    "context": "the context of the panel. Examples of these general codes include ​56850-1​ ​Interpretation and review of laboratory results​, 59464-8​ ​Microbiologist review of results​, and ​69048-7​ ​Immunologist review of results​. Guide for Using LOINC Microbiology Terms ​• 68 9 Mapping Qualitative Result Values In contrast to previous chapters, which describe ho",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "55463-4": {
    "loincCode": "55463-4",
    "context": "n to exist at the time the term was created are all included in the associated LOINC Answer List. As of version 1.1 of this guide, only a single LOINC microbiology term (LOINC: ​55463-4​ ​Influenza virus A swine origin RNA [Identifier] in Unspecified specimen by NAA with probe detection​) is bound to a ​Normative​ list (​LL745-1​), where the result values in th",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "11546-9": {
    "loincCode": "11546-9",
    "system": "has a common name of STAIN for all stains and CULT for all culture results",
    "context": "e local system has a common name of STAIN for all stains and CULT for all culture results, those two tests have to be mapped to the most generic LOINC terms for those concepts: ​11546-9​ Microscopic observation [Identifier] in Unspecified specimen by Other stain and ​11475-1​ Microorganism identified in Unspecified specimen by Culture, respectively. The specifi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "11475-1": {
    "loincCode": "11475-1",
    "context": "those two tests have to be mapped to the most generic LOINC terms for those concepts: ​11546-9​ Microscopic observation [Identifier] in Unspecified specimen by Other stain and ​11475-1​ Microorganism identified in Unspecified specimen by Culture, respectively. The specific LOINC mapping for urine culture, stool culture, Giemsa stain, etc. will take place at th",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "86143-5": {
    "loincCode": "86143-5",
    "property": "LOINC Scale LOINC term examples Presence or absence PrThr Ord 8030-9​ Streptococcus pneumoniae Ab: PrThr:Pt:Ser:Ord Example results​: Present",
    "context": "e LOINC Property LOINC Scale LOINC term examples Presence or absence PrThr Ord 8030-9​ Streptococcus pneumoniae Ab: PrThr:Pt:Ser:Ord Example results​: Present, Absent 86143-5​ Streptococcus pneumoniae Danish serotype 8 Ab:PrThr:Pt:Ser:Ord Example results​: Present, Absent Absence or, if present, the specific type or identity of what is present",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85496-8": {
    "loincCode": "85496-8",
    "context": "coccus pneumoniae Danish serotype 8 Ab:PrThr:Pt:Ser:Ord Example results​: Present, Absent Absence or, if present, the specific type or identity of what is present Prid Nom 85496-8​ Streptococcus pneumoniae serotype:Prid:Pt:XXX:Nom:Probe.amp.tar Example results:​ Absent, S. pneumoniae Danish serotype 19F, S. pneumoniae Danish serotype 3 43389-6​ Strept",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "43389-6": {
    "loincCode": "43389-6",
    "context": "rid Nom 85496-8​ Streptococcus pneumoniae serotype:Prid:Pt:XXX:Nom:Probe.amp.tar Example results:​ Absent, S. pneumoniae Danish serotype 19F, S. pneumoniae Danish serotype 3 43389-6​ Streptococcus sp identified:Prid:Pt:Isolate:Nom:Organism specific culture Example results:​ Absent, Streptococcus pneumoniae Identification of the species or sub-species w",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "86509-7": {
    "loincCode": "86509-7",
    "context": "s known that a microorganism is present Type Nom 72483-1​ BK virus subtype:Type:Pt:Ser/Plas: Nom:Probe.amp.tar Example results​: BK virus subtype I, BK virus subtype II 86509-7​ Varicella zoster virus clad:Type:Pt:XXX: Nom:Molgen Example results:​ Varicella-zoster virus clade 1, Varicella-zoster virus clade 2 Guide for Using LOINC Microbiology Term",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "22606-8": {
    "loincCode": "22606-8",
    "context": "Varicella-zoster virus clade 1, Varicella-zoster virus clade 2 Guide for Using LOINC Microbiology Terms ​• 84 Quantitative ACnc LnCnc MCnc NCnc SCnc ThreshNum Titr Qn 22606-8​ Varicella zoster virus Ab.IgM:Titr:Pt:Ser:Qn Example result​: 1:4 8048-1​ Varicella zoster virus Ab.IgM:ACnc:Pt:Ser:Qn Example result​: 18.2 IU/mL 20447-9​ HIV 1 RNA:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "8048-1": {
    "loincCode": "8048-1",
    "context": "g LOINC Microbiology Terms ​• 84 Quantitative ACnc LnCnc MCnc NCnc SCnc ThreshNum Titr Qn 22606-8​ Varicella zoster virus Ab.IgM:Titr:Pt:Ser:Qn Example result​: 1:4 8048-1​ Varicella zoster virus Ab.IgM:ACnc:Pt:Ser:Qn Example result​: 18.2 IU/mL 20447-9​ HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar Example result:​ 2,000 copies/mL 86701-0​",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "86701-0": {
    "loincCode": "86701-0",
    "units": "of measure will determine the correct LOINC ​Proper",
    "context": "8048-1​ Varicella zoster virus Ab.IgM:ACnc:Pt:Ser:Qn Example result​: 18.2 IU/mL 20447-9​ HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar Example result:​ 2,000 copies/mL 86701-0​ Rotavirus A RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.ta r Example result:​ 26 cycles For quantitative tests, the reporting units of measure will determine the correct LOINC ​Proper",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "600-7": {
    "loincCode": "600-7",
    "context": "sceptible Final 18928-2​ ​Gentamicin [Susceptibility] LA24225-7 Susceptible Final 18868-0​ ​Aztreonam [Susceptibility] LA24225-7 Susceptible Final Blood culture #2 4.1 600-7​ ​Bacteria identified in Blood by Culture LA21123-7 No growth Final Skin lesion HSV culture 4.2.2 5858-6​ ​Herpes simplex virus identified in Skin by Organism specific cu",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "630-4": {
    "loincCode": "630-4",
    "context": "600-7​ ​Bacteria identified in Blood by Culture LA21123-7 No growth Preliminary Urine culture with reflex to Gram stain, identification, and susceptibility testing 4.1 630-4​ ​Bacteria identified in Urine by Culture LA21123-7 No growth Preliminary CSF culture with reflex to Gram stain, identification, and susceptibility testing 4.1 606-4​",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "606-4": {
    "loincCode": "606-4",
    "context": "630-4​ ​Bacteria identified in Urine by Culture LA21123-7 No growth Preliminary CSF culture with reflex to Gram stain, identification, and susceptibility testing 4.1 606-4​ ​Bacteria identified in Cerebral spinal fluid by Culture LA21123-7 No growth Preliminary CSF HSV PCR 7.3 32141-4​ ​Herpes simplex virus 1+​2 DNA [Presence] in Cerebral sp",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "32141-4": {
    "loincCode": "32141-4",
    "method": "LA11883-8 Not detected Final Skin lesion HSV culture 4.2.2 5",
    "context": "m stain, identification, and susceptibility testing 4.1 606-4​ ​Bacteria identified in Cerebral spinal fluid by Culture LA21123-7 No growth Preliminary CSF HSV PCR 7.3 32141-4​ ​Herpes simplex virus 1+​2 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method LA11883-8 Not detected Final Skin lesion HSV culture 4.2.2 5",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "5858-6": {
    "loincCode": "5858-6",
    "method": "LA11883-8 Not detected Final Skin lesion HSV culture 4.2.2 5858-6​ ​Herpes simplex virus identified in Skin by Organism specific culture LA21123-7 No growth Preliminary Time period 2 Lab test Related chapter and section LOINC term(s",
    "context": "2 (ordered when blood culture #1 demonstrated growth) 4.1 600-7​ ​Bacteria identified in Blood by Culture LA21123-7 No growth Preliminary Skin lesion HSV culture 4.2.2 5858-6​ ​Herpes simplex virus identified in Skin by Organism specific culture LA21123-7 No growth Preliminary Beta-lactam resistance testing (ordered when the organism in blood",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "664-3": {
    "loincCode": "664-3",
    "context": "lood culture with reflex to Gram stain, identification, and susceptibility testing 4.1 600-7​ ​Bacteria identified in Blood by Culture Growth detected Preliminary 3.2.1 664-3 ​Microscopic observation [Identifier] in Unspecified specimen by Gram stain Moderate Gram-negative rods Preliminary Guide for Using LOINC Microbiology Terms ​• 92 Urin",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85822-5": {
    "loincCode": "85822-5",
    "context": "Organism specific culture LA21123-7 No growth Preliminary Beta-lactam resistance testing (ordered when the organism in blood culture #1 was identified as E. coli) 5.3.1 85822-5​ ​Beta-lactam resistance AmpC blaCMY+​blaMOX genes [Presence] by NAA with probe detection LA11882-0 Detected Final Guide for Using LOINC Microbiology Terms ​• 93 Exten",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85832-4": {
    "loincCode": "85832-4",
    "context": "for Using LOINC Microbiology Terms ​• 93 Extended-spectru m beta-lactam resistance testing (ordered when the organism in blood culture #1 was identified as E. coli) 5.3.1 85832-4 ​Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by NAA with probe detection LA11883-8 Not detected Final 5.3.1 85844-9​ ​Beta-lactam resistance ESBL blaCTX-M",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85844-9": {
    "loincCode": "85844-9",
    "context": "e #1 was identified as E. coli) 5.3.1 85832-4 ​Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by NAA with probe detection LA11883-8 Not detected Final 5.3.1 85844-9​ ​Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by NAA with probe detection LA11883-8 Not detected Final 5.3.1 85834-0​ ​Beta-lactam resistance ESBL blaCTX-",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85834-0": {
    "loincCode": "85834-0",
    "context": "LA11883-8 Not detected Final 5.3.1 85844-9​ ​Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by NAA with probe detection LA11883-8 Not detected Final 5.3.1 85834-0​ ​Beta-lactam resistance ESBL blaCTX-M-9 Group gene [Presence] by NAA with probe detection LA11883-8 Not detected Final Time period 4 Lab test Related chapter and sect",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18864-9": {
    "loincCode": "18864-9",
    "context": "rm(s) Result(s) (LOINC Answer codes are included where available) Result status Blood culture with reflex to Gram stain, identification, and susceptibility testing 5.1 18864-9​ ​Ampicillin [Susceptibility] LA6676-6 Resistant Final 18862-3 Amoxicillin+​Clavulanate [Susceptibility] LA16550-8 Intermediate Final 18895-3​ ​cefTRIAXone [Susceptibi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18862-3": {
    "loincCode": "18862-3",
    "context": ") Result status Blood culture with reflex to Gram stain, identification, and susceptibility testing 5.1 18864-9​ ​Ampicillin [Susceptibility] LA6676-6 Resistant Final 18862-3 Amoxicillin+​Clavulanate [Susceptibility] LA16550-8 Intermediate Final 18895-3​ ​cefTRIAXone [Susceptibility] LA16550-8 Intermediate Final 18893-8​ ​cefTAZidime [Susce",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18895-3": {
    "loincCode": "18895-3",
    "context": "sceptibility testing 5.1 18864-9​ ​Ampicillin [Susceptibility] LA6676-6 Resistant Final 18862-3 Amoxicillin+​Clavulanate [Susceptibility] LA16550-8 Intermediate Final 18895-3​ ​cefTRIAXone [Susceptibility] LA16550-8 Intermediate Final 18893-8​ ​cefTAZidime [Susceptibility] LA24225-7 Susceptible Final 18928-2​ ​Gentamicin [Susceptibility] LA",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18893-8": {
    "loincCode": "18893-8",
    "context": "-6 Resistant Final 18862-3 Amoxicillin+​Clavulanate [Susceptibility] LA16550-8 Intermediate Final 18895-3​ ​cefTRIAXone [Susceptibility] LA16550-8 Intermediate Final 18893-8​ ​cefTAZidime [Susceptibility] LA24225-7 Susceptible Final 18928-2​ ​Gentamicin [Susceptibility] LA24225-7 Susceptible Final 18868-0​ ​Aztreonam [Susceptibility] LA242",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18928-2": {
    "loincCode": "18928-2",
    "context": "] LA16550-8 Intermediate Final 18895-3​ ​cefTRIAXone [Susceptibility] LA16550-8 Intermediate Final 18893-8​ ​cefTAZidime [Susceptibility] LA24225-7 Susceptible Final 18928-2​ ​Gentamicin [Susceptibility] LA24225-7 Susceptible Final 18868-0​ ​Aztreonam [Susceptibility] LA24225-7 Susceptible Final Blood culture #2 4.1 600-7​ ​Bacteria identifi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18868-0": {
    "loincCode": "18868-0",
    "context": "ty] LA16550-8 Intermediate Final 18893-8​ ​cefTAZidime [Susceptibility] LA24225-7 Susceptible Final 18928-2​ ​Gentamicin [Susceptibility] LA24225-7 Susceptible Final 18868-0​ ​Aztreonam [Susceptibility] LA24225-7 Susceptible Final Blood culture #2 4.1 600-7​ ​Bacteria identified in Blood by Culture LA21123-7 No growth Final Skin lesion HSV",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "14125-9": {
    "loincCode": "14125-9",
    "context": "e Lab test Related chapter and section LOINC term(s) Result(s) (LOINC Answer codes are included where available) Result status Microscopic examination of stool 3.2.2 14125-9​ Entamoeba histolytica [Presence] in Stool by Trichrome stain LA11883-8 Not detected Final 3.1.2 10704-5​ ​Ova and parasites identified in Stool by Light microscopy LA2",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "10704-5": {
    "loincCode": "10704-5",
    "context": "ailable) Result status Microscopic examination of stool 3.2.2 14125-9​ Entamoeba histolytica [Presence] in Stool by Trichrome stain LA11883-8 Not detected Final 3.1.2 10704-5​ ​Ova and parasites identified in Stool by Light microscopy LA21402-5 No ova, cysts, or parasites seen Final Stool culture with reflex to Gram stain, identification, an",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "649-4": {
    "loincCode": "649-4",
    "context": "riod 2) Preliminary 625-4​ ​Bacteria identified in Stool by Culture Clostridioides difficile (time period 3) Final Guide for Using LOINC Microbiology Terms ​• 95 3.2.1 649-4​ Microscopic observation [Identifier] in Stool by Gram stain Moderate Gram-positive rods and polymorphonucl ear leukocytes Final Microorganism antigen testing LOINC con",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "80374-2": {
    "loincCode": "80374-2",
    "context": "table below are the same as their result codes, but the rotavirus, norovirus and adenovirus antigen tests can be ordered using a single order code for the three as one package: ​80374-2​ ​Adenovirus and Norovirus and Rotavirus Ag panel - Stool by Rapid immunoassay​. On the other hand, if only the Rotavirus antigen test is being performed, then that would be ord",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "5880-0": {
    "loincCode": "5880-0",
    "context": "virus and Rotavirus Ag panel - Stool by Rapid immunoassay​. On the other hand, if only the Rotavirus antigen test is being performed, then that would be ordered by itself using ​5880-0​ Rotavirus Ag [Presence] in Stool by Immunoassay​. Lab test Related chapter and section LOINC term(s) Result(s) (LOINC Answer codes are included where available) Resul",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "6363-6": {
    "loincCode": "6363-6",
    "context": "st Related chapter and section LOINC term(s) Result(s) (LOINC Answer codes are included where available) Result status Clostridioides difficile toxin A and B test 6.2 6363-6​ ​Clostridioides difficile toxin A+​B [Units/​volume] in Stool by Immunoassay LA11882-0 Detected Final Escherichia coli shiga-like toxin 1 and 2 test 64013-6​ ​Escherich",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "64013-6": {
    "loincCode": "64013-6",
    "context": "B test 6.2 6363-6​ ​Clostridioides difficile toxin A+​B [Units/​volume] in Stool by Immunoassay LA11882-0 Detected Final Escherichia coli shiga-like toxin 1 and 2 test 64013-6​ ​Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay LA11883-8 Not detected Final Rotavirus, Norovirus and Adenovirus antigen rapid immunoass",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "72174-6": {
    "loincCode": "72174-6",
    "context": "a coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay LA11883-8 Not detected Final Rotavirus, Norovirus and Adenovirus antigen rapid immunoassay profile 72174-6​ ​Rotavirus Ag [Presence] in Stool by Rapid Immunoassay LA11883-8 Not detected Final 80375-9​ ​Norovirus Ag [Presence] in Stool by Rapid immunoassay LA11883-8 Not detect",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "80375-9": {
    "loincCode": "80375-9",
    "context": "inal Rotavirus, Norovirus and Adenovirus antigen rapid immunoassay profile 72174-6​ ​Rotavirus Ag [Presence] in Stool by Rapid Immunoassay LA11883-8 Not detected Final 80375-9​ ​Norovirus Ag [Presence] in Stool by Rapid immunoassay LA11883-8 Not detected Final 78529-5​ ​Adenovirus Ag [Presence] in Stool by Rapid immunoassay LA11883-8 Not detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "78529-5": {
    "loincCode": "78529-5",
    "context": "s Ag [Presence] in Stool by Rapid Immunoassay LA11883-8 Not detected Final 80375-9​ ​Norovirus Ag [Presence] in Stool by Rapid immunoassay LA11883-8 Not detected Final 78529-5​ ​Adenovirus Ag [Presence] in Stool by Rapid immunoassay LA11883-8 Not detected Final Microorganism nucleic acid testing Nucleic-acid based tests are often multiplex assa",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82195-9": {
    "loincCode": "82195-9",
    "system": "and ​Me",
    "context": "ts match the panel in terms of ​System and ​Method​, and none of the elements in the LOINC panel are required, this example stool pathogen panel may be mapped to ​82195-9​, and ​82195-9​ can be used as the order code. However, if the example stool pathogen profile contained 15 elements, 3 of which were not contained in ​82195-9​, or if the ​Method​ for the exam",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82196-7": {
    "loincCode": "82196-7",
    "context": "panel. Lab test Related chapter and section LOINC term(s) Result(s) (LOINC Answer codes are included where available) Result status Stool pathogen profile 7.3 82196-7​ ​Campylobacter coli+​jejuni+​upsaliensis DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82197-5​ ​Clostridioides difficile toxin A+B (",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82197-5": {
    "loincCode": "82197-5",
    "context": "status Stool pathogen profile 7.3 82196-7​ ​Campylobacter coli+​jejuni+​upsaliensis DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82197-5​ ​Clostridioides difficile toxin A+B (tcdA+tscB) genes [Presence] in Stool by NAA with non-probe detection LA11882-0 Detected Final 82199-1​ ​Salmonella enterica+bongori DNA",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82199-1": {
    "loincCode": "82199-1",
    "context": "LA11883-8 Not detected Final 82197-5​ ​Clostridioides difficile toxin A+B (tcdA+tscB) genes [Presence] in Stool by NAA with non-probe detection LA11882-0 Detected Final 82199-1​ ​Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 80349-4​ ​Escherichia coli enteroaggregative pAA plasmid",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "80349-4": {
    "loincCode": "80349-4",
    "context": "non-probe detection LA11882-0 Detected Final 82199-1​ ​Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 80349-4​ ​Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82203-1​ ​Escherichia coli",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82203-1": {
    "loincCode": "82203-1",
    "context": "detected Final 80349-4​ ​Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82203-1​ ​Escherichia coli shiga-like toxin ​1+​2 (stx1+stx2) genes [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final Guide for Using LOINC Microbi",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "80350-2": {
    "loincCode": "80350-2",
    "context": "shiga-like toxin ​1+​2 (stx1+stx2) genes [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final Guide for Using LOINC Microbiology Terms ​• 97 80350-2​ ​Shigella species+EIEC invasion plasmid antigen H (ipaH) gene [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82213-0​ ​Sapovirus genogrou",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82213-0": {
    "loincCode": "82213-0",
    "context": "iology Terms ​• 97 80350-2​ ​Shigella species+EIEC invasion plasmid antigen H (ipaH) gene [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82213-0​ ​Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82207-2​ ​Entamoeba histolytica DNA [Presence] in Stoo",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82207-2": {
    "loincCode": "82207-2",
    "context": "be detection LA11883-8 Not detected Final 82213-0​ ​Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82207-2​ ​Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82208-0​ ​Giardia lamblia DNA [Presence] in Stool by NAA with n",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82208-0": {
    "loincCode": "82208-0",
    "context": "th non-probe detection LA11883-8 Not detected Final 82207-2​ ​Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82208-0​ ​Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82205-6​ ​Cryptosporidium sp DNA [Presence] in Stool by NAA with non-",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "82205-6": {
    "loincCode": "82205-6",
    "context": "NAA with non-probe detection LA11883-8 Not detected Final 82208-0​ ​Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 82205-6​ ​Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection LA11883-8 Not detected Final 11.3 Scenarios 3, 4, and 5 - multiple reporting options describe",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "85037-0": {
    "loincCode": "85037-0",
    "context": "ected. However, if this is a screening test and a positive result will trigger further confirmatory testing, it may not be necessary to report each individual result. Order: ​85037-0​ ​HIV 1 and 2 Ab and HIV 1 p24 Ag panel Option # LOINC term(s) Example results 1 - Report the three individual results 18396-2​ ​HIV 1 p24 Ag [Presence] in Serum or Plasma b",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "18396-2": {
    "loincCode": "18396-2",
    "context": "overall result 56884-1​ ​HIV 1+​2 Ab+​HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 3 - Report the three individual and overall results 18396-2​ ​HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 29893-5​ ​HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 30361",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "30361-0": {
    "loincCode": "30361-0",
    "context": "396-2​ ​HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 29893-5​ ​HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 30361-0​ ​HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 56884-1​ HIV 1+​2 Ab+​HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not dete",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "56884-1": {
    "loincCode": "56884-1",
    "context": "29893-5​ ​HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 30361-0​ ​HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay Detected/Not detected 56884-1​ HIV 1+​2 Ab+​HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay Detected/Not detected Guide for Using LOINC Microbiology Terms ​• 99 11.3.2 Scenario 4 - Single kit",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "41512-5": {
    "loincCode": "41512-5",
    "context": "result is “Detected”, then the second code becomes necessary to report the titer, and the first code is still used to report the initial finding. LOINC term Example results 41512-5​ Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence Detected/Not detected 6569-8​ Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence 1:",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "6569-8": {
    "loincCode": "6569-8",
    "context": "till used to report the initial finding. LOINC term Example results 41512-5​ Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence Detected/Not detected 6569-8​ Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence 1:4, 1:32 11.3.3 Scenario 5 - Immunoblot assay that produces multiple related results that have to be i",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9598-4": {
    "loincCode": "9598-4",
    "context": "ies may choose to report this information in different ways as shown in the following table: Option # LOINC term(s) Example results 1 - Report all of the bands separately 9598-4​ ​Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected 9599-2​ ​Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9599-2": {
    "loincCode": "9599-2",
    "context": "# LOINC term(s) Example results 1 - Report all of the bands separately 9598-4​ ​Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected 9599-2​ ​Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected Guide for Using LOINC Microbiology Terms ​• 100 9587-7​ ​Borrelia burgdorferi 4",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9587-7": {
    "loincCode": "9587-7",
    "context": "Detected/Not detected 9599-2​ ​Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected Guide for Using LOINC Microbiology Terms ​• 100 9587-7​ ​Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected 9588-5​ ​Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9588-5": {
    "loincCode": "9588-5",
    "context": "Detected/Not detected Guide for Using LOINC Microbiology Terms ​• 100 9587-7​ ​Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected 9588-5​ ​Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9589-3​ ​Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9589-3": {
    "loincCode": "9589-3",
    "context": "eri 41kD IgM Ab [Presence] in Serum by Immunoblot Detected/Not detected 9588-5​ ​Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9589-3​ ​Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9590-1​ ​Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9590-1": {
    "loincCode": "9590-1",
    "context": "eri 18kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9589-3​ ​Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9590-1​ ​Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9591-9​ ​Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9591-9": {
    "loincCode": "9591-9",
    "context": "eri 23kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9590-1​ ​Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9591-9​ ​Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9592-7​ ​Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9592-7": {
    "loincCode": "9592-7",
    "context": "eri 28kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9591-9​ ​Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9592-7​ ​Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9593-5​ ​Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9593-5": {
    "loincCode": "9593-5",
    "context": "eri 30kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9592-7​ ​Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9593-5​ ​Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9594-3​ ​Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9594-3": {
    "loincCode": "9594-3",
    "context": "eri 39kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9593-5​ ​Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9594-3​ ​Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9595-0​ ​Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9595-0": {
    "loincCode": "9595-0",
    "context": "eri 41kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9594-3​ ​Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9595-0​ ​Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9596-8​ ​Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9596-8": {
    "loincCode": "9596-8",
    "context": "eri 45kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9595-0​ ​Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9596-8​ ​Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9597-6​ ​Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot Detec",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "9597-6": {
    "loincCode": "9597-6",
    "context": "eri 58kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9596-8​ ​Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 9597-6​ ​Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 2 - Report the band pattern 13503-8​ ​Borrelia burgdorferi Ab.IgM band pattern [",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "13503-8": {
    "loincCode": "13503-8",
    "context": "erum by Immunoblot Detected/Not detected 9597-6​ ​Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot Detected/Not detected 2 - Report the band pattern 13503-8​ ​Borrelia burgdorferi Ab.IgM band pattern [Interpretation] in Serum by Immunoblot IgM to the following two bands detected, supporting a diagnosis of Lyme disease: 39, 41",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "13502-0": {
    "loincCode": "13502-0",
    "context": "​ ​Borrelia burgdorferi Ab.IgM band pattern [Interpretation] in Serum by Immunoblot IgM to the following two bands detected, supporting a diagnosis of Lyme disease: 39, 41 13502-0​ ​Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Serum by Immunoblot IgG to the following seven bands detected, which supports a diagnosis of Lyme disease: 18",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "22-65": {
    "loincCode": "22-65",
    "context": "ram (see below). The three freely available presentations include ​An Introduction to LOINC, LOINC Overview, ​and​ Understanding the Nature of LOINC Names.​ The videos range from 22-65 minutes in duration and are a great way to learn more about LOINC quickly. https://loinc.org/videos/ Through the Premium Membership program, you can gain access to real-time",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "81-90": {
    "loincCode": "81-90",
    "context": "rvation identifier names and codes (LOINC) database: a public use set of codes and names for electronic reporting of clinical laboratory test results. Clin Chem. 1996 Jan; 42(1):81-90. [PMID: ​8565239​] Guide for Using LOINC Microbiology Terms ​• 108 McDonald CJ, Huff SM, Suico JG, Hill G, Leavelle D, Aller R, Forrey A, Mercer K, DeMoor G, Hook J, William",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "624-33": {
    "loincCode": "624-33",
    "context": "rey A, Mercer K, DeMoor G, Hook J, Williams W, Case J, Maloney P. Clin Chem. LOINC, a universal standard for identifying laboratory observations: a 5-year update. 2003 Apr;49(4):624-33. [PMID: ​12651816​] Mapping and Validation Introduction to Mapping There are a variety of slideshows available on the LOINC website, with three focused specifically on mapping",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "62341-3": {
    "loincCode": "62341-3",
    "context": "is an example of a LOINC Borrelia burgdorferi panel showing the order-only panel term and its children: Guide for Using LOINC Microbiology Terms ​• 117 The fact that ​62341-3​ is a panel term is evident by its ​Property​ being a dash (​-​), being in a Class that starts with “PANEL.”, and having a Panel Type value of ​Panel​. In addition, it is designa",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  },
  "718-7": {
    "loincCode": "718-7",
    "context": "the laboratory community, these concepts may be known as “test Guide for Using LOINC Microbiology Terms ​• 119 results” and “test result values,” respectively. For example, ​718-7​ ​Hemoglobin [Mass/volume] in Blood​ is a LOINC term for an observation, and the result of that observation is a quantitative value, such as 14 mg/dL. A different way to think a",
    "sourceFile": "GuideForUsingLoincMicrobiologyTerms1.1.pdf"
  }
}